0001046257-24-000018.txt : 20240509 0001046257-24-000018.hdr.sgml : 20240509 20240509135351 ACCESSION NUMBER: 0001046257-24-000018 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 81 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingredion Inc CENTRAL INDEX KEY: 0001046257 STANDARD INDUSTRIAL CLASSIFICATION: GRAIN MILL PRODUCTS [2040] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 223514823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-13397 FILM NUMBER: 24929780 BUSINESS ADDRESS: STREET 1: 5 WESTBROOK CORPORATE CENTER CITY: WESTCHESTER STATE: IL ZIP: 60154 BUSINESS PHONE: 7085512600 MAIL ADDRESS: STREET 1: INGREDION INCORPORATED STREET 2: 5 WESTBROOK CORPORATE CENTER CITY: WESTCHESTER STATE: IL ZIP: 60154 FORMER COMPANY: FORMER CONFORMED NAME: CORN PRODUCTS INTERNATIONAL INC DATE OF NAME CHANGE: 19970917 10-Q 1 ingr-20240331.htm 10-Q ingr-20240331
00010462572024Q112/31falsehttp://fasb.org/us-gaap/2023#AccountsPayableCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#AccountsPayableCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent612xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesingr:segmentiso4217:KRWiso4217:ARSiso4217:USDutr:buutr:MMBTUxbrli:pureingr:metric00010462572024-01-012024-03-3100010462572024-05-0600010462572023-01-012023-03-3100010462572024-03-3100010462572023-12-310001046257us-gaap:CommonStockMember2023-12-310001046257us-gaap:AdditionalPaidInCapitalMember2023-12-310001046257us-gaap:TreasuryStockCommonMember2023-12-310001046257us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001046257us-gaap:RetainedEarningsMember2023-12-310001046257us-gaap:NoncontrollingInterestMember2023-12-310001046257us-gaap:RetainedEarningsMember2024-01-012024-03-310001046257us-gaap:NoncontrollingInterestMember2024-01-012024-03-310001046257us-gaap:TreasuryStockCommonMember2024-01-012024-03-310001046257us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001046257us-gaap:CommonStockMember2024-03-310001046257us-gaap:AdditionalPaidInCapitalMember2024-03-310001046257us-gaap:TreasuryStockCommonMember2024-03-310001046257us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001046257us-gaap:RetainedEarningsMember2024-03-310001046257us-gaap:NoncontrollingInterestMember2024-03-310001046257us-gaap:CommonStockMember2022-12-310001046257us-gaap:AdditionalPaidInCapitalMember2022-12-310001046257us-gaap:TreasuryStockCommonMember2022-12-310001046257us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001046257us-gaap:RetainedEarningsMember2022-12-310001046257us-gaap:NoncontrollingInterestMember2022-12-3100010462572022-12-310001046257us-gaap:RetainedEarningsMember2023-01-012023-03-310001046257us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001046257us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001046257us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001046257us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001046257us-gaap:CommonStockMember2023-03-310001046257us-gaap:AdditionalPaidInCapitalMember2023-03-310001046257us-gaap:TreasuryStockCommonMember2023-03-310001046257us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001046257us-gaap:RetainedEarningsMember2023-03-310001046257us-gaap:NoncontrollingInterestMember2023-03-3100010462572023-03-310001046257us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberingr:SouthKoreaDivestitureMember2024-02-010001046257us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberingr:SouthKoreaDivestitureMember2024-02-012024-02-010001046257us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberingr:SouthKoreaDivestitureMember2024-01-012024-03-3100010462572024-01-010001046257ingr:TextureAndHealthfulSolutionsSegmentMemberus-gaap:OperatingSegmentsMember2023-12-310001046257ingr:FoodAndIndustrialIngredientsLATAMSegmentMemberus-gaap:OperatingSegmentsMember2023-12-310001046257us-gaap:OperatingSegmentsMemberingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember2023-12-310001046257us-gaap:MaterialReconcilingItemsMember2023-12-310001046257ingr:TextureAndHealthfulSolutionsSegmentMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310001046257ingr:FoodAndIndustrialIngredientsLATAMSegmentMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310001046257us-gaap:OperatingSegmentsMemberingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember2024-01-012024-03-310001046257us-gaap:MaterialReconcilingItemsMember2024-01-012024-03-310001046257ingr:TextureAndHealthfulSolutionsSegmentMemberus-gaap:OperatingSegmentsMember2024-03-310001046257ingr:FoodAndIndustrialIngredientsLATAMSegmentMemberus-gaap:OperatingSegmentsMember2024-03-310001046257us-gaap:OperatingSegmentsMemberingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember2024-03-310001046257us-gaap:MaterialReconcilingItemsMember2024-03-310001046257ingr:ArgentinaJointVentureMember2024-01-012024-03-3100010462572023-12-1200010462572023-12-130001046257ingr:CornCommodityMember2024-03-310001046257ingr:CornCommodityMember2023-12-310001046257ingr:NaturalGasCommodityMember2024-03-310001046257ingr:NaturalGasCommodityMember2023-12-310001046257us-gaap:ShortMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-03-310001046257us-gaap:ShortMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-12-310001046257us-gaap:LongMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-03-310001046257us-gaap:LongMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-12-310001046257us-gaap:ShortMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2024-03-310001046257us-gaap:ShortMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-12-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:LongMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2024-03-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:LongMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2024-03-310001046257us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2023-12-310001046257us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2024-03-310001046257us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-12-310001046257us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMember2024-03-310001046257us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMember2023-12-310001046257us-gaap:CashFlowHedgingMember2024-03-310001046257us-gaap:CashFlowHedgingMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberingr:AccountsReceivableNetMember2024-03-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberingr:AccountsReceivableNetMember2024-03-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberingr:AccountsReceivableNetMember2024-03-310001046257us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberingr:AccountsReceivableNetMember2024-03-310001046257us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberingr:AccountsReceivableNetMember2024-03-310001046257us-gaap:NondesignatedMemberingr:AccountsReceivableNetMember2024-03-310001046257us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2024-03-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2024-03-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2024-03-310001046257us-gaap:CommodityContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:NondesignatedMember2024-03-310001046257us-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-03-310001046257us-gaap:OtherNoncurrentAssetsMemberus-gaap:NondesignatedMember2024-03-310001046257us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-03-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2024-03-310001046257us-gaap:DesignatedAsHedgingInstrumentMember2024-03-310001046257us-gaap:CommodityContractMemberus-gaap:NondesignatedMember2024-03-310001046257us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-03-310001046257us-gaap:NondesignatedMember2024-03-310001046257us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableMember2024-03-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:AccountsPayableMember2024-03-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableMember2024-03-310001046257us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:AccountsPayableMember2024-03-310001046257us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:AccountsPayableMember2024-03-310001046257us-gaap:NondesignatedMemberus-gaap:AccountsPayableMember2024-03-310001046257us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMember2024-03-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2024-03-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMember2024-03-310001046257us-gaap:CommodityContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2024-03-310001046257us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2024-03-310001046257us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2024-03-310001046257us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberingr:AccountsReceivableNetMember2023-12-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberingr:AccountsReceivableNetMember2023-12-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberingr:AccountsReceivableNetMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberingr:AccountsReceivableNetMember2023-12-310001046257us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberingr:AccountsReceivableNetMember2023-12-310001046257us-gaap:NondesignatedMemberingr:AccountsReceivableNetMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2023-12-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-12-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:NondesignatedMember2023-12-310001046257us-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-12-310001046257us-gaap:OtherNoncurrentAssetsMemberus-gaap:NondesignatedMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2023-12-310001046257us-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:NondesignatedMember2023-12-310001046257us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-12-310001046257us-gaap:NondesignatedMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableMember2023-12-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:AccountsPayableMember2023-12-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:AccountsPayableMember2023-12-310001046257us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:AccountsPayableMember2023-12-310001046257us-gaap:NondesignatedMemberus-gaap:AccountsPayableMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMember2023-12-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2023-12-310001046257us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-12-310001046257us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-12-310001046257us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-12-310001046257us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2024-01-012024-03-310001046257us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2023-01-012023-03-310001046257us-gaap:CommodityContractMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2024-01-012024-03-310001046257us-gaap:CommodityContractMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2023-01-012023-03-310001046257us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2024-01-012024-03-310001046257us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-01-012023-03-310001046257us-gaap:CashFlowHedgingMemberingr:NetSalesAndCostOfSalesMemberus-gaap:ForeignExchangeContractMember2024-01-012024-03-310001046257us-gaap:CashFlowHedgingMemberingr:NetSalesAndCostOfSalesMemberus-gaap:ForeignExchangeContractMember2023-01-012023-03-310001046257us-gaap:CashFlowHedgingMember2024-01-012024-03-310001046257us-gaap:CashFlowHedgingMember2023-01-012023-03-310001046257us-gaap:FairValueMeasurementsRecurringMember2024-03-310001046257us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-03-310001046257us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-03-310001046257us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-310001046257us-gaap:FairValueMeasurementsRecurringMember2023-12-310001046257us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-12-310001046257us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001046257us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001046257ingr:SeniorNotes2.2PercentDue1june2030Member2023-12-310001046257ingr:SeniorNotes2.2PercentDue1june2030Member2024-03-310001046257ingr:SeniorNotes3.20PercentDueOctober12026Member2023-12-310001046257ingr:SeniorNotes3.20PercentDueOctober12026Member2024-03-310001046257ingr:SeniorNotes3.9PercentDue1june2050Member2024-03-310001046257ingr:SeniorNotes3.9PercentDue1june2050Member2023-12-310001046257ingr:SeniorNotes6.625PercentDue2037Member2024-03-310001046257ingr:SeniorNotes6.625PercentDue2037Member2023-12-310001046257us-gaap:RevolvingCreditFacilityMember2024-03-310001046257us-gaap:RevolvingCreditFacilityMember2023-12-310001046257ingr:OtherLongTermBorrowingsMember2024-03-310001046257ingr:OtherLongTermBorrowingsMember2023-12-310001046257ingr:CommercialPaperProgramMember2024-03-310001046257ingr:CommercialPaperProgramMember2023-12-310001046257ingr:OtherShortTermBorrowingsMember2024-03-310001046257ingr:OtherShortTermBorrowingsMember2023-12-310001046257ingr:CommercialPaperProgramMember2024-01-012024-03-310001046257ingr:CommercialPaperProgramMember2023-01-012023-03-310001046257ingr:CommercialPaperProgramMember2023-01-012023-12-310001046257country:USus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-03-310001046257country:USus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310001046257us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2024-01-012024-03-310001046257us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2023-01-012023-03-310001046257country:USus-gaap:PensionPlansDefinedBenefitMember2024-03-310001046257us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2024-03-310001046257us-gaap:PostemploymentRetirementBenefitsMember2023-01-012023-03-310001046257us-gaap:PostemploymentRetirementBenefitsMember2024-01-012024-03-310001046257ingr:StockRepurchaseProgram2022Member2022-09-260001046257us-gaap:EmployeeStockOptionMember2024-01-012024-03-310001046257us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001046257ingr:EmployeeMemberus-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310001046257ingr:EmployeeMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001046257ingr:PerformanceSharesAndOtherShareBasedAwardsMember2024-01-012024-03-310001046257ingr:PerformanceSharesAndOtherShareBasedAwardsMember2023-01-012023-03-3100010462572023-01-012023-12-310001046257us-gaap:EmployeeStockOptionMember2024-03-310001046257ingr:EmployeeMemberus-gaap:RestrictedStockUnitsRSUMember2023-12-310001046257ingr:EmployeeMemberus-gaap:RestrictedStockUnitsRSUMember2024-03-310001046257us-gaap:PerformanceSharesMember2024-01-012024-03-310001046257ingr:PerformanceSharesMarketBasedMember2024-01-012024-03-310001046257ingr:PerformanceSharesVestingBasedOnAdjustedROICMember2024-01-012024-03-310001046257ingr:PerformanceSharesMarketBasedMembersrt:MinimumMember2024-01-012024-03-310001046257srt:MaximumMemberingr:PerformanceSharesMarketBasedMember2024-01-012024-03-310001046257ingr:PerformanceSharesVestingBasedOnAdjustedROICMembersrt:MinimumMember2024-01-012024-03-310001046257srt:MaximumMemberingr:PerformanceSharesVestingBasedOnAdjustedROICMember2024-01-012024-03-310001046257us-gaap:PerformanceSharesMember2024-03-310001046257ingr:A2021AwardsMemberus-gaap:PerformanceSharesMember2024-02-012024-02-290001046257ingr:A2022AwardsMemberus-gaap:PerformanceSharesMember2024-01-012024-03-310001046257us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001046257us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310001046257us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001046257us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310001046257us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-03-310001046257us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-310001046257us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310001046257us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-03-310001046257us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310001046257us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001046257us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001046257us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001046257us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310001046257us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310001046257us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310001046257us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310001046257us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310001046257us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310001046257ingr:OperatingSegmentsAndCorporateNonSegmentMember2024-01-012024-03-310001046257ingr:TextureAndHealthfulSolutionsSegmentMemberus-gaap:IntersegmentEliminationMember2024-01-012024-03-310001046257ingr:FoodAndIndustrialIngredientsLATAMSegmentMemberus-gaap:IntersegmentEliminationMember2024-01-012024-03-310001046257us-gaap:IntersegmentEliminationMemberingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember2024-01-012024-03-310001046257ingr:EliminationsAndReconcilingItemsMember2024-01-012024-03-310001046257us-gaap:IntersegmentEliminationMember2024-01-012024-03-310001046257ingr:TextureAndHealthfulSolutionsSegmentMember2024-01-012024-03-310001046257ingr:FoodAndIndustrialIngredientsLATAMSegmentMember2024-01-012024-03-310001046257ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember2024-01-012024-03-310001046257ingr:CorporateReconcilingItemsAndEliminationsMember2024-01-012024-03-310001046257ingr:TextureAndHealthfulSolutionsSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001046257ingr:FoodAndIndustrialIngredientsLATAMSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001046257us-gaap:OperatingSegmentsMemberingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember2023-01-012023-03-310001046257us-gaap:MaterialReconcilingItemsMember2023-01-012023-03-310001046257ingr:OperatingSegmentsAndCorporateNonSegmentMember2023-01-012023-03-310001046257ingr:TextureAndHealthfulSolutionsSegmentMemberus-gaap:IntersegmentEliminationMember2023-01-012023-03-310001046257ingr:FoodAndIndustrialIngredientsLATAMSegmentMemberus-gaap:IntersegmentEliminationMember2023-01-012023-03-310001046257us-gaap:IntersegmentEliminationMemberingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember2023-01-012023-03-310001046257ingr:EliminationsAndReconcilingItemsMember2023-01-012023-03-310001046257us-gaap:IntersegmentEliminationMember2023-01-012023-03-310001046257ingr:TextureAndHealthfulSolutionsSegmentMember2023-01-012023-03-310001046257ingr:FoodAndIndustrialIngredientsLATAMSegmentMember2023-01-012023-03-310001046257ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember2023-01-012023-03-310001046257ingr:CorporateReconcilingItemsAndEliminationsMember2023-01-012023-03-310001046257us-gaap:CorporateNonSegmentMember2024-01-012024-03-310001046257us-gaap:CorporateNonSegmentMember2023-01-012023-03-3100010462572022-10-012022-12-310001046257country:BRus-gaap:ReductionInTaxesMemberus-gaap:ForeignCountryMember2023-12-310001046257country:BRus-gaap:ReductionInTaxesMemberus-gaap:ForeignCountryMember2024-03-310001046257ingr:LarryFernandesMember2024-01-012024-03-310001046257ingr:LarryFernandesMember2024-03-310001046257ingr:RobertRitchieMember2024-01-012024-03-310001046257ingr:RobertRitchieMember2024-03-310001046257ingr:RobertRitchieMember2024-01-012024-03-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2024
or
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from     to
Commission file number 1-13397
Ingredion_Logo_SM_rgbHEX.gif
INGREDION INCORPORATED
(Exact name of registrant as specified in its charter)
Delaware22-3514823
(State or other jurisdiction of incorporation or organization)(I.R.S Employer Identification No.)
5 Westbrook Corporate Center, Westchester, Illinois
60154
(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code (708) 551-2600

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per share
INGR
New York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerxAccelerated filer
o
Non-accelerated filer
o
Smaller reporting company
o
Emerging growth company
o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.
Class
Outstanding at May 6, 2024
Common Stock, $0.01 par value
65,647,485 shares

INGREDION INCORPORATED
FORM 10-Q
TABLE OF CONTENTS
Page No.
2
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Ingredion Incorporated
Condensed Consolidated Statements of Income
(Unaudited)
(dollars and shares in millions, except per share amounts)
Three Months Ended
March 31,
20242023
Net sales$1,882 $2,137 
Cost of sales1,465 1,650 
Gross profit417 487 
Operating expenses189 187 
Other operating expense12 9 
Restructuring/impairment charges3 — 
Operating income213 291 
Financing costs19 32 
Net gain on sale of business(82)— 
Income before income taxes 276 259 
Provision for income taxes58 65 
Net income218 194 
Less: Net income attributable to non-controlling interests2 3 
Net income attributable to Ingredion$216 $191 
Earnings per common share attributable to Ingredion common shareholders:
Weighted average common shares outstanding:
Basic65.766.1
Diluted66.867.1
Earnings per common share of Ingredion:
Basic$3.29 $2.89 
Diluted$3.23 $2.85 
See the Notes to the Condensed Consolidated Financial Statements.
3
Ingredion Incorporated
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
(in millions)
Three Months Ended
March 31,
20242023
Net income$218 $194 
Other comprehensive income:
(Losses) on cash flow hedges, net of income tax effect of $10 and $16
(31)(42)
Losses (gains) on cash flow hedges reclassified to earnings, net of income tax effect of $9 and $4
24 (14)
Losses related to pension and other postretirement obligations reclassified to earnings, net of income tax effect of $0
1 — 
Currency translation adjustment— 6 
Comprehensive income212 144 
Less: Comprehensive income (loss) attributable to non-controlling interests 1 (3)
Comprehensive income attributable to Ingredion$211 $147 
See the Notes to the Condensed Consolidated Financial Statements.
4
Ingredion Incorporated
Condensed Consolidated Balance Sheets
(dollars and shares in millions, except per share amounts)
March 31,
2024		December 31,
2023
(Unaudited)
Assets
Current assets:
Cash and cash equivalents$438 $401 
Short-term investments 7 8 
Accounts receivable, net1,284 1,279 
Inventories1,344 1,450 
Prepaid expenses and assets held for sale52 261 
Total current assets3,125 3,399 
Property, plant and equipment, net of accumulated depreciation of $3,444 and $3,428
2,334 2,370 
Intangible assets, net of accumulated amortization of $305 and $299
1,286 1,303 
Other non-current assets574 570 
Total assets$7,319 $7,642 
Liabilities and stockholders' equity
Current liabilities:
Short-term borrowings $141 $448 
Accounts payable659 778 
Accrued liabilities and liabilities held for sale483 546 
Total current liabilities1,283 1,772 
Long-term debt1,740 1,740 
Other non-current liabilities471 480 
Total liabilities3,494 3,992 
Share-based payments subject to redemption43 55 
Redeemable non-controlling interests42 43 
Ingredion stockholders’ equity:
Preferred stock — authorized 25.0 shares — $0.01 par value, none issued
— — 
   Common stock — authorized 200.0 shares — $0.01 par value, 77.8 shares issued at
      March 31, 2024 and December 31, 2023
1 1 
Additional paid-in capital1,146 1,146 
Less: Treasury stock (common stock: 12.2 and 12.6 shares at March 31, 2024 and
   December 31, 2023) at cost
(1,179)(1,207)
Accumulated other comprehensive loss(1,062)(1,056)
Retained earnings4,818 4,654 
Total Ingredion stockholders’ equity3,724 3,538 
Non-redeemable non-controlling interests16 14 
Total stockholders' equity3,740 3,552 
Total liabilities and stockholders' equity$7,319 $7,642 
See the Notes to the Condensed Consolidated Financial Statements.
5
Ingredion Incorporated
Condensed Consolidated Statements of Equity and Redeemable Equity
(Unaudited)
(in millions)
Total EquityShare-based
Payments
Subject to
Redemption		Redeemable
Non-
Controlling
Interests
Preferred
Stock		Common
Stock		Additional
Paid-In
Capital		Treasury
Stock		Accumulated Other
Comprehensive
Loss		Retained
Earnings		Non-
Redeemable
Non-
Controlling
Interests
Balance, December 31, 2023$— $1 $1,146 $(1,207)$(1,056)$4,654 $14 $55 $43 
Net income attributable to Ingredion— — — — — 216 — — — 
Net income attributable to non-controlling interests— — — — — — 2 — — 
Dividends declared, common stock ($0.78/share)
— — — — — (52)— — — 
Repurchases of common stock, net— — — (1)— — — — — 
Share-based compensation, net of issuance— — — 29 — — — (12)— 
Other comprehensive (loss)— — — — (6)— — — (1)
Balance, March 31, 2024$— $1 $1,146 $(1,179)$(1,062)$4,818 $16 $43 $42 

Total EquityShare-based
Payments
Subject to
Redemption		Redeemable
Non-
Controlling
Interests
Preferred
Stock		Common
Stock		Additional
Paid-In
Capital		Treasury
Stock		Accumulated Other
Comprehensive
Loss		Retained
Earnings		Non-
Redeemable
Non-
Controlling
Interests
Balance, December 31, 2022$— $1 $1,132 $(1,148)$(1,048)$4,210 $16 $48 $51 
Net income attributable to Ingredion— — — — — 191 — — — 
Net income attributable to non-controlling interests— — — — — — 3 — — 
Dividends declared, common stock ($0.71/share)
— — — — — (47)— — — 
Share-based compensation, net of issuance— — 1 21 — — — (10)— 
Other comprehensive (loss)— — — — (50)— (6)— — 
Balance, March 31, 2023$— $1 $1,133 $(1,127)$(1,098)$4,354 $13 $38 $51 
See the Notes to the Condensed Consolidated Financial Statements.
6
Ingredion Incorporated
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(in millions)
Three Months Ended
March 31,
20242023
Cash from operating activities
Net income$218 $194 
Non-cash charges to net income:
Depreciation and amortization53 54 
Mechanical stores expense14 18 
Net gain on sale of business(82)— 
Other non-cash charges32 20 
Changes in working capital:
Accounts receivable and prepaid expenses6 (44)
Inventories104 (87)
Accounts payable and accrued liabilities(135)(171)
Margin accounts(11)(19)
Other 10 (16)
Cash provided by (used for) operating activities209 (51)
Cash from investing activities
Capital expenditures and mechanical stores purchases(65)(76)
Proceeds from disposal of manufacturing facilities and properties— 1 
Proceeds from sale of business247 — 
Other(1)(6)
Cash provided by (used for) investing activities181 (81)
Cash from financing activities
Proceeds from borrowings149 318 
Payments on debt(134)(267)
Commercial paper borrowings, net(312)107 
Repurchases of common stock, net(1)— 
Issuances of common stock for share-based compensation, net2 2 
Dividends paid, including to non-controlling interests(51)(47)
Cash (used for) provided by financing activities(347)113 
Effects of foreign exchange rate changes on cash(6)(1)
Increase (decrease) in cash and cash equivalents37 (20)
Cash and cash equivalents, beginning of period401 236 
Cash and cash equivalents, end of period$438 $216 
See the Notes to the Condensed Consolidated Financial Statements.
7
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)


 1. Basis of Presentation and New Accounting Standards
Unless the context otherwise requires, all references herein to the “Company,” “Ingredion,” “we,” “us,” and “our” shall mean Ingredion Incorporated and its consolidated subsidiaries. These statements should be read in conjunction with the consolidated financial statements and the related notes to those statements contained in Ingredion’s Annual Report on Form 10-K for the year ended December 31, 2023.
The unaudited Condensed Consolidated Financial Statements as of March 31, 2024 and for the first quarter of 2024 and 2023 included herein were prepared by us on the same basis as our audited Consolidated Financial Statements for the year ended December 31, 2023 and reflect all adjustments (consisting solely of normal recurring items unless otherwise noted) that are, in our opinion, necessary for the fair presentation of the Condensed Consolidated Statements of Income, Condensed Consolidated Statements of Comprehensive Income, Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Equity and Redeemable Equity, and Condensed Consolidated Statements of Cash Flows. The results for the interim period are not necessarily indicative of the results expected for the full year or any other future period.
The significant accounting policies and estimates used in preparing these Condensed Consolidated Financial Statements were applied on the same basis consistent with those reflected in Ingredion’s Annual Report on Form 10-K for the year ended December 31, 2023.
In November 2023, we announced a strategic reorganization of our business. As more fully described in Note 10, under our new reportable segments, effective January 1, 2024, there are three reportable segments consisting of - Texture & Healthful Solutions (“T&HS”), Food & Industrial Ingredients - Latin America (“F&II - LATAM”) and Food & Industrial Ingredients - U.S./Canada (“F&II - US/Canada”).
New Accounting Standards
In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The amendments require filers to disclose information about supplier finance programs that is sufficient to allow financial statement users to understand their nature, activity during the period, changes from period to period and potential magnitude. The amendments in this ASU are effective for annual periods beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. We adopted this ASU at the beginning of our 2023 fiscal year and adopted the amendment on rollforward information at the beginning of our 2024 fiscal year. The disclosures required by this ASU are reflected in Note 12.
In August 2023, the FASB issued ASU No. 2023-05, Business Combinations - Joint Venture Formations (Subtopic 805-60). The amendments in this ASU require that a joint venture apply a new basis of accounting upon formation. By applying a new basis of accounting, a joint venture, upon formation, will recognize and initially measure its assets and liabilities at fair value (with exceptions to fair value measurement that are consistent with the business combinations guidance). The amendments in this ASU are effective prospectively for all joint venture formations with a formation date on or after January 1, 2025. A joint venture that was formed before January 1, 2025 may elect to apply the amendments retrospectively. We will adopt this ASU on a prospective basis at the beginning of our 2025 fiscal year and do not believe it will have a material impact on the Condensed Consolidated Financial Statements.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280). The amendments in this ASU improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this ASU are effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Entities must apply the amendments in this ASU retrospectively to all prior periods presented in the financial statements. We are currently assessing the impact of this ASU on the Condensed Consolidated Financial Statements.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments require public business entities on an annual basis to disclose specific categories in the rate
8
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Additionally, the amendment requires information pertaining to taxes paid (net of refunds received) to be disaggregated by federal, state, and foreign taxes with further disaggregation for specific jurisdictions to the extent the related amounts exceed a quantitative threshold. The amendments in this ASU are effective for annual periods beginning after December 15, 2024, with early adoption permitted. We are currently waiting for additional guidance to be issued on the quantitative thresholds before we can assess the impact of this ASU on the Condensed Consolidated Financial Statements.
 2. Divestitures
South Korea Divestiture
On February 1, 2024, we completed the sale of our South Korea business, which we report for segment purposes in All Other, for a total consideration of 384.0 billion South Korean won, or approximately $294 million. We received 330.0 billion South Korea won, or $247 million net of certain transaction costs, when the transaction closed, and we will receive the remaining consideration in equal annual payments through February 2027. As a result, we recognized a pre-tax net gain of $82 million within Net gain on sale of business in the Condensed Consolidated Statements of Income.
 3. Intangible Assets
Goodwill represents the excess of the cost of an acquired entity over the fair value assigned to identifiable assets acquired and liabilities assumed. Ingredion assesses goodwill and indefinite-lived intangible assets for impairment annually (or more frequently if impairment indicators arise). Changes to our reportable segments effective January 1, 2024, as described in Note 10, resulted in a change to our reporting units.
As of this effective date, we performed a qualitative assessment of the goodwill under our former reporting units to determine if it is more likely than not that the reporting unit’s goodwill is impaired. As a result of this analysis, we did not identify any indications that any of the carrying amounts of the reporting units exceeded their respective fair values. Next, we performed a quantitative assessment to reallocate goodwill to our new reporting units using a relative fair value approach. We evaluated these new reporting units for impairment as of January 1, 2024, and determined the fair value was in excess of carrying value for all our reporting units indicating no impairments are present.
The original carrying values of goodwill and accumulated impairment charges by reportable segment and All Other as of March 31, 2024 are presented below. There were no accumulated impairment charges by reportable segment.
T&HSF&II - LATAMF&II - U.S./CanadaAll OtherTotal
Balance as of January 1, 2024$388 $146 $296 $88 $918 
Currency translation(5)(1)— (2)(8)
Balance as of March 31, 2024$383 $145 $296 $86 $910 
 4. Investments

Investments as of March 31, 2024 and December 31, 2023 are as follows:
March 31,
2024		December 31,
2023
Equity investments$29 $27 
Equity method investments98 112 
Marketable securities4 4 
Total investments$131 $143 
Our investments classified as equity investments do not have readily determinable fair values. Beginning on the dates we entered into the agreements for equity method investments, our share of income from these investments is included within Other operating expense in the Condensed Consolidated Statements of Income.
9
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

Argentina Joint Venture
On February 12, 2021, we entered into an agreement with an affiliate of Grupo Arcor, an Argentine food company, to establish Ingrear Holding S.A. (the “Argentina joint venture”), a joint venture to sell value-added ingredients to customers in the food, beverage, pharmaceutical and other industries in Argentina, Chile and Uruguay. Ingredion and Grupo Arcor have completed all closing conditions, pending customary antitrust review, to combine the manufacturing facilities, finalize the transaction and formally establish the Argentina joint venture, which is managed by a jointly appointed team of executives. The Argentina joint venture is accounted for on the equity method of accounting, and we recognize our share of income or expense in Other operating expense one month in arrears due to the timing of when results are available. On December 13, 2023, the new Argentine government allowed the Argentine peso to devalue from the exchange rate of approximately 366 pesos to one U.S. dollar, to 800 pesos to one U.S. dollar. As we recognize our share of earnings one month in arrears, the loss from the change in value of the peso in December 2023 was recorded in Other operating expense during the first quarter of 2024.
 5. Derivative Instruments and Hedging Activities
Commodity price hedging: We had outstanding futures and option contracts that hedged the forecasted purchase of approximately 96 million and 109 million bushels of corn as of March 31, 2024 and December 31, 2023. We also had outstanding swap contracts that hedged the forecasted purchase of approximately 26 million and 28 million mmbtus of natural gas as of March 31, 2024 and December 31, 2023.
Foreign currency hedging: We hedge certain assets using foreign currency derivatives not designated as hedging instruments, which had a notional value of $445 million and $694 million as of March 31, 2024 and December 31, 2023. We also hedge certain liabilities using foreign currency derivatives not designated as hedging instruments, which had a notional value of $171 million and $182 million as of March 31, 2024 and December 31, 2023.
We hedge certain assets using foreign currency cash flow hedging instruments, which had a notional value of $328 million and $449 million as of March 31, 2024 and December 31, 2023. We also hedge certain liability positions using foreign currency cash flow hedging instruments, which had a notional value of $480 million and $621 million as of March 31, 2024 and December 31, 2023.
Interest rate hedging: We periodically enter into T-Locks to hedge our exposure to interest rate changes. We have settled T-Locks associated with the issuance of our senior notes due in 2030 and 2050. The realized loss upon settlement of these T-Locks was recorded in Accumulated other comprehensive loss (“AOCL”) and is amortized into earnings over the term of the senior notes. We did not have outstanding T-Locks as of either March 31, 2024 or December 31, 2023.
The derivative instruments designated as cash flow hedges included in AOCL as of March 31, 2024 and December 31, 2023 are as follows:
(Losses) included in AOCL as of
March 31,
2024		December 31,
2023
Commodity contracts, net of income tax effect of $19 and $17
$(53)$(46)
Foreign currency contracts, net of income tax effect of $2 and $1
— — 
Interest rate contracts, net of income tax effect of $1
(2)(2)
Total$(55)$(48)
As of March 31, 2024, AOCL included $52 million of net losses (net of income taxes of $18 million) on commodities-related derivative instruments, T-Locks and foreign currency hedges designated as cash flow hedges that are expected to be reclassified into earnings during the next 12 months.
10
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

The fair value and balance sheet location of our derivative instruments, presented gross in the Condensed Consolidated Balance Sheets, are as follows:
Fair Value of Hedging Instruments as of March 31, 2024
Designated Hedging InstrumentsNon-Designated Hedging Instruments
Balance Sheet LocationCommodity ContractsForeign Currency ContractsTotalCommodity ContractsForeign Currency ContractsTotal
Accounts receivable, net$8 $10 $18 $1 $6 $7 
Other non-current assets— 4 4 — 1 1 
Assets8 14 22 1 7 8 
Accounts payable58 14 72 3 6 9 
Other non-current liabilities2 — 2 — — — 
Liabilities60 14 74 3 6 9 
Net Assets/(Liabilities)$(52)$— $(52)$(2)$1 $(1)
Fair Value of Hedging Instruments as of December 31, 2023
Designated Hedging InstrumentsNon-Designated Hedging Instruments
Balance Sheet LocationCommodity ContractsForeign Currency ContractsTotalCommodity ContractsForeign Currency ContractsTotal
Accounts receivable, net$6 $11 $17 $— $5 $5 
Other non-current assets—44—— — 
Assets61521—55
Accounts payable44145821214
Other non-current liabilities224—— — 
Liabilities46166221214
Net Assets/(Liabilities)$(40)$(1)$(41)$(2)$(7)$(9)
Additional information relating to our derivative instruments are as follows:
(Losses) Gains
Recognized in AOCL on Derivatives		(Losses) Gains
Reclassified from AOCL into Income
Derivatives in Cash FlowThree Months Ended March 31,Income StatementThree Months Ended March 31,
Hedging Relationships20242023Location20242023
Commodity contracts$(42)$(67)Cost of sales$(33)$9 
Foreign currency contracts1 9 Net sales/Cost of sales— 9 
Total$(41)$(58)$(33)$18 
 6. Fair Value Measurements
We measure certain assets and liabilities at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. In determining fair value, we use various valuation approaches. The hierarchy of those valuation approaches is in three levels based on the reliability of inputs. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Below is a summary of the hierarchy levels:
•Level 1 inputs consist of quoted prices (unadjusted) in active markets for identical assets or liabilities.
•Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 2 inputs are
11
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability or can be derived principally from or corroborated by observable market data.
•Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
Assets and liabilities measured at fair value on a recurring basis are presented below:
As of March 31, 2024As of December 31, 2023
TotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Marketable securities$4 $4 $— $— $4 $4 $— $— 
Derivative assets30 29 1 — 26 26 — — 
Derivative liabilities83 53 30 — 76 43 33 — 
Long-term debt1,575 — 1,575 — 1,591 — 1,591 — 
The carrying values of cash equivalents, short-term investments, accounts receivable, short-term borrowings and accounts payable approximate fair values. Commodity futures, options and swap contracts are recognized at fair value. Foreign currency forward contracts, swaps and options are also recognized at fair value. The fair value of our Long-term debt is estimated based on quotations of major securities dealers who are market makers in the securities.
 7. Financing Arrangements
Presented below are our debt carrying amounts, net of related discounts, premiums and debt issuance costs, as of March 31, 2024 and December 31, 2023:
As of
March 31, 2024		As of
December 31, 2023
2.900% senior notes due June 1, 2030
$596 $596 
3.200% senior notes due October 1, 2026
499 499 
3.900% senior notes due June 1, 2050
391 391 
6.625% senior notes due April 15, 2037
253 253 
Revolving credit agreement— — 
Other long-term borrowings1 1 
Total long-term debt1,740 1,740 
Commercial paper16 327 
Other short-term borrowings125 121 
Total short-term borrowings141 448 
Total debt$1,881 $2,188 
We maintain a commercial paper program under which we may issue senior unsecured notes of short maturities up to a maximum aggregate principal amount of $1.0 billion outstanding at any time. The notes may be sold from time to time on customary terms in the U.S. commercial paper market. We use the note proceeds for general corporate purposes. During the first quarter of 2024, the average amount of commercial paper outstanding was $118 million with an average interest rate of 5.51 percent and a weighted average maturity of 8 days. During the first quarter of 2023, the average amount of commercial paper outstanding was $460 million with an average interest rate of 4.79 percent and a weighted average maturity of 7 days. As of March 31, 2024, $16 million of commercial paper was outstanding with an average interest rate of 5.45 percent and a weighted average maturity of 4 days. As of December 31, 2023, $327 million of commercial paper was outstanding with an average interest rate of 5.50 percent and a weighted average maturity of 11 days. The amount of commercial paper outstanding under this program for the remainder of 2024 is expected to fluctuate.
12
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

Our short-term borrowings as of March 31, 2024 and December 31, 2023 primarily include amounts outstanding under various unsecured local country operating lines of credit.
 8. Pension and Other Postretirement Benefits
Components of net periodic cost consist of the following for the periods presented:
Three Months Ended March 31,
U.S. PlansNon-U.S. Plans
2024202320242023
Service cost$1 $— $1 $1 
Interest cost3 4 2 2 
Expected return on plan assets(4)(4)(2)(2)
Net periodic cost (a)
$— $— $1 $1 
_______________________________________
(a)The service cost component of net periodic cost is presented within either Cost of sales or Operating expenses in the Condensed Consolidated Statements of Income. The remainder of the net periodic cost primarily net.
We anticipate that we will make cash contributions of $1 million and $4 million to our U.S. and non-U.S. pension plans in 2024. For the first quarter of 2024, we made an insignificant cash contribution to the U.S. plans and $1 million to the non-U.S. plans.
During the first quarter of 2024 and 2023, the net periodic benefit cost for the postretirement plans consisted of $1 million of interest costs and no service costs.
 9. Equity
Treasury Stock: On September 26, 2022, the Board of Directors approved a stock repurchase program authorizing us to purchase up to 6.0 million shares of our outstanding common stock until December 31, 2025. We may repurchase shares from time to time in the open market, in privately negotiated transactions, or otherwise, at prices we deem appropriate. We are not obligated to repurchase any shares under the authorization, and the repurchase program may be suspended, discontinued, or modified at any time, for any reason and without notice. The parameters of our stock repurchase program are not established solely with reference to the dilutive impact of shares issued under our stock incentive plan. However, we expect that, over time, share repurchases will offset the dilutive impact of shares issued under the stock incentive plan.

During the first quarter of 2024, we repurchased approximately 5 thousand shares of common stock in open market transactions at a net cost of $1 million. During the first quarter of 2023, we did not repurchase any shares of common stock.
13
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

Share-based Payments: Share-based compensation expense for the periods presented is as follows:
Three Months Ended
March 31,
20242023
Stock options:
Pre-tax compensation expense$2 $1 
Income tax benefit— — 
Stock option expense, net of income taxes2 1 
Restricted stock units (“RSUs”):
Pre-tax compensation expense7 4 
Income tax benefit(1)(1)
RSU expenses, net of income taxes6 3 
Performance shares and other share-based awards:
Pre-tax compensation expense4 4 
Income tax benefit— — 
Performance shares and other share-based compensation expense, net of income taxes4 4 
Total share-based compensation:
Pre-tax compensation expense13 9 
Income tax benefit(1)(1)
Total share-based compensation expense, net of income taxes$12 $8 
Stock Options: Under our stock incentive plan, stock options are granted at exercise prices that equal the market value of the underlying common stock on the date of grant. The options have a 10-year term and are exercisable upon vesting, which occurs over a three-year period at the anniversary dates of the date of grant. We generally recognize compensation expense on a straight-line basis for all awards over the employee’s vesting period. We estimate a forfeiture rate at the time of grant and update the estimate throughout the vesting period of the stock options within the amount of compensation costs recognized in each period.
We granted non-qualified options to purchase 178 thousand shares and 197 thousand shares for the first quarter of 2024 and 2023. We estimated the fair value of each option grant by using the Black-Scholes option-pricing model with the following assumptions:
Three Months Ended March 31,
20242023
Expected life (in years)5.55.5
Risk-free interest rate4.2%4.0%
Expected volatility28.1%28.3%
Expected dividend yield2.9%2.9%
The expected life of options represents the weighted average period that we expect options granted to be outstanding giving consideration to vesting schedules and our historical exercise patterns. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the grant date for the period corresponding to the expected life of the options. Expected volatility is based on historical volatilities of our common stock, and dividend yields are based on our dividend yield at the date of issuance.
14
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

Stock option activity for the first quarter of 2024 is as follows:
Number of Options
(in thousands)		Weighted Average Exercise Price per ShareAverage Remaining Contractual Term (Years)Aggregate Intrinsic Value
(in millions)
Outstanding as of December 31, 20231,953$96.61 4.97$29 
Granted178108.38 
Exercised(165)79.87 
Cancelled(21)103.69 
Outstanding as of March 31, 20241,945$99.03 5.44$38 
Exercisable as of March 31, 20241,573$98.53 4.56$32 
For the first quarter of 2024, cash received from the exercise of stock options was approximately $13 million. As of March 31, 2024, the unrecognized compensation cost related to non-vested stock options totaled $6 million, which we expect to amortize over the weighted-average period of approximately 1.5 years.
Additional information pertaining to stock option activity is as follows:
Three Months Ended
March 31,
20242023
Weighted average grant date fair value of stock options granted (per share)$26.33 $23.80 
Total intrinsic value of stock options exercised5 6 
RSUs: We have granted RSUs to certain key employees. The RSUs are primarily subject to cliff vesting, generally after three years, provided the employee remains in our service. The fair value of the RSUs is determined based upon the number of shares granted and the quoted market price of our common stock at the grant date.
The following table summarizes RSU activity in 2024:
Number of
Restricted
Shares
(in thousands)		Weighted
Average
Fair Value
per Share
Non-vested as of December 31, 2023552$92.05 
Granted191107.65 
Vested(161)87.15 
Cancelled(18)92.77 
Non-vested as of March 31, 2024564$98.84 
As of March 31, 2024, the total remaining unrecognized compensation cost related to RSUs was $32 million, which will be amortized on a weighted-average basis over approximately 2.0 years.
Performance Shares: We have a long-term incentive plan for senior management in the form of performance shares. The vesting of the performance shares is generally based on two performance metrics. Fifty percent of the performance shares awarded vest based on our total shareholder return as compared to the total shareholder return of our peer group, and the remaining fifty percent vest based on the calculation of our three-year average Adjusted Return on Invested Capital (“Adjusted ROIC”) against an established ROIC target.
15
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

For the 2024 performance shares awarded based on our total shareholder return, the number of shares that ultimately vest can range from zero to 200 percent of the grant depending on our total shareholder return as compared to the total shareholder return of our peer group. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the People, Culture, and Compensation Committee (“Compensation Committee”) of the Board of Directors. Compensation expense is based on the fair value of the performance shares at the grant date, established using a Monte Carlo simulation model. We amortize the total compensation expense for these awards over a three-year graded vesting schedule.
For the 2024 performance shares awarded based on Adjusted ROIC, the number of shares that ultimately vest can range from zero to 200 percent of the grant depending on our Adjusted ROIC performance against the target. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the Compensation Committee. We base compensation expense on the market price of our common stock on the grant date and the final number of shares that ultimately vest. We estimate the potential share vesting at least annually to adjust the compensation expense for these awards over the vesting period to reflect our estimated Adjusted ROIC performance against the target. We amortize the total compensation expense for these awards over a three-year graded vesting schedule.
For the first quarter of 2024, we awarded 86 thousand performance shares at a weighted average fair value of $127.97 per share. As of March 31, 2024, the unrecognized compensation cost related to these awards was $20 million, which we will amortize over the remaining service period of 2.4 years. The 2021 performance share awards that vested in February 2024 achieved a 200 percent payout of the granted performance shares. As of March 31, 2024, we estimated the 2022 performance share awards will pay out at 200 percent. For the first quarter of 2024, one thousand performance shares were cancelled.
Accumulated Other Comprehensive Loss: The following is a summary of accumulated other comprehensive (loss) for the first quarter of 2024 and 2023:
Cumulative Translation AdjustmentHedging ActivitiesPension and Postretirement AdjustmentAOCL
Balance as of December 31, 2023$(961)$(48)$(47)$(1,056)
Other comprehensive (loss) before reclassification adjustments — (41)— (41)
Loss reclassified from AOCL— 33 1 34 
Tax benefit— 1 — 1 
Net other comprehensive (loss) income— (7)1 (6)
Balance as of March 31, 2024$(961)$(55)$(46)$(1,062)
Cumulative Translation AdjustmentHedging ActivitiesPension and Postretirement AdjustmentAOCL
Balance as of December 31, 2022$(1,008)$6 $(46)$(1,048)
Other comprehensive gain (loss) before reclassification adjustments6 (58)— (52)
(Gain) reclassified from AOCL— (18)— (18)
Tax benefit— 20 — 20 
Net other comprehensive income (loss)6 (56)— (50)
Balance as of March 31, 2023$(1,002)$(50)$(46)$(1,098)
16
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

Supplemental Information: The following table provides the computation of basic and diluted earnings per common share (“EPS”) for the periods presented.
Three Months Ended March 31, 2024Three Months Ended March 31, 2023
Net Income
Available
to Ingredion		Weighted
Average
Shares		Per
Share
Amount		Net Income
Available
to Ingredion		Weighted
Average
Shares		Per
Share
Amount
Basic EPS$216 65.7$3.29 $191 66.1$2.89 
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards1.11.0
Diluted EPS$216 66.8$3.23 $191 67.1$2.85 
Approximately 0.5 million and 0.7 million share-based awards of common stock were excluded for the first quarter of 2024 and 2023 from the calculation of the weighted average number of shares outstanding for diluted EPS because their effects were anti-dilutive.
 10. Segment Information
Effective January 1, 2024, we changed our reportable segments to align them with changes in how our Chief Executive Officer, as the Chief Operating Decision Maker (“CODM”), manages the business, evaluates performance, and allocates resources. Our revised reportable segments consist of (1) Texture & Healthful Solutions (“T&HS”), (2) F&II - LATAM, and (3) F&II - U.S./Canada. In All Other, we include the business in Pakistan, PureCircle, Sugar Reduction, Protein Fortification, and South Korea until its sale on February 1, 2024.
We are principally engaged in the production and sale of starches and sweeteners for a wide range of industries. Our T&HS segment has a global focus and primarily manufactures texturizing food ingredients. Our F&II - LATAM segment has a local focus and primarily manufactures food, ingredient, and industrial products, which we process from raw materials that we primarily source within South America and Mexico. Our F&II - U.S./Canada segment has a local focus and primarily manufactures food, ingredient, and industrial products, which we process from raw materials sourced within the U.S. and Canada. All Other consists of the businesses of multiple operating segments that are not individually or collectively classified as reportable segments. Revenues from All Other are generated primarily by sweetener and starches sales by our Pakistan business, sales of stevia and other ingredients from our PureCircle and Sugar Reduction businesses, and pea protein ingredients from our Protein Fortification business. Net sales by product are not presented because such presentation is not practicable.
17
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

Presented below are our net sales to affiliated and unaffiliated customers by reportable segment and All Other for the periods presented:
Three months endedT&HSF&II - LATAMF&II - U.S./CanadaAll OtherConsolidated
 Totals
March 31, 2024
Net sales including intersegment sales$612 $626 $567 $131 $1,936 
Less: Intersegment sales
$(15)$(10)$(26)$(3)$(54)
Net sales$597 $616 $541 $128 $1,882 
March 31, 2023
Net sales including intersegment sales$698 $677 $635 $201 $2,211 
Less: Intersegment sales
$(33)$(10)$(27)$(4)$(74)
Net sales$665 $667 $608 $197 $2,137 
Presented below is our operating income by reportable segment and All Other for the periods presented:
Three Months Ended
March 31,
20242023
Operating income (loss):
Texture & Healthful Solutions$74 $127 
Food & Industrial Ingredients - LATAM101 122 
Food & Industrial Ingredients - U.S./Canada87 92 
All Other(4)(8)
Corporate(42)(37)
Subtotal216 296 
Resegmentation costs(3)— 
Other matters— (5)
Total operating income$213 $291 
The CODM evaluates performance, makes strategic decisions, and allocates resources based on Property, plant and equipment, net for internal and external reporting purposes. Presented below is Property, plant and equipment, net by reportable segment and All Other as of March 31, 2024 and December 31, 2023:
As of
March 31, 2024		As of
December 31, 2023
Property, plant and equipment, net:
Texture & Healthful Solutions$838 $855 
Food & Industrial Ingredients - LATAM543 552 
Food & Industrial Ingredients - U.S./Canada542 548 
All Other (a)411 415 
Total Property, plant and equipment, net$2,334 $2,370 
_____________________
(a)For purposes of presentation, All Other includes Corporate assets.
18
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

 11. Commitments and Contingencies
We have filed an action in Brazil to recover previously taxable local government tax incentives. As we believe recovery is probable, we recorded a $27 million income tax benefit in 2022. As of both March 31, 2024 and December 31, 2023, we had $32 million of remaining tax incentives recorded within Other non-current assets in the Condensed Consolidated Balance Sheets.
 12. Supplementary Information
Accounts Receivable, Net
Accounts receivable, net as of March 31, 2024 and December 31, 2023 were as follows:
As of
March 31, 2024		As of
December 31, 2023
Accounts receivable — trade$1,128 $1,145 
Accounts receivable — other173 154 
Allowance for credit losses(17)(20)
Total accounts receivable, net$1,284 $1,279 
There were no significant contract assets or contract liabilities associated with our customers as of either March 31, 2024 or December 31, 2023. Liabilities for volume discounts and incentives were also not significant as of either March 31, 2024 or December 31, 2023.
Inventories
Inventories as of March 31, 2024 and December 31, 2023 were as follows:
As of
March 31, 2024		As of
December 31, 2023
Finished and in process$852 $926 
Raw materials402 434 
Manufacturing supplies90 90 
Total inventories$1,344 $1,450 
Supply Chain Finance Programs
Under supply chain finance programs administered by third-party banks, our suppliers have the opportunity to sell receivables due from us to participating financing institutions and receive earlier payment at a discount. Our responsibility is limited to making payment on the terms originally negotiated with our supplier, regardless of whether such supplier sells its receivables to a financial institution. The payment terms we negotiate with a supplier are independent of whether such supplier participates in a supply chain finance program, and participation in any such program by a supplier has no effect on our income or cash flows.
As of March 31, 2024 and December 31, 2023, participating financial institutions held $149 million and $153 million of our liabilities recorded in Accounts payable and Accrued liabilities and liabilities held for sale on our Condensed
19
Ingredion Incorporated
Notes to Condensed Consolidated Financial Statements
(dollars in millions, except per share data, unless otherwise noted)

Consolidated Balance Sheets. As of March 31, 2024, supply chain finance programs existed for operations in Brazil, China, Thailand, Mexico, Colombia and Peru.
The rollforward of our outstanding obligations confirmed as valid under our supply chain finance programs for the quarter ending March 31, 2024 is as follows.
As of
March 31, 2024
Outstanding at the beginning of the year$153 
Invoices added during the year141
Invoices paid during the year(141)
Currency translation adjustment(4)
Outstanding as of March 31, 2024$149 
20

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Unless otherwise indicated or the context otherwise requires, as used in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” the terms “the Company,” “Ingredion,” “we,” “us,” and “our” and similar terms refer to Ingredion Incorporated and its consolidated subsidiaries. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read in conjunction with the unaudited interim Condensed Consolidated Financial Statements and related notes included elsewhere in this report and with the audited Consolidated Financial Statements and the related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. This discussion contains forward-looking statements that are subject to numerous risks and uncertainties. Actual results may differ materially from those contained in any forward-looking statements. See “Forward-Looking Statements” at the end of this discussion.
Overview
We are a leading global ingredients solutions provider that transforms grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. Our innovative ingredient solutions help customers stay on trend with simple ingredients and other in-demand ingredients. In November 2023, we announced a strategic reorganization of our business. Under the new structure, effective January 1, 2024, we have three reportable business segments that we operate and manage as strategic business units: Texture & Healthful Solutions (“T&HS”), Food & Industrial Ingredients (“F&II”) - Latin America (“LATAM”), and F&II - U.S./Canada. In All Other, we include the business in Pakistan, PureCircle, Sugar Reduction, Protein Fortification, and the South Korea business until its sale on February 1, 2024.
During the quarter ended March 31, 2024, net sales, operating income, net income and diluted earnings per share decreased when compared to the same quarter last year. The decrease in our net sales was driven by price mix and lower volumes, which were partly offset by favorable impacts of foreign exchange rates. Cost of sales decreased primarily due lower input costs and lower volume. These factors led to lower gross profit and lower operating income compared to the first quarter of 2023.
Results of Operations
The following discusses our results for our three reportable segments effective January 1, 2024, consisting of: T&HS, F&II - LATAM and F&II - U.S./Canada. In addition, we discuss the results of All Other. Fluctuations in foreign currency exchange rates affect the U.S. dollar amounts of our foreign subsidiaries’ net sales and expenses. For most of our foreign subsidiaries, the local foreign currency is the functional currency. Accordingly, net sales and expenses denominated in the functional currencies of these subsidiaries are translated into U.S. dollars at the applicable average exchange rates for the period.
Our consolidated financial statements include the results of our business in South Korea prior to the date the sale of the business was completed on February 1, 2024.

For the Three Months Ended March 31, 2024
Compared to Three Months Ended March 31, 2023
Net sales. Net sales decreased 12 percent to $1,882 million for the first quarter of 2024 compared to $2,137 million for the first quarter of 2023. The decrease in net sales was driven by unfavorable price mix, the divestiture of our South Korea business, and lower volumes.
Cost of sales. Cost of sales decreased 11 percent to $1,465 million during the first quarter of 2024 compared to cost of sales of $1,650 million during the first quarter of 2023. The decrease in cost of sales was due primarily to lower volumes, partially offset by carryover of higher cost inventory. Our gross profit margin of 22 percent during the first quarter of 2024 decreased from 23 percent for the first quarter of 2023.
Operating expenses. Operating expenses increased 1 percent to $189 million during the first quarter of 2024 compared to $187 million during the first quarter of 2023. The increase in operating expenses was primarily attributable to increased compensation cost. Operating expenses as a percentage of net sales were 10 percent and 9 percent for the first quarter of 2024 and 2023.
21

Other operating expense. Other operating expense was $12 million during the first quarter of 2024 compared to $9 million during the first quarter of 2023. The change was primarily due to a loss from the December 2023 devaluation of the Argentine peso, which was reflected in our share of earnings from the joint venture in Argentina that we recognize one month in arrears.
Restructuring and impairment charges. Restructuring and impairment charges increased $3 million during the first quarter of 2024 compared to an insignificant amount during the first quarter of 2023, reflecting costs incurred during the first quarter of 2024 in connection with changes to our operating segments.
Financing costs. Financing costs decreased 41 percent to $19 million during the first quarter of 2024 compared to $32 million during the first quarter of 2023. The decrease in financing costs was primarily due to lower average outstanding debt balances during the first quarter of 2024 compared to the first quarter of 2023.
Net gain on sale of business. Net gain on sale of business was $82 million during the first quarter of 2024 to reflect the sale of our South Korea business, which was completed on February 1, 2024. There was no such gain recorded in the first quarter of 2023.
Provision for income taxes. Our effective income tax rates for the first quarter of 2024 and 2023 were 21.0 percent and 25.1 percent. The decrease in the effective tax rate was primarily driven by favorable tax treatment on the sale of our South Korea business during the first quarter of 2024.
Net income attributable to Ingredion. Net income attributable to Ingredion for the first quarter of 2024 increased to $216 million from $191 million for the first quarter of 2023. The increase in net income was primarily due to the gain on the sale of our South Korea business and reduced financing costs.
Segment Results
Texture & Healthful Solutions
Net sales. T&HS net sales decreased 10 percent to $597 million during the first quarter of 2024 from $665 million during the first quarter of 2023. The decrease was primarily driven by an unfavorable price mix of 9 percent and foreign exchange impacts of 1 percent.
Operating income. T&HS operating income decreased 42 percent to $74 million during the first quarter of 2024 from $127 million during the first quarter of 2023. The decrease was primarily driven by unfavorable price mix and the carry-forward of higher cost inventory.
Food & Industrial Ingredients - LATAM
Net sales. F&II- LATAM net sales decreased 8 percent to $616 million in the first quarter of 2024 from $667 million in the first quarter of 2023. The decrease was primarily driven by an unfavorable price mix of 9 percent, and a reduction in volume of 2 percent, which were partially offset by favorable foreign exchange impacts of 3 percent.
Operating income. F&II - LATAM operating income decreased 17 percent to $101 million in the first quarter of 2024 from $122 million in the first quarter of 2023. The decrease was primarily driven by the decrease of Argentine peso, on December 13, 2023, the new Argentine government allowed the Argentine peso to devalue from the exchange rate of approximately 366 pesos to one U.S. dollar to 800 pesos to one U.S. dollar. Because our accounting policy is to recognize our share of income from the Argentina joint venture one month in arrears, our 2024 results reflect the impact of this devaluation. The balance of the change was driven primarily by unfavorable volume.
Food & Industrial Ingredients - U.S./Canada
Net sales. F&II - U.S./Canada net sales decreased 11 percent to $541 million in the first quarter of 2024 from $608 million in the first quarter of 2023. The decrease was driven by unfavorable price mix of 7 percent and a reduction in volume of 4 percent.
22

Operating income. F&II - U.S./Canada operating income decreased 5 percent to $87 million during the first quarter of 2024 from $92 million during the first quarter of 2023. The decrease was primarily driven by downtime due to the impacts of cold weather, partly offset by stronger industrial demand.
All Other
Net sales. All Other net sales decreased 35 percent to $128 million in the first quarter of 2024 from $197 million in the first quarter of 2023. The decrease was primarily driven by lower volumes of 25 percent from the sale of our South Korea business, unfavorable price mix of 6 percent and foreign exchange impacts of 4 percent.
Operating income (loss). All Other operating (loss) decreased 50 percent to $(4) million in the first quarter of 2024 compared to $(8) million in the first quarter of 2023.
Liquidity and Capital Resources
As of March 31, 2024, we had total available liquidity of $2.0 billion. Domestic liquidity of $996 million consisted of $12 million in cash and cash equivalents and $984 million available through a $1.0 billion commercial paper program that had $16 million of outstanding borrowings. The commercial paper program is backed by $1.0 billion of borrowing availability under a five-year revolving credit agreement.
As of March 31, 2024, we had international liquidity of $1.0 billion, consisting of $578 million of unused operating lines of credit, $426 million of cash and cash equivalents, and $7 million of short-term investments. As the parent company, we guarantee certain obligations of our consolidated subsidiaries. These guarantees totaled $41 million as of March 31, 2024. We believe that those consolidated subsidiaries will be able to meet their financial obligations as they become due.
As of March 31, 2024, we had total debt outstanding of $1.9 billion, or $1.7 billion excluding the outstanding commercial paper and other short-term borrowings. Our outstanding debt consists of senior notes that do not require principal repayment until 2026 through 2050. The weighted average interest rate on our total indebtedness was approximately 4.1 percent and 4.3 percent for the first quarter of 2024 and 2023.
The principal source of our liquidity is our internally generated cash flow, which we supplement as necessary with our ability to borrow under our credit facilities and commercial paper program and raise funds in the capital markets. During the first quarter of 2024, we supplemented liquidity from these sources with $247 million of proceeds from our divestiture of our South Korea business. We currently expect that our available cash balances, future cash flow from operations, access to debt markets and borrowing capacity under our revolving credit facility and commercial paper program will provide us with sufficient liquidity to fund our anticipated capital expenditures, dividends and other operating, investing and financing activities for at least the next twelve months and for the foreseeable future thereafter. Our future cash flow needs will depend on many factors, including our rate of revenue growth, cost of raw materials, changing working capital requirements, the timing and extent of our expansion into new markets, the timing of introductions of new products, potential acquisitions of complementary businesses and technologies, continuing market acceptance of our new products and general economic and market conditions. We may need to raise additional capital or incur indebtedness to fund our needs for less predictable strategic initiatives, such as acquisitions.
Net Cash Flows
Our cash provided by operating activities was $209 million during the first quarter of 2024 compared to cash used for operating activities of $51 million during the first quarter of 2023. The increase was primarily due to changes in working capital and current period net income. Cash provided by changes in working capital increased $285 million during the first quarter of 2024 compared to the first quarter of 2023 primarily due to decreases in inventory and trade accounts receivable.
Our cash provided by investing activities was $181 million during the first quarter of 2024 compared to cash used for investing activities of $81 million during the first quarter of 2023. The increase was primarily due to our receipt of $247 million of proceeds from the sale of our South Korea business completed on February 1, 2024. We used $65 million of cash for capital expenditures and mechanical stores purchases to update, expand and improve our facilities during the first quarter of 2024, compared to $76 million that we paid during the first quarter of 2023 for the same purposes. Capital investment commitments for 2024 are anticipated to be approximately $340 million.
23

Our cash used for financing activities was $347 million during the first quarter of 2024 compared to cash provided by financing activities of $113 million during the first quarter of 2023. The decrease was primarily attributable to a net $312 million reduction of our commercial paper borrowings during the first quarter of 2024, as compared to $107 million net borrowings of commercial paper during the first quarter of 2023.
We declare and pay cash dividends to our common stockholders of record on a quarterly basis. Dividends paid, including those to non-controlling interests, was $51 million during the first quarter of 2024 compared to $47 million during the first quarter of 2023. The increase in dividend payments was due to an increase in our quarterly dividend rate to $0.78 per share of common stock during the first quarter of 2024 from $0.71 per share during the first quarter of 2023. On December 12, 2023, our Board of Directors declared a quarterly cash dividend of $0.78 per share of common stock, which was paid on January 23, 2024 to stockholders of record at the close of business on January 2, 2024.
During the first quarter of 2024, we repurchased 5 thousand outstanding shares of common stock in open market transactions at a net cost of $1 million. During the first quarter of 2023, there were zero shares of common stock repurchased.
We have not provided foreign withholding taxes, state income taxes and federal and state taxes on foreign currency gains/losses on accumulated undistributed earnings of certain foreign subsidiaries because these earnings are considered to be permanently reinvested. It is not practicable to determine the amount of the unrecognized deferred tax liability related to the undistributed earnings. We do not anticipate the need to repatriate funds to the U.S. to satisfy domestic liquidity needs arising in the ordinary course of business, including liquidity needs associated with our domestic debt service requirements.
Critical Accounting Policies and Estimates
Our critical accounting policies and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2023. There have been no changes to our critical accounting policies and estimates during the first quarter of 2024.
New Accounting Pronouncements
The information called for by this section is incorporated herein by reference to Note 1 to the Condensed Consolidated Financial Statements included in this report.
Forward-Looking Statements
This Form 10-Q contains or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Ingredion Incorporated intends these forward-looking statements to be covered by the safe harbor provisions for such statements.
Forward-looking statements include, among others, any statements regarding our prospects, future operations, or future financial condition, earnings, net sales, tax rates, capital expenditures, cash flows, expenses or other financial items, including management’s plans or strategies and objectives for any of the foregoing and any assumptions, expectations or beliefs underlying any of the foregoing.
These statements can sometimes be identified by the use of forward-looking words such as “may,” “will,” “should,” “anticipate,” “assume,” “believe,” “plan,” “project,” “estimate,” “expect,” “intend,” “continue,” “pro forma,” “forecast,” “outlook,” “propels,” “opportunities,” “potential,” “provisional,” or other similar expressions or the negative thereof. All statements other than statements of historical facts therein are “forward-looking statements.”
These statements are based on current circumstances or expectations, but are subject to certain inherent risks and uncertainties, many of which are difficult to predict and beyond our control. Although we believe our expectations reflected in these forward-looking statements are based on reasonable assumptions, investors are cautioned that no assurance can be given that our expectations will prove correct.
Actual results and developments may differ materially from the expectations expressed in or implied by these statements, based on various risks and uncertainties, including geopolitical conflicts and actions arising from them, including the impacts on the availability and prices of raw materials and energy supplies, supply chain interruptions, and volatility in foreign exchange and interest rates; changing consumer consumption preferences that may lessen demand for products we make; the effects of global economic conditions and the general political, economic, business, and market conditions that
24

affect customers and consumers in the various geographic regions and countries in which we buy our raw materials or manufacture or sell our products, and the impact these factors may have on our sales volumes, the pricing of our products and our ability to collect our receivables from customers; future purchases of our products by major industries which we serve and from which we derive a significant portion of our sales, including, without limitation, the food, animal nutrition, beverage and brewing industries; the risks associated with pandemics; the uncertainty of acceptance of products developed through genetic modification and biotechnology; our ability to develop or acquire new products and services at rates or of qualities sufficient to gain market acceptance; increased competitive and/or customer pressure in the corn-refining industry and related industries, including with respect to the markets and prices for our primary products and our co-products, particularly corn oil; price fluctuations, supply chain disruptions, and shortages affecting inputs to our production processes and delivery channels, including raw materials, energy costs and availability and cost of freight and logistics; our ability to contain costs, achieve budgets and realize expected synergies, including with respect to our ability to complete planned maintenance and investment projects on time and on budget as well as with respect to freight and shipping costs and hedging activities; operating difficulties at our manufacturing facilities and liabilities relating to product safety and quality; the effects of climate change and legal, regulatory, and market measures to address climate change; our ability to successfully identify and complete acquisitions, divestitures, or strategic alliances on favorable terms as well as our ability to successfully conduct due diligence, integrate acquired businesses or implement and maintain strategic alliances and achieve anticipated synergies with respect to all of the foregoing; economic, political and other risks inherent in conducting operations in foreign countries and in foreign currencies; the failure to maintain satisfactory labor relations; our ability to attract, develop, motivate, and maintain good relationships with our workforce; the impact on our business of natural disasters, war, threats or acts of terrorism, or the occurrence of other significant events beyond our control; the impact of impairment charges on our goodwill or long-lived assets; changes in government policy, law, or regulation and costs of legal compliance, including compliance with environmental regulation; changes in our tax rates or exposure to additional income tax liability; increases in our borrowing costs that could result from increased interest rates; our ability to raise funds at reasonable rates and other factors affecting our access to sufficient funds for future growth and expansion; interruptions, security incidents, or failures with respect to information technology systems, processes, and sites; volatility in the stock market and other factors that could adversely affect our stock price; risks affecting the continuation of our dividend policy; and our ability to maintain effective internal control over financial reporting.
Our forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement as a result of new information or future events or developments. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections. For a further description of these and other risks, see “Risk Factors” and other information included in our Annual Report on Form 10-K for the year ended December 31, 2023 and in our subsequent reports on Form 10-Q and Form 8-K filed with the Securities and Exchange Commission.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
See the discussion set forth in Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K for the year ended December 31, 2023 for a discussion of the manner in which we address risks with respect to interest rates, raw material and energy costs and foreign currencies. There have been no material changes in the information provided with respect to those risks during the first quarter of 2024.
ITEM 4. CONTROLS AND PROCEDURES
Our management, including our Chief Executive Officer and our Chief Financial Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures as of March 31, 2024. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that, as of March 31, 2024, our disclosure controls and procedures (a) are effective in providing reasonable assurance that all information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, has been recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (b) are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.
Except in connection with changes to our reportable segments effective January 1, 2024, there have been no changes in our internal control over financial reporting during the first quarter of 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
25

PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS

There have been no material developments in the environmental proceedings related to our Bedford, Illinois manufacturing facility discussed in Part I, Item 3. Legal Proceedings in our Annual Report for the year ended December 31, 2023.

In addition to the foregoing matter, we are currently subject to claims and suits arising in the ordinary course of business, including those relating to labor matters, certain environmental proceedings, and commercial claims. We also routinely receive inquiries from regulators and other government authorities relating to various aspects of our business, including with respect to compliance with laws and regulations relating to the environment, and at any given time, we have matters at various stages of resolution with the applicable governmental authorities. The outcomes of these matters are not within our complete control and may not be known for prolonged periods of time. We do not believe that the results of currently known legal proceedings and inquires will be material to us. There can be no assurance, however, that such claims, suits, or investigations or those arising in the future, whether taken individually or in the aggregate, will not have a material adverse effect on our financial condition or results of operations.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES
Issuer Purchases of Equity Securities:
The following table presents information regarding our repurchase of shares of our common stock during the first quarter of 2024:
(shares in thousands)Total
Number
of Shares
Purchased		Average
Price
Paid
per Share		Total Number
of Shares
Purchased as
Part of Publicly
Announced Plans or
Programs		Maximum Number
(or Approximate
Dollar Value) of
Shares That May Yet
be Purchased Under
the Plans or Programs at End of Period
January 1 – January 31, 2024—— —5,000
February 1 – February 29, 20245108.00 54,995
March 1 – March 31, 2024—— —4,995
Total5108.00 5
On September 26, 2022, the Board of Directors approved a stock repurchase program permitting us to purchase up to 6.0 million shares of our outstanding common stock until December 31, 2025. As of March 31, 2024, we had 5.0 million shares available for repurchase under the stock repurchase program.

ITEM 5. OTHER INFORMATION

Trading Arrangements

On February 16, 2024, Larry Fernandes, our Senior Vice President, Chief Commercial and Sustainability Officer, terminated an existing written plan that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The original plan was adopted on February 27, 2023 and provided for the sale of up to 9,738 shares of our common stock between May 29, 2023 and January 31, 2025. As of the date of termination, Mr. Fernandes had sold 5,000 shares of common stock pursuant to the terms of the plan.

On February 29, 2024, Robert Ritchie, our Senior Vice President, Food & Industrial Ingredients, LATAM and U.S./Canada, entered into an amended written plan for the sale of up to 4,044 shares of our common stock that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The plan commences on May 30, 2024 and will expire on February 1, 2026, or on any earlier date on which all of the shares have been sold.

26

ITEM 6. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
a) Exhibits
Exhibits required by Item 601 of Regulation S-K are listed in the Exhibit Index below:
EXHIBIT INDEX
Exhibit No.Description
31.1†
31.2†
32.1††
32.2††
101.INS†XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH†Inline XBRL Taxonomy Extension Schema Document.
101.CAL†Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF†Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB†Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE†Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104†Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document, which is contained in Exhibit 101).
_____________________
†
Filed with this report.
††
Furnished with this report.
27

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
INGREDION INCORPORATED
Date: May 9, 2024
By:/s/ James D. Gray
James D. Gray
Executive Vice President and Chief Financial Officer
Date: May 9, 2024
By:/s/ Davida M. Gable
Davida M. Gable
Vice President, Global Controller, and Environmental, Social, and Governance

28
 EX-31.1 2 ingr-20240331xex311.htm EX-31.1 Document

EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
I, James P. Zallie, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Ingredion Incorporated;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 9, 2024
/s/ James P. Zallie
James P. Zallie
President and Chief Executive Officer
1
 EX-31.2 3 ingr-20240331xex312.htm EX-31.2 Document

EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
I, James D. Gray, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Ingredion Incorporated;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 9, 2024
/s/ James D. Gray
James D. Gray
Executive Vice President and Chief Financial Officer
1
 EX-32.1 4 ingr-20240331xex321.htm EX-32.1 Document

EXHIBIT 32.1
Certification Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the
Sarbanes-Oxley Act of 2002
I, James P. Zallie, the Chief Executive Officer of Ingredion Incorporated, certify that to my knowledge (i) the report on Form 10-Q for the quarter ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Ingredion Incorporated.
/s/ James P. Zallie
James P. Zallie
Chief Executive Officer
May 9, 2024
A signed original of this written statement required by Section 906 has been provided to Ingredion Incorporated and will be retained by Ingredion Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.

 EX-32.2 5 ingr-20240331xex322.htm EX-32.2 Document

EXHIBIT 32.2
Certification Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the
Sarbanes-Oxley Act of 2002
I, James D. Gray, the Chief Financial Officer of Ingredion Incorporated, certify that to my knowledge (i) the report on Form 10-Q for the quarter ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Ingredion Incorporated.
/s/ James D. Gray
James D. Gray
Chief Financial Officer
May 9, 2024
A signed original of this written statement required by Section 906 has been provided to Ingredion Incorporated and will be retained by Ingredion Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.

 EX-101.SCH 6 ingr-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed Consolidated Statements of Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Basis of Presentation and New Accounting Standards link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Divestitures link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Derivative Instruments and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Financing Arrangements link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Pension and Other Postretirement Benefits link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Supplementary Information link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Basis of Presentation and New Accounting Standards (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Derivative Instruments and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Financing Arrangements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Pension and Other Postretirement Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Supplementary Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Basis of Presentation and New Accounting Standards (Details) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Divestitures (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Intangible Assets - Schedule of goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Investments - Schedule of investments (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Investments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of cash flow hedges included in AOCI (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet Location (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Derivative Instruments and Hedging Activities - Cash Flow Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Financing Arrangements - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Financing Arrangements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Pension and Other Postretirement Benefits - Components of net periodic benefit cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Equity - Treasury Stock (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Equity - Schedule of stock based compensation expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Equity - Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Equity - Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Equity - Performance Shares (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Equity - AOCL (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Equity - EPS (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Segment Information - Net Sales and Operating Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Segment Information - Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Supplementary Information - Accounts Receivable, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Supplementary Information - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Supplementary Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Supplementary Information - Schedule of Supply Chain Finance Program (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ingr-20240331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 ingr-20240331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 ingr-20240331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Short-term investments Other Short-Term Investments Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Less: Net income attributable to non-controlling interests Net Income (Loss) Attributable to Noncontrolling Interest Issuances of common stock for share-based compensation, net Proceeds From Payments Of Issuance Of Shares Under Incentive And Share Based Compensation Plans, Net Of Settlements Proceeds From Payments Of Issuance Of Shares Under Incentive And Share Based Compensation Plans, Net Of Settlements Pay vs Performance Disclosure [Line Items] Other non-current liabilities Other Noncurrent Liabilities [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Maximum aggregate principal amount Line of Credit Facility, Maximum Borrowing Capacity Changes in working capital: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Remaining requisite service period (in years) Deferred Compensation Arrangement with Individual, Requisite Service Period Term of award Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Treasury stock: Treasury Stock Transactions, Excluding Value of Shares Reissued [Abstract] Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Non-vested at the beginning of the period (in shares) Non-vested at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Financing Arrangements Debt Disclosure [Text Block] Performance shares and other share-based awards Performance shares and other share-based awards Share-based payment arrangement awarded for meeting performance target. Also includes other share based awards including RSUs granted to non-employee directors. Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] F&II - LATAM Food And Industrial Ingredients - LATAM Segment [Member] Food And Industrial Ingredients - LATAM Segment Revolving credit agreement Revolving Credit Facility [Member] Effects of foreign exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Performance shares calculation period Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Performance Shares Calculation Period The length of time used to calculate the final payments for performance shares. MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Performance Shares Performance Shares [Member] Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable Accounts Payable, Current Average Remaining Contractual Term, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Discontinued Operations and Disposal Groups [Abstract] Restatement Determination Date: Restatement Determination Date [Axis] South Korea Divestiture South Korea Divestiture [Member] South Korea Divestiture Insider Trading Policies and Procedures [Line Items] Exercisable at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Resegmentation costs Resegment Costs Resegment Costs Mechanical stores expense Mechanical Stores Expense The aggregate expense recognized in the current period for mechanical stores. Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Tax effect of gains (losses) on cash flow hedges Accumulated Other Comprehensive Income (Loss) Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges Effect Tax Effect Total tax effect of the accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. The change includes an entity's share of an equity investee's increase or decrease in deferred hedging gains or losses. Schedule of Goodwill [Table] Schedule of Goodwill [Table] Geographical [Axis] Geographical [Axis] Supplementary Information Supplementary Information No definition available. Non-U.S. Plans Foreign Plan [Member] Commercial paper Commercial Paper Program [Member] Commercial paper program established in July 2021. Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Current liabilities: Liabilities, Current [Abstract] Accumulated goodwill impairment Goodwill, Impaired, Accumulated Impairment Loss Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock — authorized 25.0 shares — $0.01 par value, none issued Preferred Stock, Value, Issued Intersegment sales Intersegment Eliminations [Member] Proceeds from sale of business Proceeds from Divestiture of Businesses Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Cancelled (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Hedging relationships Derivative Instruments, Gain (Loss) [Line Items] Diluted (in dollars per share) Diluted earnings per common share of Ingredion (in dollars per share) Earnings Per Share, Diluted PEO Total Compensation Amount PEO Total Compensation Amount Total accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Hedging Relationship [Axis] Hedging Relationship [Axis] Losses (gains) on cash flow hedges reclassified to earnings, net of income tax effect of $9 and $4 Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Treasury stock (in shares) Treasury Stock, Common, Shares Outstanding at the beginning of the period (in shares) Outstanding at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Components of net periodic benefit cost Schedule of Net Benefit Costs [Table Text Block] (Losses) Gains Recognized in AOCL on Derivatives Other Comprehensive Income (Loss), before Reclassifications, before Tax Share-based compensation, net of issuance Share Based Compensation During Period Increase (decrease) in equity for aggregate amount of noncash, equity-based remuneration. This may include the value of stock options, amortization of restricted stock, restricted stock units and adjustment for officers' compensation. This also includes the issuance of common shares upon the exercise of options. Redeemable non-controlling interests Redeemable non-controlling interests, beginning balance Redeemable non-controlling interests, ending balance Redeemable Noncontrolling Interest, Equity, Carrying Amount Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average grant date fair value of stock options granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Net income attributable to Ingredion Net Income (Loss) Attributable to Parent Net Income (Loss) Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Liabilities and stockholders' equity Liabilities and Equity [Abstract] Currency translation adjustment Supplier Finance Program, Obligation, Foreign Currency Translation Gain (Loss) Supplier Finance Program, Obligation, Foreign Currency Translation Gain (Loss) Proceeds from borrowings Proceeds from Borrowings The cash inflows from short-term and long-term borrowings. Excludes commercial paper. Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Ingredion stockholders’ equity: Equity, Attributable to Parent [Abstract] Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Schedule of basic and diluted earnings per common share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cost of sales Cost of Goods and Services Sold Service cost Defined Benefit Plan, Service Cost Period of vesting Vesting terms Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Executive Category: Executive Category [Axis] Foreign Currency Contracts Foreign currency contracts Foreign Exchange Contract [Member] Number of Restricted Shares (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Average amount of commercial paper outstanding Commercial Paper, Average Outstanding Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Level 1 Fair Value, Inputs, Level 1 [Member] Name Measure Name Margin accounts Increase (Decrease) in Margin Deposits Outstanding Name Forgone Recovery, Individual Name Other disclosures Other Share Based Awards, under Stock Incentive Plan [Abstract] No definition available. Balance at the beginning of the period Balance at the end of the period Goodwill Equity Components [Axis] Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Hedging Relationship [Domain] Hedging Relationship [Domain] 2021 Awards 2021 Awards [Member] Award granted in 2021. Fair value of derivative instruments, net assets/(liabilities) Derivative Assets (Liabilities), at Fair Value, Net Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Local Phone Number Local Phone Number Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Supplier finance program obligation Outstanding at the beginning of the year Outstanding as of March 31, 2024 Supplier Finance Program, Obligation Derivative notional amount Derivative, Notional Amount Dividends declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Measurement Frequency [Axis] Measurement Frequency [Axis] (Gain) reclassified from AOCL Reclassification from AOCI, Current Period, before Tax, Attributable to Parent Retirement Plan Type [Domain] Retirement Plan Type [Domain] RSUs Restricted Stock Units (RSUs) [Member] Schedule of restricted unit activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Brazilian deferred tax credits Deferred Tax Liabilities, Indirect Tax Credits Amount of deferred tax liability attributable to taxable temporary differences from indirect tax credits. Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Retirement Benefits [Abstract] Retirement Benefits [Abstract] (Losses) Gains Reclassified from AOCL into Income Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Restructuring/impairment charges Restructuring, Settlement and Impairment Provisions Income Statement Location [Axis] Income Statement Location [Axis] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Total share-based compensation expense, net of income taxes Share-Based Payment Arrangement, Expense, after Tax Intangible assets, net of accumulated amortization of $305 and $299 Intangible Assets, Net (Including Goodwill) Schedule of additional information pertaining to stock option activity Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block] 2.900% senior notes due June 1, 2030 2.9% senior notes due June 1, 2030 Represents the 2.9 Percent Senior notes due June 1, 2030. Other long-term borrowings Other long-term borrowings The member represents the other long-term borrowings. Other non-current liabilities Liabilities, Other than Long-Term Debt, Noncurrent Share-based payments subject to redemption Share-based payments subject to redemption, beginning balance Share-based payments subject to redemption, ending balance Temporary Equity, Carrying Amount, Attributable to Parent Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Inventories Increase (Decrease) in Inventories Domestic Plan Domestic Plan [Member] Non-redeemable non-controlling interests Nonredeemable Noncontrolling Interest Cash from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Antidilutive securities excluded from computation of earnings per share amount (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Document Quarterly Report Document Quarterly Report Dividends declared, common stock Dividends, Common Stock Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Supplementary Information Additional Financial Information Disclosure [Text Block] Hedging Designation [Axis] Hedging Designation [Axis] Goodwill [Line Items] Goodwill [Line Items] Average Remaining Contractual Term, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Trading Arrangement: Trading Arrangement [Axis] Cash contributions Defined Benefit Plan, Plan Assets, Contributions by Employer PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Fair value of derivatives Derivatives, Fair Value [Line Items] Futures contract (in bushels for corn) Derivative Nonmonetary Notional Amount Volume1 Nominal volume used to calculate payments on a derivative instrument as of the reporting date. Entity File Number Entity File Number Postemployment Retirement Benefits Postemployment Retirement Benefits [Member] Entity Shell Company Entity Shell Company New Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Award Date [Domain] Award Date [Domain] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization F&II - U.S./Canada Food And Industrial Ingredients - U.S./Canada Segment [Member] Food And Industrial Ingredients - U.S./Canada Segment Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Common stock, issued (in shares) Common Stock, Shares, Issued Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Gross profit Gross Profit Schedule of valuation assumptions for stock options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Less: Treasury stock (common stock: 12.2 and 12.6 shares at March 31, 2024 and December 31, 2023) at cost Treasury Stock, Common, Value Security Exchange Name Security Exchange Name Payments on debt Payments on Debt The cash outflows for short-term and long-term debt obligations. Accumulated other comprehensive loss (Losses) included in AOCL Accumulated Other Comprehensive Income (Loss), Net of Tax Performance shares available for vesting (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Cumulative Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Stock options Employee Stock Option [Member] Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Weighted-average period for amortization of unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Comprehensive income attributable to Ingredion Comprehensive Income (Loss), Net of Tax, Attributable to Parent Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Invoices added during the year Supplier Finance Program, Obligation, Addition Finished and in process Inventory, Finished Goods and Work in Process, Gross Tabular List, Table Tabular List [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Share-based compensation, net of issuance Temporary Equity, Share-Based Compensation, Net of Issuance Increase (decrease) in temporary equity for share-based compensation, net of issuance during the period. Repurchases of common stock, net Repurchases of common stock Treasury Stock, Value, Acquired, Cost Method Accounts receivable, net Accounts Receivable, Net [Member] Accounts receivable, an item in the statement of financial position in which the fair value amounts of the derivative instruments are included. Other short-term borrowings Other Short-term Borrowings [Member] The member represents the other short-term borrowings. Allowance for credit losses Accounts Receivable, Allowance for Credit Loss, Current Accrued liabilities and liabilities held for sale Other Liabilities, Current Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Income Statement [Abstract] Income Statement [Abstract] Cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title of 12(b) Security Title of 12(b) Security Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Fair value of derivative instruments, liabilities Derivative liabilities Derivative Liability Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Operating segments Operating Segments [Member] Non-vested at the beginning of the period (in dollars per share) Non-vested at the end of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Accounts receivable — trade Accounts Receivable, Trade, Current Amount of trade receivables, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Diluted EPS: Earnings Per Share, Diluted [Abstract] Schedule of accounts receivable, net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Entity Tax Identification Number Entity Tax Identification Number Currency translation Goodwill, Foreign Currency Translation Gain (Loss) Equity method investments Equity Method Investments Total debt Debt, Long-Term and Short-Term, Combined Amount Inventories Total inventories Inventory, Net Statistical Measurement [Axis] Statistical Measurement [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Divestitures Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Entity Interactive Data Current Entity Interactive Data Current Financing costs Financing Costs, Net The net amount of expense (income) derived from financing activities, including: the aggregate cost of borrowed funds accounted for as interest that was charged against earnings during the period; the noncash expenses charged against earnings in the period to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments; income derived from investments in cash and cash equivalents; and foreign currency transaction gains and losses. Non-cash charges to net income: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Segments [Domain] Segments [Domain] Share-based compensation Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Retained earnings Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Long-term debt Long-term Debt, Fair Value, Noncurrent The fair value amount of long-term debt, classified as noncurrent, whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. Repurchases of common stock, net Proceeds from (Repurchase of) Equity Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Equity Method Investment, Nonconsolidated Investee [Domain] Equity Method Investment, Nonconsolidated Investee [Domain] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Short Short [Member] Cash from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Loss expected to be reclassified into earnings during the next twelve months, income tax effect Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months, Tax Represents the estimated amount of income tax effect on existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months. Schedule of stock based compensation expense Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of supplier chain finance program Supplier Finance Program [Table Text Block] Disposal Group Name [Domain] Disposal Group Name [Domain] Basic EPS Earnings Per Share, Basic [Abstract] Interest cost Defined Benefit Plan, Interest Cost PEO PEO [Member] Benefit plans Defined Benefit Plan Disclosure [Line Items] Pension and Other Postretirement Benefits Retirement Benefits [Text Block] Accounts receivable and prepaid expenses Increase (Decrease) in Accounts Receivable and Prepaid Expense The net change during the reporting period in the total amount due within one year (or one business cycle) from all parties associated with underlying transactions that are classified as operating activities, plus the net change during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. Award pay out achieved (as a percent) Performance Share Units Award Achieved As Percent Represents the vesting percentage achieved. Other Other Operating Activities, Cash Flow Statement Summary of accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss) [Line Items] Increase (Decrease) in Temporary Equity Increase (Decrease) in Temporary Equity [Roll Forward] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Cash provided by (used for) investing activities Net Cash Provided by (Used in) Investing Activities Net Income Available to Ingredion Net Income (Loss) Available to Common Stockholders, Basic Schedule of inventories Schedule of Inventory, Current [Table Text Block] Stock options, Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt Instrument [Axis] Debt Instrument [Axis] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Total liabilities Liabilities Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Divestiture, consideration Disposal Group, Including Discontinued Operation, Consideration Equity Shareholders' Equity and Share-Based Payments [Text Block] Commercial paper borrowings, net Proceeds from (Repayments of) Commercial Paper Accumulated Other Comprehensive Loss AOCL AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount BRAZIL BRAZIL Measurement Frequency [Domain] Measurement Frequency [Domain] All Executive Categories All Executive Categories [Member] Robert Ritchie [Member] Robert Ritchie Title of Individual [Axis] Title of Individual [Axis] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Accounts payable Accounts Payable [Member] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Pension and Postretirement Adjustment Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Income tax benefit Share-Based Payment Arrangement, Expense, Tax Benefit Disposed of by Sale Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Number of reportable segments Number of Reportable Segments Earnings per common share of Ingredion: Earnings per share Earnings Per Share [Abstract] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Common stock — authorized 200.0 shares — $0.01 par value, 77.8 shares issued at March 31, 2024 and December 31, 2023 Common Stock, Value, Issued Tax benefit Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Antidilutive securities excluded in calculation of diluted EPS: Earnings Per Share, Diluted, Other Disclosure [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Gain Contingencies, Nature [Axis] Gain Contingencies, Nature [Axis] Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Losses on pension and other postretirement obligations reclassified to earnings, income tax effect Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total current assets Assets, Current Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Net periodic cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) All Individuals All Individuals [Member] Operating income, subtotal Operating Income Loss Before Other Charges The net result for the period of deducting operating expenses from operating revenues excluding specified charges. Entity Filer Category Entity Filer Category Equity Method Investments Schedule of Equity Method Investments [Line Items] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Schedule of cash flow hedges included in AOCI Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Income Tax Authority [Axis] Income Tax Authority [Axis] PEO Name PEO Name Summary of net changes in accumulated other comprehensive loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized Quarterly Financial Information Disclosure [Abstract] Total investments Investments Granted (in dollars per share) Weighted-average fair value per share, granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Foreign currency exchange rate Foreign Currency Exchange Rate, Translation Schedule of goodwill Schedule of Goodwill [Table Text Block] Natural Gas Commodity Natural Gas Commodity [Member] Represents the commodity futures contract of the entity having the underlying commodity as natural. Schedule of investments Investment [Table Text Block] Cash provided by (used for) operating activities Net Cash Provided by (Used in) Operating Activities Aggregate Intrinsic Value, Exercisable (in dollars) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Corn Commodity Corn Commodity [Member] Represents the commodity futures contract of the entity having the underlying commodity as corn. Corporate Corporate, Non-Segment [Member] Depreciation and amortization Depreciation, Depletion and Amortization Accounts receivable — other Accounts Receivable, Other, Current Amount of other receivables, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Other operating expense Other Operating Income (Expense), Net Debt, interest rate Debt Instrument, Interest Rate, Stated Percentage Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Net gain on sale of business Net gain on sale of business Gain (Loss) on Disposition of Business Total Ingredion stockholders’ equity Equity, Attributable to Parent Consolidation Items [Axis] Consolidation Items [Axis] Operating segments and all other Operating Segments And Corporate Non Segment [Member] Operating Segments And Corporate Non Segment Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Invoices paid during the year Supplier Finance Program, Obligation, Settlement Currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Larry Fernandes [Member] Larry Fernandes Hedging Activities Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Expected life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Equity investments Equity Securities without Readily Determinable Fair Value, Amount Not Designated as Hedging Instrument Non-Designated Hedging Instruments Not Designated as Hedging Instrument [Member] Earnings per common share attributable to Ingredion common shareholders: Earnings Per Share Reconciliation [Abstract] Other comprehensive (loss) before reclassification adjustments OCI, before Reclassifications, before Tax, Attributable to Parent Preferred stock, issued (in shares) Preferred Stock, Shares Issued Hedging Designation [Domain] Hedging Designation [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Net sales/Cost of sales Net sales/Cost of sales Primary financial statement caption encompassing net sales and cost of sales. Assumptions used to measure the fair value of awards Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Manufacturing supplies Other Inventory, Supplies, Gross Other non-current assets Other Noncurrent Assets [Member] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Schedule of amount of gains and losses recognized in OCI and income statement location Derivative Instruments, Gain (Loss) [Table Text Block] Increase (Decrease) in Stockholders' Equity Accumulated Other Comprehensive Loss Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Title Trading Arrangement, Individual Title Outstanding at the beginning of the period (in dollars per share) Outstanding at the end of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Position [Domain] Position [Domain] Common Stock Common Stock [Member] Foreign Tax Authority Foreign Tax Authority [Member] Performance shares, vesting based on TSR Performance shares, vesting based on TSR Represents a stock-based award with vesting based on achievement of external market based performance targets (e.g. total shareholder return as compared to the total shareholder return of its peer group). Options granted (in shares) Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code 2022 Stock Repurchase Program Stock Repurchase Program 2022 [Member] Stock Repurchase Program 2022 Income Statement Location [Domain] Income Statement Location [Domain] Investments, All Other Investments [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Weighted Average Fair Value per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Total stockholders' equity Balance at beginning of period Balance at end of period Equity, Including Portion Attributable to Noncontrolling Interest Investments [Abstract] Investments [Abstract] (Losses) gains on cash flow hedges, income tax effect Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax Minimum Minimum [Member] Property, plant and equipment, net of accumulated depreciation of $3,444 and $3,428 Total Property, plant and equipment, net Property, Plant and Equipment, Net Weighted average common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Gain Contingencies [Table] Gain Contingencies [Table] Share Repurchase Program [Domain] Share Repurchase Program [Domain] 3.200% senior notes due October 1, 2026 3.2% senior notes due October 1, 2026 Represents the 3.20 Percent Senior notes issued on September 22,2016. Schedule of stock option transactions Share-Based Payment Arrangement, Option, Activity [Table Text Block] Accounts receivable, net Receivables, Net, Current Exercise Price Award Exercise Price Other comprehensive (loss) Other Comprehensive Income (Loss), Net of Tax Loss expected to be reclassified into earnings during the next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Disposal Group Classification [Axis] Disposal Group Classification [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Equity Equity, Class of Treasury Stock [Line Items] Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Commodity contracts Commodity Contracts Commodity Contract [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Schedule of fair value and balance sheet location of derivative instruments Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Net income Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Cash (used for) provided by financing activities Net Cash Provided by (Used in) Financing Activities Retirement Plan Type [Axis] Retirement Plan Type [Axis] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Other Payments for (Proceeds from) Other Investing Activities Retained Earnings Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and stockholders' equity Liabilities and Equity Other non-current assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Basic (in dollars per share) Basic earnings per common share of Ingredion (in dollars per share) Earnings Per Share, Basic Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Class of Treasury Stock [Table] Class of Treasury Stock [Table] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Supplier Finance Program, Obligation [Roll Forward] Supplier Finance Program, Obligation [Roll Forward] Total intrinsic value of stock options exercised (in dollars) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Net Income Available to Ingredion Net Income (Loss) Available to Common Stockholders, Diluted Arrangement Duration Trading Arrangement Duration T&HS Texture & Healthful Solutions Texture And Healthful Solutions Segment [Member] Represents information pertaining to Asia Pacific segment. Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Schedule of segment reporting of net sales, operating income and total assets Schedule of Segment Reporting Information, by Segment [Table Text Block] Share-based compensation expense Share-Based Payment Arrangement, Additional Disclosure [Abstract] Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Weighted average interest rate Short-Term Debt, Weighted Average Interest Rate, over Time Weighted average maturity of outstanding balance Short Term Debt Weighted Average Maturity, Point In Time Weighted average maturity of outstanding balance of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Termination Date Trading Arrangement Termination Date Common stock, authorized (in shares) Common Stock, Shares Authorized Losses (gains) on cash flow hedges reclassified to earnings, income tax effect Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax Marketable securities Debt Securities, Available-for-Sale Tax benefit related to the exclusion of certain tax incentives Effective Income Tax Rate Reconciliation, Tax Expense (Benefit) Related to Non-Taxable Brazil ICMS Incentives Effective Income Tax Rate Reconciliation, Non-Taxable Brazil ICMS Incentives, Amount Short-term borrowings Short-Term Debt Fair value of assets and liabilities Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Derivative Instrument [Axis] Derivative Instrument [Axis] All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Award Timing Disclosures [Line Items] Title of Individual [Domain] Title of Individual [Domain] Investments Investment [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Equity Method Investment, Nonconsolidated Investee [Axis] Equity Method Investment, Nonconsolidated Investee [Axis] Less: Comprehensive income (loss) attributable to non-controlling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Performance shares, vesting based on Adjusted ROIC Performance Shares, Vesting Based on Adjusted ROIC [Member] Represents a stock-based award with vesting based on achievement of internal performance based targets (e.g. three-year average Adjusted Return on Invested Capital ("Adjusted ROIC") against an established Adjusted ROIC target). Operating expenses Operating Expenses Excluding Restructuring Charges Represent the amount of operating expenses excluding restructuring charges. Net income Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Fair value of derivative instruments, assets Derivative assets Derivative Asset Cancelled (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Cash received from exercise of stock options Proceeds from Stock Options Exercised Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Short-term borrowings Total short-term borrowings Debt, Current Prepaid expenses and assets held for sale Prepaid Expense and Other Assets, Current Cancelled (in shares) Cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Other comprehensive (loss) Temporary Equity, Other Comprehensive Income The portion of other comprehensive income or loss attributable to temporary equity interest. Insider Trading Arrangements [Line Items] Other matters Operating Income (Expense), Other Matters, Net The net amount of other matters included in operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. Cash contribution expected during fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year Argentina joint venture Argentina joint venture [Member] Joint venture between Grupo Arcor and Ingredion ("Arcor" joint venture). Number of tranches Share-based Compensation Arrangement by Share-based Payment Award, Number of Tranches Number of tranches in share-based compensation award. Aggregate Intrinsic Value, Outstanding (in dollars) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Commitments and Contingencies Gain Contingencies [Line Items] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Adjustment to Compensation, Amount Adjustment to Compensation Amount Proceeds from disposal of manufacturing facilities and properties Proceeds from Sale of Property, Plant, and Equipment Cost of sales Cost of Sales [Member] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Adoption Date Trading Arrangement Adoption Date Property, plant and equipment, accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Disposal Group Name [Axis] Disposal Group Name [Axis] Schedule of assets and liabilities measured at fair value on a recurring basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Exercisable at the end of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Treasury Stock Treasury Stock, Common [Member] Entity Central Index Key Entity Central Index Key Segment information Segment Reporting Information [Line Items] Basis of Presentation and New Accounting Standards Basis of Presentation and Significant Accounting Policies [Text Block] Pre-tax compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Provision for income taxes Income Tax Expense (Benefit) Designated as Hedging Instrument Designated Hedging Instruments Designated as Hedging Instrument [Member] Income Tax Authority [Domain] Income Tax Authority [Domain] Other non-cash charges Other Non Cash Charges Credits To Net Income Total other non-cash charges (credits) included in net income that results in no cash inflows or outflows in the period. Number of operating segments Number of Operating Segments Name Trading Arrangement, Individual Name Net other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Award Date [Axis] Award Date [Axis] Net sales Revenue from Contract with Customer, Excluding Assessed Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Amendment Flag Amendment Flag Estimated pay out (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Estimated Pay Out Percentage (as a percent) Estimated pay out percentage of share-based compensation award as of balance sheet date. Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Employee Employee Employee of entity. Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Purchase/acquisition of treasury stock (in shares) Treasury Stock, Shares, Acquired 2022 Awards 2022 Awards [Member] 2022 Awards Basis spread Debt Instrument, Basis Spread on Variable Rate Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Long-term debt Total long-term debt Long-Term Debt, Excluding Current Maturities Reduction in Taxes Reduction in Taxes [Member] Diluted (in shares) Weighted average number of shares outstanding - diluted, Total Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Intersegment sales, all other Eliminations And Reconciling Items [Member] Eliminations And Reconciling Items Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Interest rate contracts Interest Rate Contract [Member] Capital expenditures and mechanical stores purchases Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid-In Capital Additional Paid-in Capital [Member] (Losses) on cash flow hedges, net of income tax effect of $10 and $16 Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Gain Contingency, Nature [Domain] Gain Contingency, Nature [Domain] Effect of Dilutive Securities: Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract] 3.900% senior notes due June 1, 2050 3.9% senior notes due June 1, 2050 Represents the 3.9 Percent Senior notes due June 1, 2050. Balance Sheet Location [Axis] Balance Sheet Location [Axis] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Share Repurchase Program [Axis] Share Repurchase Program [Axis] Cover [Abstract] Cover [Abstract] Position [Axis] Position [Axis] U.S. Plans UNITED STATES Fair Value, Recurring Fair Value, Recurring [Member] Natural gas swap contract (in mmbtu of natural gas) Derivative Nonmonetary Notional Amount Energy Measure1 Nominal energy measure used to calculate payments on a derivative instrument as reporting date. All Other Segment Reconciling Items [Member] Fair Value Measurements Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block] Dividends paid, including to non-controlling interests Payments of Dividends Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Raw materials Inventory, Raw Materials and Supplies, Gross Weighted average maturity Short Term Debt Weighted Average Maturity Weighted average maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Pension Plan Pension Plan [Member] Cash flow hedging Cash Flow Hedging [Member] Segment Information Segment Reporting Disclosure [Text Block] Increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Non-PEO NEO Non-PEO NEO [Member] Marketable securities Marketable Securities Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] 6.625% senior notes due April 15, 2037 Senior Notes 6.625 Percent Due 2037 [Member] Represents the senior note due on April 15, 2037. Joint venture, period in arrears Income (Loss) From Equity Method Investment, Period In Arrears Income (Loss) From Equity Method Investment, Period In Arrears Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Financing Arrangements Long-term debt Debt Instrument [Line Items] Basic (in shares) Weighted average number of shares outstanding, basic Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Operating income Operating Income (Loss) All other, excluding intersegment sales Corporate Reconciling Items And Eliminations [Member] Segment Reporting, Reconciling Item And Eliminations Percentage of share-based compensation award Share Based Compensation Arrangement By Share Based Payment Award, Percentage of Award Percentage of share-based compensation award. Long Long [Member] Additional information pertaining to stock options Share Based Compensation Arrangement by Share Based Payment Award, Stock Options, Additional Disclosures [Abstract] No definition available. Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Segments [Axis] Segments [Axis] Statement [Line Items] Statement [Line Items] Other comprehensive income: Other Comprehensive Income (Loss), Net of Tax [Abstract] Losses related to pension and other postretirement obligations reclassified to earnings, net of income tax effect of $0 Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax Stock options, Weighted Average Exercise Price per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Schedule of debt Schedule of Debt [Table Text Block] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Stock repurchase program, number of shares authorized Stock Repurchase Program, Number of Shares Authorized to be Repurchased Non- Redeemable Non- Controlling Interests Noncontrolling Interest [Member] EX-101.PRE 10 ingr-20240331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 ingr-20240331_g1.gif begin 644 ingr-20240331_g1.gif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end XML 13 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover - shares
 3 Months Ended
Mar. 31, 2024
May 06, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 1-13397  
Entity Registrant Name INGREDION INCORPORATED  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 22-3514823  
Entity Address, Address Line One 5 Westbrook Corporate Center  
Entity Address, City or Town Westchester  
Entity Address, State or Province IL  
Entity Address, Postal Zip Code 60154  
City Area Code 708  
Local Phone Number 551-2600  
Title of 12(b) Security Common Stock  
Trading Symbol INGR  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   65,647,485
Entity Central Index Key 0001046257  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net sales $ 1,882 $ 2,137
Cost of sales 1,465 1,650
Gross profit 417 487
Operating expenses 189 187
Other operating expense 12 9
Restructuring/impairment charges 3 0
Operating income 213 291
Financing costs 19 32
Net gain on sale of business (82) 0
Income before income taxes 276 259
Provision for income taxes 58 65
Net income 218 194
Less: Net income attributable to non-controlling interests 2 3
Net income attributable to Ingredion $ 216 $ 191
Weighted average common shares outstanding:    
Basic (in shares) 65.7 66.1
Diluted (in shares) 66.8 67.1
Earnings per common share of Ingredion:    
Basic (in dollars per share) $ 3.29 $ 2.89
Diluted (in dollars per share) $ 3.23 $ 2.85
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net income $ 218 $ 194
Other comprehensive income:    
(Losses) on cash flow hedges, net of income tax effect of $10 and $16 (31) (42)
Losses (gains) on cash flow hedges reclassified to earnings, net of income tax effect of $9 and $4 24 (14)
Losses related to pension and other postretirement obligations reclassified to earnings, net of income tax effect of $0 1 0
Currency translation adjustment 0 6
Comprehensive income 212 144
Less: Comprehensive income (loss) attributable to non-controlling interests 1 (3)
Comprehensive income attributable to Ingredion $ 211 $ 147
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
(Losses) gains on cash flow hedges, income tax effect $ 10 $ 16
Losses (gains) on cash flow hedges reclassified to earnings, income tax effect 9 4
Losses on pension and other postretirement obligations reclassified to earnings, income tax effect $ 0 $ 0
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 438 $ 401
Short-term investments 7 8
Accounts receivable, net 1,284 1,279
Inventories 1,344 1,450
Prepaid expenses and assets held for sale 52 261
Total current assets 3,125 3,399
Property, plant and equipment, net of accumulated depreciation of $3,444 and $3,428 2,334 2,370
Intangible assets, net of accumulated amortization of $305 and $299 1,286 1,303
Other non-current assets 574 570
Total assets 7,319 7,642
Current liabilities:    
Short-term borrowings 141 448
Accounts payable 659 778
Accrued liabilities and liabilities held for sale 483 546
Total current liabilities 1,283 1,772
Long-term debt 1,740 1,740
Other non-current liabilities 471 480
Total liabilities 3,494 3,992
Share-based payments subject to redemption 43 55
Redeemable non-controlling interests 42 43
Ingredion stockholders’ equity:    
Preferred stock — authorized 25.0 shares — $0.01 par value, none issued 0 0
Common stock — authorized 200.0 shares — $0.01 par value, 77.8 shares issued at March 31, 2024 and December 31, 2023 1 1
Additional paid-in capital 1,146 1,146
Less: Treasury stock (common stock: 12.2 and 12.6 shares at March 31, 2024 and December 31, 2023) at cost (1,179) (1,207)
Accumulated other comprehensive loss (1,062) (1,056)
Retained earnings 4,818 4,654
Total Ingredion stockholders’ equity 3,724 3,538
Non-redeemable non-controlling interests 16 14
Total stockholders' equity 3,740 3,552
Total liabilities and stockholders' equity $ 7,319 $ 7,642
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Property, plant and equipment, accumulated depreciation $ 3,444 $ 3,428
Intangible assets, accumulated amortization $ 305 $ 299
Preferred stock, authorized (in shares) 25,000,000.0 25,000,000.0
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, issued (in shares) 0 0
Common stock, authorized (in shares) 200,000,000.0 200,000,000.0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, issued (in shares) 77,800,000 77,800,000
Treasury stock (in shares) 12,200,000 12,600,000
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Non- Redeemable Non- Controlling Interests
Balance at beginning of period at Dec. 31, 2022   $ 1 $ 1,132 $ (1,148) $ (1,048) $ 4,210 $ 16
Increase (Decrease) in Stockholders' Equity              
Net income           191 3
Dividends declared, common stock           (47)  
Share-based compensation, net of issuance     1 21      
Other comprehensive (loss)         (50)   (6)
Balance at end of period at Mar. 31, 2023   1 1,133 (1,127) (1,098) 4,354 13
Share-based payments subject to redemption, beginning balance at Dec. 31, 2022 $ 48            
Increase (Decrease) in Temporary Equity              
Share-based compensation, net of issuance (10)            
Share-based payments subject to redemption, ending balance at Mar. 31, 2023 38            
Redeemable non-controlling interests, beginning balance at Dec. 31, 2022 51            
Redeemable non-controlling interests, ending balance at Mar. 31, 2023 51            
Balance at beginning of period at Dec. 31, 2023 3,552 1 1,146 (1,207) (1,056) 4,654 14
Increase (Decrease) in Stockholders' Equity              
Net income           216 2
Dividends declared, common stock           (52)  
Repurchases of common stock, net       (1)      
Share-based compensation, net of issuance       29      
Other comprehensive (loss)         (6)    
Balance at end of period at Mar. 31, 2024 3,740 $ 1 $ 1,146 $ (1,179) $ (1,062) $ 4,818 $ 16
Share-based payments subject to redemption, beginning balance at Dec. 31, 2023 55            
Increase (Decrease) in Temporary Equity              
Share-based compensation, net of issuance (12)            
Share-based payments subject to redemption, ending balance at Mar. 31, 2024 43            
Redeemable non-controlling interests, beginning balance at Dec. 31, 2023 43            
Increase (Decrease) in Temporary Equity              
Other comprehensive (loss) (1)            
Redeemable non-controlling interests, ending balance at Mar. 31, 2024 $ 42            
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited) (Parenthetical) - $ / shares
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]    
Dividends declared (in dollars per share) $ 0.78 $ 0.71
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash from operating activities    
Net income $ 218 $ 194
Non-cash charges to net income:    
Depreciation and amortization 53 54
Mechanical stores expense 14 18
Net gain on sale of business (82) 0
Other non-cash charges 32 20
Changes in working capital:    
Accounts receivable and prepaid expenses 6 (44)
Inventories 104 (87)
Accounts payable and accrued liabilities (135) (171)
Margin accounts (11) (19)
Other 10 (16)
Cash provided by (used for) operating activities 209 (51)
Cash from investing activities    
Capital expenditures and mechanical stores purchases (65) (76)
Proceeds from disposal of manufacturing facilities and properties 0 1
Proceeds from sale of business 247 0
Other (1) (6)
Cash provided by (used for) investing activities 181 (81)
Cash from financing activities    
Proceeds from borrowings 149 318
Payments on debt (134) (267)
Commercial paper borrowings, net (312) 107
Repurchases of common stock, net (1) 0
Issuances of common stock for share-based compensation, net 2 2
Dividends paid, including to non-controlling interests (51) (47)
Cash (used for) provided by financing activities (347) 113
Effects of foreign exchange rate changes on cash (6) (1)
Increase (decrease) in cash and cash equivalents 37 (20)
Cash and cash equivalents, beginning of period 401 236
Cash and cash equivalents, end of period $ 438 $ 216
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of Presentation and New Accounting Standards
 3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and New Accounting Standards 1. Basis of Presentation and New Accounting Standards
Unless the context otherwise requires, all references herein to the “Company,” “Ingredion,” “we,” “us,” and “our” shall mean Ingredion Incorporated and its consolidated subsidiaries. These statements should be read in conjunction with the consolidated financial statements and the related notes to those statements contained in Ingredion’s Annual Report on Form 10-K for the year ended December 31, 2023.
The unaudited Condensed Consolidated Financial Statements as of March 31, 2024 and for the first quarter of 2024 and 2023 included herein were prepared by us on the same basis as our audited Consolidated Financial Statements for the year ended December 31, 2023 and reflect all adjustments (consisting solely of normal recurring items unless otherwise noted) that are, in our opinion, necessary for the fair presentation of the Condensed Consolidated Statements of Income, Condensed Consolidated Statements of Comprehensive Income, Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Equity and Redeemable Equity, and Condensed Consolidated Statements of Cash Flows. The results for the interim period are not necessarily indicative of the results expected for the full year or any other future period.
The significant accounting policies and estimates used in preparing these Condensed Consolidated Financial Statements were applied on the same basis consistent with those reflected in Ingredion’s Annual Report on Form 10-K for the year ended December 31, 2023.
In November 2023, we announced a strategic reorganization of our business. As more fully described in Note 10, under our new reportable segments, effective January 1, 2024, there are three reportable segments consisting of - Texture & Healthful Solutions (“T&HS”), Food & Industrial Ingredients - Latin America (“F&II - LATAM”) and Food & Industrial Ingredients - U.S./Canada (“F&II - US/Canada”).
New Accounting Standards
In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The amendments require filers to disclose information about supplier finance programs that is sufficient to allow financial statement users to understand their nature, activity during the period, changes from period to period and potential magnitude. The amendments in this ASU are effective for annual periods beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. We adopted this ASU at the beginning of our 2023 fiscal year and adopted the amendment on rollforward information at the beginning of our 2024 fiscal year. The disclosures required by this ASU are reflected in Note 12.
In August 2023, the FASB issued ASU No. 2023-05, Business Combinations - Joint Venture Formations (Subtopic 805-60). The amendments in this ASU require that a joint venture apply a new basis of accounting upon formation. By applying a new basis of accounting, a joint venture, upon formation, will recognize and initially measure its assets and liabilities at fair value (with exceptions to fair value measurement that are consistent with the business combinations guidance). The amendments in this ASU are effective prospectively for all joint venture formations with a formation date on or after January 1, 2025. A joint venture that was formed before January 1, 2025 may elect to apply the amendments retrospectively. We will adopt this ASU on a prospective basis at the beginning of our 2025 fiscal year and do not believe it will have a material impact on the Condensed Consolidated Financial Statements.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280). The amendments in this ASU improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this ASU are effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Entities must apply the amendments in this ASU retrospectively to all prior periods presented in the financial statements. We are currently assessing the impact of this ASU on the Condensed Consolidated Financial Statements.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments require public business entities on an annual basis to disclose specific categories in the rate
reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Additionally, the amendment requires information pertaining to taxes paid (net of refunds received) to be disaggregated by federal, state, and foreign taxes with further disaggregation for specific jurisdictions to the extent the related amounts exceed a quantitative threshold. The amendments in this ASU are effective for annual periods beginning after December 15, 2024, with early adoption permitted. We are currently waiting for additional guidance to be issued on the quantitative thresholds before we can assess the impact of this ASU on the Condensed Consolidated Financial Statements.
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Divestitures
 3 Months Ended
Mar. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Divestitures 2. Divestitures
South Korea Divestiture
On February 1, 2024, we completed the sale of our South Korea business, which we report for segment purposes in All Other, for a total consideration of 384.0 billion South Korean won, or approximately $294 million. We received 330.0 billion South Korea won, or $247 million net of certain transaction costs, when the transaction closed, and we will receive the remaining consideration in equal annual payments through February 2027. As a result, we recognized a pre-tax net gain of $82 million within Net gain on sale of business in the Condensed Consolidated Statements of Income.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Intangible Assets
 3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets 3. Intangible Assets
Goodwill represents the excess of the cost of an acquired entity over the fair value assigned to identifiable assets acquired and liabilities assumed. Ingredion assesses goodwill and indefinite-lived intangible assets for impairment annually (or more frequently if impairment indicators arise). Changes to our reportable segments effective January 1, 2024, as described in Note 10, resulted in a change to our reporting units.
As of this effective date, we performed a qualitative assessment of the goodwill under our former reporting units to determine if it is more likely than not that the reporting unit’s goodwill is impaired. As a result of this analysis, we did not identify any indications that any of the carrying amounts of the reporting units exceeded their respective fair values. Next, we performed a quantitative assessment to reallocate goodwill to our new reporting units using a relative fair value approach. We evaluated these new reporting units for impairment as of January 1, 2024, and determined the fair value was in excess of carrying value for all our reporting units indicating no impairments are present.
The original carrying values of goodwill and accumulated impairment charges by reportable segment and All Other as of March 31, 2024 are presented below. There were no accumulated impairment charges by reportable segment.
T&HSF&II - LATAMF&II - U.S./CanadaAll OtherTotal
Balance as of January 1, 2024$388 $146 $296 $88 $918 
Currency translation(5)(1)— (2)(8)
Balance as of March 31, 2024$383 $145 $296 $86 $910 
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Investments
 3 Months Ended
Mar. 31, 2024
Investments [Abstract]  
Investments 4. Investments
Investments as of March 31, 2024 and December 31, 2023 are as follows:
March 31,
2024		December 31,
2023
Equity investments$29 $27 
Equity method investments98 112 
Marketable securities4 4 
Total investments$131 $143 
Our investments classified as equity investments do not have readily determinable fair values. Beginning on the dates we entered into the agreements for equity method investments, our share of income from these investments is included within Other operating expense in the Condensed Consolidated Statements of Income.
Argentina Joint Venture
On February 12, 2021, we entered into an agreement with an affiliate of Grupo Arcor, an Argentine food company, to establish Ingrear Holding S.A. (the “Argentina joint venture”), a joint venture to sell value-added ingredients to customers in the food, beverage, pharmaceutical and other industries in Argentina, Chile and Uruguay. Ingredion and Grupo Arcor have completed all closing conditions, pending customary antitrust review, to combine the manufacturing facilities, finalize the transaction and formally establish the Argentina joint venture, which is managed by a jointly appointed team of executives. The Argentina joint venture is accounted for on the equity method of accounting, and we recognize our share of income or expense in Other operating expense one month in arrears due to the timing of when results are available. On December 13, 2023, the new Argentine government allowed the Argentine peso to devalue from the exchange rate of approximately 366 pesos to one U.S. dollar, to 800 pesos to one U.S. dollar. As we recognize our share of earnings one month in arrears, the loss from the change in value of the peso in December 2023 was recorded in Other operating expense during the first quarter of 2024
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities
 3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities 5. Derivative Instruments and Hedging Activities
Commodity price hedging: We had outstanding futures and option contracts that hedged the forecasted purchase of approximately 96 million and 109 million bushels of corn as of March 31, 2024 and December 31, 2023. We also had outstanding swap contracts that hedged the forecasted purchase of approximately 26 million and 28 million mmbtus of natural gas as of March 31, 2024 and December 31, 2023.
Foreign currency hedging: We hedge certain assets using foreign currency derivatives not designated as hedging instruments, which had a notional value of $445 million and $694 million as of March 31, 2024 and December 31, 2023. We also hedge certain liabilities using foreign currency derivatives not designated as hedging instruments, which had a notional value of $171 million and $182 million as of March 31, 2024 and December 31, 2023.
We hedge certain assets using foreign currency cash flow hedging instruments, which had a notional value of $328 million and $449 million as of March 31, 2024 and December 31, 2023. We also hedge certain liability positions using foreign currency cash flow hedging instruments, which had a notional value of $480 million and $621 million as of March 31, 2024 and December 31, 2023.
Interest rate hedging: We periodically enter into T-Locks to hedge our exposure to interest rate changes. We have settled T-Locks associated with the issuance of our senior notes due in 2030 and 2050. The realized loss upon settlement of these T-Locks was recorded in Accumulated other comprehensive loss (“AOCL”) and is amortized into earnings over the term of the senior notes. We did not have outstanding T-Locks as of either March 31, 2024 or December 31, 2023.
The derivative instruments designated as cash flow hedges included in AOCL as of March 31, 2024 and December 31, 2023 are as follows:
(Losses) included in AOCL as of
March 31,
2024		December 31,
2023
Commodity contracts, net of income tax effect of $19 and $17
$(53)$(46)
Foreign currency contracts, net of income tax effect of $2 and $1
— — 
Interest rate contracts, net of income tax effect of $1
(2)(2)
Total$(55)$(48)
As of March 31, 2024, AOCL included $52 million of net losses (net of income taxes of $18 million) on commodities-related derivative instruments, T-Locks and foreign currency hedges designated as cash flow hedges that are expected to be reclassified into earnings during the next 12 months.
The fair value and balance sheet location of our derivative instruments, presented gross in the Condensed Consolidated Balance Sheets, are as follows:
Fair Value of Hedging Instruments as of March 31, 2024
Designated Hedging InstrumentsNon-Designated Hedging Instruments
Balance Sheet LocationCommodity ContractsForeign Currency ContractsTotalCommodity ContractsForeign Currency ContractsTotal
Accounts receivable, net$8 $10 $18 $1 $6 $7 
Other non-current assets— 4 4 — 1 1 
Assets8 14 22 1 7 8 
Accounts payable58 14 72 3 6 9 
Other non-current liabilities2 — 2 — — — 
Liabilities60 14 74 3 6 9 
Net Assets/(Liabilities)$(52)$— $(52)$(2)$1 $(1)
Fair Value of Hedging Instruments as of December 31, 2023
Designated Hedging InstrumentsNon-Designated Hedging Instruments
Balance Sheet LocationCommodity ContractsForeign Currency ContractsTotalCommodity ContractsForeign Currency ContractsTotal
Accounts receivable, net$6 $11 $17 $— $5 $5 
Other non-current assets—44—— — 
Assets61521—55
Accounts payable44145821214
Other non-current liabilities224—— — 
Liabilities46166221214
Net Assets/(Liabilities)$(40)$(1)$(41)$(2)$(7)$(9)
Additional information relating to our derivative instruments are as follows:
(Losses) Gains
Recognized in AOCL on Derivatives		(Losses) Gains
Reclassified from AOCL into Income
Derivatives in Cash FlowThree Months Ended March 31,Income StatementThree Months Ended March 31,
Hedging Relationships20242023Location20242023
Commodity contracts$(42)$(67)Cost of sales$(33)$9 
Foreign currency contracts1 9 Net sales/Cost of sales— 9 
Total$(41)$(58)$(33)$18 
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements 6. Fair Value Measurements
We measure certain assets and liabilities at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. In determining fair value, we use various valuation approaches. The hierarchy of those valuation approaches is in three levels based on the reliability of inputs. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Below is a summary of the hierarchy levels:
•Level 1 inputs consist of quoted prices (unadjusted) in active markets for identical assets or liabilities.
•Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 2 inputs are
based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability or can be derived principally from or corroborated by observable market data.
•Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
Assets and liabilities measured at fair value on a recurring basis are presented below:
As of March 31, 2024As of December 31, 2023
TotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Marketable securities$4 $4 $— $— $4 $4 $— $— 
Derivative assets30 29 1 — 26 26 — — 
Derivative liabilities83 53 30 — 76 43 33 — 
Long-term debt1,575 — 1,575 — 1,591 — 1,591 — 
The carrying values of cash equivalents, short-term investments, accounts receivable, short-term borrowings and accounts payable approximate fair values. Commodity futures, options and swap contracts are recognized at fair value. Foreign currency forward contracts, swaps and options are also recognized at fair value. The fair value of our Long-term debt is estimated based on quotations of major securities dealers who are market makers in the securities.
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financing Arrangements
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Financing Arrangements 7. Financing Arrangements
Presented below are our debt carrying amounts, net of related discounts, premiums and debt issuance costs, as of March 31, 2024 and December 31, 2023:
As of
March 31, 2024		As of
December 31, 2023
2.900% senior notes due June 1, 2030
$596 $596 
3.200% senior notes due October 1, 2026
499 499 
3.900% senior notes due June 1, 2050
391 391 
6.625% senior notes due April 15, 2037
253 253 
Revolving credit agreement— — 
Other long-term borrowings1 1 
Total long-term debt1,740 1,740 
Commercial paper16 327 
Other short-term borrowings125 121 
Total short-term borrowings141 448 
Total debt$1,881 $2,188 
We maintain a commercial paper program under which we may issue senior unsecured notes of short maturities up to a maximum aggregate principal amount of $1.0 billion outstanding at any time. The notes may be sold from time to time on customary terms in the U.S. commercial paper market. We use the note proceeds for general corporate purposes. During the first quarter of 2024, the average amount of commercial paper outstanding was $118 million with an average interest rate of 5.51 percent and a weighted average maturity of 8 days. During the first quarter of 2023, the average amount of commercial paper outstanding was $460 million with an average interest rate of 4.79 percent and a weighted average maturity of 7 days. As of March 31, 2024, $16 million of commercial paper was outstanding with an average interest rate of 5.45 percent and a weighted average maturity of 4 days. As of December 31, 2023, $327 million of commercial paper was outstanding with an average interest rate of 5.50 percent and a weighted average maturity of 11 days. The amount of commercial paper outstanding under this program for the remainder of 2024 is expected to fluctuate.
Our short-term borrowings as of March 31, 2024 and December 31, 2023 primarily include amounts outstanding under various unsecured local country operating lines of credit.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pension and Other Postretirement Benefits
 3 Months Ended
Mar. 31, 2024
Retirement Benefits [Abstract]  
Pension and Other Postretirement Benefits 8. Pension and Other Postretirement Benefits
Components of net periodic cost consist of the following for the periods presented:
Three Months Ended March 31,
U.S. PlansNon-U.S. Plans
2024202320242023
Service cost$1 $— $1 $1 
Interest cost3 4 2 2 
Expected return on plan assets(4)(4)(2)(2)
Net periodic cost (a)
$— $— $1 $1 
_______________________________________
(a)The service cost component of net periodic cost is presented within either Cost of sales or Operating expenses in the Condensed Consolidated Statements of Income. The remainder of the net periodic cost primarily net.
We anticipate that we will make cash contributions of $1 million and $4 million to our U.S. and non-U.S. pension plans in 2024. For the first quarter of 2024, we made an insignificant cash contribution to the U.S. plans and $1 million to the non-U.S. plans.
During the first quarter of 2024 and 2023, the net periodic benefit cost for the postretirement plans consisted of $1 million of interest costs and no service costs.
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity
 3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Equity 9. Equity
Treasury Stock: On September 26, 2022, the Board of Directors approved a stock repurchase program authorizing us to purchase up to 6.0 million shares of our outstanding common stock until December 31, 2025. We may repurchase shares from time to time in the open market, in privately negotiated transactions, or otherwise, at prices we deem appropriate. We are not obligated to repurchase any shares under the authorization, and the repurchase program may be suspended, discontinued, or modified at any time, for any reason and without notice. The parameters of our stock repurchase program are not established solely with reference to the dilutive impact of shares issued under our stock incentive plan. However, we expect that, over time, share repurchases will offset the dilutive impact of shares issued under the stock incentive plan.

During the first quarter of 2024, we repurchased approximately 5 thousand shares of common stock in open market transactions at a net cost of $1 million. During the first quarter of 2023, we did not repurchase any shares of common stock.
Share-based Payments: Share-based compensation expense for the periods presented is as follows:
Three Months Ended
March 31,
20242023
Stock options:
Pre-tax compensation expense$2 $1 
Income tax benefit— — 
Stock option expense, net of income taxes2 1 
Restricted stock units (“RSUs”):
Pre-tax compensation expense7 4 
Income tax benefit(1)(1)
RSU expenses, net of income taxes6 3 
Performance shares and other share-based awards:
Pre-tax compensation expense4 4 
Income tax benefit— — 
Performance shares and other share-based compensation expense, net of income taxes4 4 
Total share-based compensation:
Pre-tax compensation expense13 9 
Income tax benefit(1)(1)
Total share-based compensation expense, net of income taxes$12 $8 
Stock Options: Under our stock incentive plan, stock options are granted at exercise prices that equal the market value of the underlying common stock on the date of grant. The options have a 10-year term and are exercisable upon vesting, which occurs over a three-year period at the anniversary dates of the date of grant. We generally recognize compensation expense on a straight-line basis for all awards over the employee’s vesting period. We estimate a forfeiture rate at the time of grant and update the estimate throughout the vesting period of the stock options within the amount of compensation costs recognized in each period.
We granted non-qualified options to purchase 178 thousand shares and 197 thousand shares for the first quarter of 2024 and 2023. We estimated the fair value of each option grant by using the Black-Scholes option-pricing model with the following assumptions:
Three Months Ended March 31,
20242023
Expected life (in years)5.55.5
Risk-free interest rate4.2%4.0%
Expected volatility28.1%28.3%
Expected dividend yield2.9%2.9%
The expected life of options represents the weighted average period that we expect options granted to be outstanding giving consideration to vesting schedules and our historical exercise patterns. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the grant date for the period corresponding to the expected life of the options. Expected volatility is based on historical volatilities of our common stock, and dividend yields are based on our dividend yield at the date of issuance.
Stock option activity for the first quarter of 2024 is as follows:
Number of Options
(in thousands)		Weighted Average Exercise Price per ShareAverage Remaining Contractual Term (Years)Aggregate Intrinsic Value
(in millions)
Outstanding as of December 31, 20231,953$96.61 4.97$29 
Granted178108.38 
Exercised(165)79.87 
Cancelled(21)103.69 
Outstanding as of March 31, 20241,945$99.03 5.44$38 
Exercisable as of March 31, 20241,573$98.53 4.56$32 
For the first quarter of 2024, cash received from the exercise of stock options was approximately $13 million. As of March 31, 2024, the unrecognized compensation cost related to non-vested stock options totaled $6 million, which we expect to amortize over the weighted-average period of approximately 1.5 years.
Additional information pertaining to stock option activity is as follows:
Three Months Ended
March 31,
20242023
Weighted average grant date fair value of stock options granted (per share)$26.33 $23.80 
Total intrinsic value of stock options exercised5 6 
RSUs: We have granted RSUs to certain key employees. The RSUs are primarily subject to cliff vesting, generally after three years, provided the employee remains in our service. The fair value of the RSUs is determined based upon the number of shares granted and the quoted market price of our common stock at the grant date.
The following table summarizes RSU activity in 2024:
Number of
Restricted
Shares
(in thousands)		Weighted
Average
Fair Value
per Share
Non-vested as of December 31, 2023552$92.05 
Granted191107.65 
Vested(161)87.15 
Cancelled(18)92.77 
Non-vested as of March 31, 2024564$98.84 
As of March 31, 2024, the total remaining unrecognized compensation cost related to RSUs was $32 million, which will be amortized on a weighted-average basis over approximately 2.0 years.
Performance Shares: We have a long-term incentive plan for senior management in the form of performance shares. The vesting of the performance shares is generally based on two performance metrics. Fifty percent of the performance shares awarded vest based on our total shareholder return as compared to the total shareholder return of our peer group, and the remaining fifty percent vest based on the calculation of our three-year average Adjusted Return on Invested Capital (“Adjusted ROIC”) against an established ROIC target.
For the 2024 performance shares awarded based on our total shareholder return, the number of shares that ultimately vest can range from zero to 200 percent of the grant depending on our total shareholder return as compared to the total shareholder return of our peer group. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the People, Culture, and Compensation Committee (“Compensation Committee”) of the Board of Directors. Compensation expense is based on the fair value of the performance shares at the grant date, established using a Monte Carlo simulation model. We amortize the total compensation expense for these awards over a three-year graded vesting schedule.
For the 2024 performance shares awarded based on Adjusted ROIC, the number of shares that ultimately vest can range from zero to 200 percent of the grant depending on our Adjusted ROIC performance against the target. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the Compensation Committee. We base compensation expense on the market price of our common stock on the grant date and the final number of shares that ultimately vest. We estimate the potential share vesting at least annually to adjust the compensation expense for these awards over the vesting period to reflect our estimated Adjusted ROIC performance against the target. We amortize the total compensation expense for these awards over a three-year graded vesting schedule.
For the first quarter of 2024, we awarded 86 thousand performance shares at a weighted average fair value of $127.97 per share. As of March 31, 2024, the unrecognized compensation cost related to these awards was $20 million, which we will amortize over the remaining service period of 2.4 years. The 2021 performance share awards that vested in February 2024 achieved a 200 percent payout of the granted performance shares. As of March 31, 2024, we estimated the 2022 performance share awards will pay out at 200 percent. For the first quarter of 2024, one thousand performance shares were cancelled.
Accumulated Other Comprehensive Loss: The following is a summary of accumulated other comprehensive (loss) for the first quarter of 2024 and 2023:
Cumulative Translation AdjustmentHedging ActivitiesPension and Postretirement AdjustmentAOCL
Balance as of December 31, 2023$(961)$(48)$(47)$(1,056)
Other comprehensive (loss) before reclassification adjustments — (41)— (41)
Loss reclassified from AOCL— 33 1 34 
Tax benefit— 1 — 1 
Net other comprehensive (loss) income— (7)1 (6)
Balance as of March 31, 2024$(961)$(55)$(46)$(1,062)
Cumulative Translation AdjustmentHedging ActivitiesPension and Postretirement AdjustmentAOCL
Balance as of December 31, 2022$(1,008)$6 $(46)$(1,048)
Other comprehensive gain (loss) before reclassification adjustments6 (58)— (52)
(Gain) reclassified from AOCL— (18)— (18)
Tax benefit— 20 — 20 
Net other comprehensive income (loss)6 (56)— (50)
Balance as of March 31, 2023$(1,002)$(50)$(46)$(1,098)
Supplemental Information: The following table provides the computation of basic and diluted earnings per common share (“EPS”) for the periods presented.
Three Months Ended March 31, 2024Three Months Ended March 31, 2023
Net Income
Available
to Ingredion		Weighted
Average
Shares		Per
Share
Amount		Net Income
Available
to Ingredion		Weighted
Average
Shares		Per
Share
Amount
Basic EPS$216 65.7$3.29 $191 66.1$2.89 
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards1.11.0
Diluted EPS$216 66.8$3.23 $191 67.1$2.85 
Approximately 0.5 million and 0.7 million share-based awards of common stock were excluded for the first quarter of 2024 and 2023 from the calculation of the weighted average number of shares outstanding for diluted EPS because their effects were anti-dilutive.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information
 3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Segment Information 10. Segment Information
Effective January 1, 2024, we changed our reportable segments to align them with changes in how our Chief Executive Officer, as the Chief Operating Decision Maker (“CODM”), manages the business, evaluates performance, and allocates resources. Our revised reportable segments consist of (1) Texture & Healthful Solutions (“T&HS”), (2) F&II - LATAM, and (3) F&II - U.S./Canada. In All Other, we include the business in Pakistan, PureCircle, Sugar Reduction, Protein Fortification, and South Korea until its sale on February 1, 2024.
We are principally engaged in the production and sale of starches and sweeteners for a wide range of industries. Our T&HS segment has a global focus and primarily manufactures texturizing food ingredients. Our F&II - LATAM segment has a local focus and primarily manufactures food, ingredient, and industrial products, which we process from raw materials that we primarily source within South America and Mexico. Our F&II - U.S./Canada segment has a local focus and primarily manufactures food, ingredient, and industrial products, which we process from raw materials sourced within the U.S. and Canada. All Other consists of the businesses of multiple operating segments that are not individually or collectively classified as reportable segments. Revenues from All Other are generated primarily by sweetener and starches sales by our Pakistan business, sales of stevia and other ingredients from our PureCircle and Sugar Reduction businesses, and pea protein ingredients from our Protein Fortification business. Net sales by product are not presented because such presentation is not practicable.
Presented below are our net sales to affiliated and unaffiliated customers by reportable segment and All Other for the periods presented:
Three months endedT&HSF&II - LATAMF&II - U.S./CanadaAll OtherConsolidated
 Totals
March 31, 2024
Net sales including intersegment sales$612 $626 $567 $131 $1,936 
Less: Intersegment sales
$(15)$(10)$(26)$(3)$(54)
Net sales$597 $616 $541 $128 $1,882 
March 31, 2023
Net sales including intersegment sales$698 $677 $635 $201 $2,211 
Less: Intersegment sales
$(33)$(10)$(27)$(4)$(74)
Net sales$665 $667 $608 $197 $2,137 
Presented below is our operating income by reportable segment and All Other for the periods presented:
Three Months Ended
March 31,
20242023
Operating income (loss):
Texture & Healthful Solutions$74 $127 
Food & Industrial Ingredients - LATAM101 122 
Food & Industrial Ingredients - U.S./Canada87 92 
All Other(4)(8)
Corporate(42)(37)
Subtotal216 296 
Resegmentation costs(3)— 
Other matters— (5)
Total operating income$213 $291 
The CODM evaluates performance, makes strategic decisions, and allocates resources based on Property, plant and equipment, net for internal and external reporting purposes. Presented below is Property, plant and equipment, net by reportable segment and All Other as of March 31, 2024 and December 31, 2023:
As of
March 31, 2024		As of
December 31, 2023
Property, plant and equipment, net:
Texture & Healthful Solutions$838 $855 
Food & Industrial Ingredients - LATAM543 552 
Food & Industrial Ingredients - U.S./Canada542 548 
All Other (a)411 415 
Total Property, plant and equipment, net$2,334 $2,370 
_____________________
(a)For purposes of presentation, All Other includes Corporate assets.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies 11. Commitments and Contingencies
We have filed an action in Brazil to recover previously taxable local government tax incentives. As we believe recovery is probable, we recorded a $27 million income tax benefit in 2022. As of both March 31, 2024 and December 31, 2023, we had $32 million of remaining tax incentives recorded within Other non-current assets in the Condensed Consolidated Balance Sheets.
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplementary Information
 3 Months Ended
Mar. 31, 2024
Supplementary Information  
Supplementary Information 12. Supplementary Information
Accounts Receivable, Net
Accounts receivable, net as of March 31, 2024 and December 31, 2023 were as follows:
As of
March 31, 2024		As of
December 31, 2023
Accounts receivable — trade$1,128 $1,145 
Accounts receivable — other173 154 
Allowance for credit losses(17)(20)
Total accounts receivable, net$1,284 $1,279 
There were no significant contract assets or contract liabilities associated with our customers as of either March 31, 2024 or December 31, 2023. Liabilities for volume discounts and incentives were also not significant as of either March 31, 2024 or December 31, 2023.
Inventories
Inventories as of March 31, 2024 and December 31, 2023 were as follows:
As of
March 31, 2024		As of
December 31, 2023
Finished and in process$852 $926 
Raw materials402 434 
Manufacturing supplies90 90 
Total inventories$1,344 $1,450 
Supply Chain Finance Programs
Under supply chain finance programs administered by third-party banks, our suppliers have the opportunity to sell receivables due from us to participating financing institutions and receive earlier payment at a discount. Our responsibility is limited to making payment on the terms originally negotiated with our supplier, regardless of whether such supplier sells its receivables to a financial institution. The payment terms we negotiate with a supplier are independent of whether such supplier participates in a supply chain finance program, and participation in any such program by a supplier has no effect on our income or cash flows.
As of March 31, 2024 and December 31, 2023, participating financial institutions held $149 million and $153 million of our liabilities recorded in Accounts payable and Accrued liabilities and liabilities held for sale on our Condensed
Consolidated Balance Sheets. As of March 31, 2024, supply chain finance programs existed for operations in Brazil, China, Thailand, Mexico, Colombia and Peru.
The rollforward of our outstanding obligations confirmed as valid under our supply chain finance programs for the quarter ending March 31, 2024 is as follows.
As of
March 31, 2024
Outstanding at the beginning of the year$153 
Invoices added during the year141
Invoices paid during the year(141)
Currency translation adjustment(4)
Outstanding as of March 31, 2024$149 
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) Attributable to Parent $ 216 $ 191
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Larry Fernandes [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On February 16, 2024, Larry Fernandes, our Senior Vice President, Chief Commercial and Sustainability Officer, terminated an existing written plan that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The original plan was adopted on February 27, 2023 and provided for the sale of up to 9,738 shares of our common stock between May 29, 2023 and January 31, 2025. As of the date of termination, Mr. Fernandes had sold 5,000 shares of common stock pursuant to the terms of the plan.
Name Larry Fernandes
Title Senior Vice President, Chief Commercial and Sustainability Officer
Adoption Date February 27, 2023
Rule 10b5-1 Arrangement Terminated true
Termination Date February 16, 2024
Aggregate Available 9,738
Robert Ritchie [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On February 29, 2024, Robert Ritchie, our Senior Vice President, Food & Industrial Ingredients, LATAM and U.S./Canada, entered into an amended written plan for the sale of up to 4,044 shares of our common stock that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The plan commences on May 30, 2024 and will expire on February 1, 2026, or on any earlier date on which all of the shares have been sold.
Name Robert Ritchie
Title Senior Vice President, Food & Industrial Ingredients, LATAM and U.S./Canada
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 29, 2024
Aggregate Available 4,044
Robert Ritchie [Member]  
Trading Arrangements, by Individual  
Arrangement Duration 612 days
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of Presentation and New Accounting Standards (Policies)
 3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
New Accounting Standards
New Accounting Standards
In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The amendments require filers to disclose information about supplier finance programs that is sufficient to allow financial statement users to understand their nature, activity during the period, changes from period to period and potential magnitude. The amendments in this ASU are effective for annual periods beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. We adopted this ASU at the beginning of our 2023 fiscal year and adopted the amendment on rollforward information at the beginning of our 2024 fiscal year. The disclosures required by this ASU are reflected in Note 12.
In August 2023, the FASB issued ASU No. 2023-05, Business Combinations - Joint Venture Formations (Subtopic 805-60). The amendments in this ASU require that a joint venture apply a new basis of accounting upon formation. By applying a new basis of accounting, a joint venture, upon formation, will recognize and initially measure its assets and liabilities at fair value (with exceptions to fair value measurement that are consistent with the business combinations guidance). The amendments in this ASU are effective prospectively for all joint venture formations with a formation date on or after January 1, 2025. A joint venture that was formed before January 1, 2025 may elect to apply the amendments retrospectively. We will adopt this ASU on a prospective basis at the beginning of our 2025 fiscal year and do not believe it will have a material impact on the Condensed Consolidated Financial Statements.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280). The amendments in this ASU improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this ASU are effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Entities must apply the amendments in this ASU retrospectively to all prior periods presented in the financial statements. We are currently assessing the impact of this ASU on the Condensed Consolidated Financial Statements.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments require public business entities on an annual basis to disclose specific categories in the rate
reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Additionally, the amendment requires information pertaining to taxes paid (net of refunds received) to be disaggregated by federal, state, and foreign taxes with further disaggregation for specific jurisdictions to the extent the related amounts exceed a quantitative threshold. The amendments in this ASU are effective for annual periods beginning after December 15, 2024, with early adoption permitted. We are currently waiting for additional guidance to be issued on the quantitative thresholds before we can assess the impact of this ASU on the Condensed Consolidated Financial Statements.
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Intangible Assets (Tables)
 3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill
The original carrying values of goodwill and accumulated impairment charges by reportable segment and All Other as of March 31, 2024 are presented below. There were no accumulated impairment charges by reportable segment.
T&HSF&II - LATAMF&II - U.S./CanadaAll OtherTotal
Balance as of January 1, 2024$388 $146 $296 $88 $918 
Currency translation(5)(1)— (2)(8)
Balance as of March 31, 2024$383 $145 $296 $86 $910 
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Investments (Tables)
 3 Months Ended
Mar. 31, 2024
Investments [Abstract]  
Schedule of investments
Investments as of March 31, 2024 and December 31, 2023 are as follows:
March 31,
2024		December 31,
2023
Equity investments$29 $27 
Equity method investments98 112 
Marketable securities4 4 
Total investments$131 $143 
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities (Tables)
 3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of cash flow hedges included in AOCI
The derivative instruments designated as cash flow hedges included in AOCL as of March 31, 2024 and December 31, 2023 are as follows:
(Losses) included in AOCL as of
March 31,
2024		December 31,
2023
Commodity contracts, net of income tax effect of $19 and $17
$(53)$(46)
Foreign currency contracts, net of income tax effect of $2 and $1
— — 
Interest rate contracts, net of income tax effect of $1
(2)(2)
Total$(55)$(48)
Schedule of fair value and balance sheet location of derivative instruments
The fair value and balance sheet location of our derivative instruments, presented gross in the Condensed Consolidated Balance Sheets, are as follows:
Fair Value of Hedging Instruments as of March 31, 2024
Designated Hedging InstrumentsNon-Designated Hedging Instruments
Balance Sheet LocationCommodity ContractsForeign Currency ContractsTotalCommodity ContractsForeign Currency ContractsTotal
Accounts receivable, net$8 $10 $18 $1 $6 $7 
Other non-current assets— 4 4 — 1 1 
Assets8 14 22 1 7 8 
Accounts payable58 14 72 3 6 9 
Other non-current liabilities2 — 2 — — — 
Liabilities60 14 74 3 6 9 
Net Assets/(Liabilities)$(52)$— $(52)$(2)$1 $(1)
Fair Value of Hedging Instruments as of December 31, 2023
Designated Hedging InstrumentsNon-Designated Hedging Instruments
Balance Sheet LocationCommodity ContractsForeign Currency ContractsTotalCommodity ContractsForeign Currency ContractsTotal
Accounts receivable, net$6 $11 $17 $— $5 $5 
Other non-current assets—44—— — 
Assets61521—55
Accounts payable44145821214
Other non-current liabilities224—— — 
Liabilities46166221214
Net Assets/(Liabilities)$(40)$(1)$(41)$(2)$(7)$(9)
Schedule of amount of gains and losses recognized in OCI and income statement location
Additional information relating to our derivative instruments are as follows:
(Losses) Gains
Recognized in AOCL on Derivatives		(Losses) Gains
Reclassified from AOCL into Income
Derivatives in Cash FlowThree Months Ended March 31,Income StatementThree Months Ended March 31,
Hedging Relationships20242023Location20242023
Commodity contracts$(42)$(67)Cost of sales$(33)$9 
Foreign currency contracts1 9 Net sales/Cost of sales— 9 
Total$(41)$(58)$(33)$18 
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of assets and liabilities measured at fair value on a recurring basis
Assets and liabilities measured at fair value on a recurring basis are presented below:
As of March 31, 2024As of December 31, 2023
TotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Marketable securities$4 $4 $— $— $4 $4 $— $— 
Derivative assets30 29 1 — 26 26 — — 
Derivative liabilities83 53 30 — 76 43 33 — 
Long-term debt1,575 — 1,575 — 1,591 — 1,591 — 
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financing Arrangements (Tables)
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of debt
Presented below are our debt carrying amounts, net of related discounts, premiums and debt issuance costs, as of March 31, 2024 and December 31, 2023:
As of
March 31, 2024		As of
December 31, 2023
2.900% senior notes due June 1, 2030
$596 $596 
3.200% senior notes due October 1, 2026
499 499 
3.900% senior notes due June 1, 2050
391 391 
6.625% senior notes due April 15, 2037
253 253 
Revolving credit agreement— — 
Other long-term borrowings1 1 
Total long-term debt1,740 1,740 
Commercial paper16 327 
Other short-term borrowings125 121 
Total short-term borrowings141 448 
Total debt$1,881 $2,188 
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pension and Other Postretirement Benefits (Tables)
 3 Months Ended
Mar. 31, 2024
Retirement Benefits [Abstract]  
Components of net periodic benefit cost
Components of net periodic cost consist of the following for the periods presented:
Three Months Ended March 31,
U.S. PlansNon-U.S. Plans
2024202320242023
Service cost$1 $— $1 $1 
Interest cost3 4 2 2 
Expected return on plan assets(4)(4)(2)(2)
Net periodic cost (a)
$— $— $1 $1 
_______________________________________
(a)The service cost component of net periodic cost is presented within either Cost of sales or Operating expenses in the Condensed Consolidated Statements of Income. The remainder of the net periodic cost primarily net.
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity (Tables)
 3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of stock based compensation expense Share-based compensation expense for the periods presented is as follows:
Three Months Ended
March 31,
20242023
Stock options:
Pre-tax compensation expense$2 $1 
Income tax benefit— — 
Stock option expense, net of income taxes2 1 
Restricted stock units (“RSUs”):
Pre-tax compensation expense7 4 
Income tax benefit(1)(1)
RSU expenses, net of income taxes6 3 
Performance shares and other share-based awards:
Pre-tax compensation expense4 4 
Income tax benefit— — 
Performance shares and other share-based compensation expense, net of income taxes4 4 
Total share-based compensation:
Pre-tax compensation expense13 9 
Income tax benefit(1)(1)
Total share-based compensation expense, net of income taxes$12 $8 
Schedule of valuation assumptions for stock options We estimated the fair value of each option grant by using the Black-Scholes option-pricing model with the following assumptions:
Three Months Ended March 31,
20242023
Expected life (in years)5.55.5
Risk-free interest rate4.2%4.0%
Expected volatility28.1%28.3%
Expected dividend yield2.9%2.9%
Schedule of stock option transactions
Stock option activity for the first quarter of 2024 is as follows:
Number of Options
(in thousands)		Weighted Average Exercise Price per ShareAverage Remaining Contractual Term (Years)Aggregate Intrinsic Value
(in millions)
Outstanding as of December 31, 20231,953$96.61 4.97$29 
Granted178108.38 
Exercised(165)79.87 
Cancelled(21)103.69 
Outstanding as of March 31, 20241,945$99.03 5.44$38 
Exercisable as of March 31, 20241,573$98.53 4.56$32 
Schedule of additional information pertaining to stock option activity
Additional information pertaining to stock option activity is as follows:
Three Months Ended
March 31,
20242023
Weighted average grant date fair value of stock options granted (per share)$26.33 $23.80 
Total intrinsic value of stock options exercised5 6 
Schedule of restricted unit activity
The following table summarizes RSU activity in 2024:
Number of
Restricted
Shares
(in thousands)		Weighted
Average
Fair Value
per Share
Non-vested as of December 31, 2023552$92.05 
Granted191107.65 
Vested(161)87.15 
Cancelled(18)92.77 
Non-vested as of March 31, 2024564$98.84 
Summary of net changes in accumulated other comprehensive loss The following is a summary of accumulated other comprehensive (loss) for the first quarter of 2024 and 2023:
Cumulative Translation AdjustmentHedging ActivitiesPension and Postretirement AdjustmentAOCL
Balance as of December 31, 2023$(961)$(48)$(47)$(1,056)
Other comprehensive (loss) before reclassification adjustments — (41)— (41)
Loss reclassified from AOCL— 33 1 34 
Tax benefit— 1 — 1 
Net other comprehensive (loss) income— (7)1 (6)
Balance as of March 31, 2024$(961)$(55)$(46)$(1,062)
Cumulative Translation AdjustmentHedging ActivitiesPension and Postretirement AdjustmentAOCL
Balance as of December 31, 2022$(1,008)$6 $(46)$(1,048)
Other comprehensive gain (loss) before reclassification adjustments6 (58)— (52)
(Gain) reclassified from AOCL— (18)— (18)
Tax benefit— 20 — 20 
Net other comprehensive income (loss)6 (56)— (50)
Balance as of March 31, 2023$(1,002)$(50)$(46)$(1,098)
Schedule of basic and diluted earnings per common share The following table provides the computation of basic and diluted earnings per common share (“EPS”) for the periods presented.
Three Months Ended March 31, 2024Three Months Ended March 31, 2023
Net Income
Available
to Ingredion		Weighted
Average
Shares		Per
Share
Amount		Net Income
Available
to Ingredion		Weighted
Average
Shares		Per
Share
Amount
Basic EPS$216 65.7$3.29 $191 66.1$2.89 
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards1.11.0
Diluted EPS$216 66.8$3.23 $191 67.1$2.85 
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of segment reporting of net sales, operating income and total assets
Presented below are our net sales to affiliated and unaffiliated customers by reportable segment and All Other for the periods presented:
Three months endedT&HSF&II - LATAMF&II - U.S./CanadaAll OtherConsolidated
 Totals
March 31, 2024
Net sales including intersegment sales$612 $626 $567 $131 $1,936 
Less: Intersegment sales
$(15)$(10)$(26)$(3)$(54)
Net sales$597 $616 $541 $128 $1,882 
March 31, 2023
Net sales including intersegment sales$698 $677 $635 $201 $2,211 
Less: Intersegment sales
$(33)$(10)$(27)$(4)$(74)
Net sales$665 $667 $608 $197 $2,137 
Presented below is our operating income by reportable segment and All Other for the periods presented:
Three Months Ended
March 31,
20242023
Operating income (loss):
Texture & Healthful Solutions$74 $127 
Food & Industrial Ingredients - LATAM101 122 
Food & Industrial Ingredients - U.S./Canada87 92 
All Other(4)(8)
Corporate(42)(37)
Subtotal216 296 
Resegmentation costs(3)— 
Other matters— (5)
Total operating income$213 $291 
The CODM evaluates performance, makes strategic decisions, and allocates resources based on Property, plant and equipment, net for internal and external reporting purposes. Presented below is Property, plant and equipment, net by reportable segment and All Other as of March 31, 2024 and December 31, 2023:
As of
March 31, 2024		As of
December 31, 2023
Property, plant and equipment, net:
Texture & Healthful Solutions$838 $855 
Food & Industrial Ingredients - LATAM543 552 
Food & Industrial Ingredients - U.S./Canada542 548 
All Other (a)411 415 
Total Property, plant and equipment, net$2,334 $2,370 
_____________________
(a)For purposes of presentation, All Other includes Corporate assets.
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplementary Information (Tables)
 3 Months Ended
Mar. 31, 2024
Supplementary Information  
Schedule of accounts receivable, net
Accounts receivable, net as of March 31, 2024 and December 31, 2023 were as follows:
As of
March 31, 2024		As of
December 31, 2023
Accounts receivable — trade$1,128 $1,145 
Accounts receivable — other173 154 
Allowance for credit losses(17)(20)
Total accounts receivable, net$1,284 $1,279 
Schedule of inventories
Inventories as of March 31, 2024 and December 31, 2023 were as follows:
As of
March 31, 2024		As of
December 31, 2023
Finished and in process$852 $926 
Raw materials402 434 
Manufacturing supplies90 90 
Total inventories$1,344 $1,450 
Schedule of supplier chain finance program
The rollforward of our outstanding obligations confirmed as valid under our supply chain finance programs for the quarter ending March 31, 2024 is as follows.
As of
March 31, 2024
Outstanding at the beginning of the year$153 
Invoices added during the year141
Invoices paid during the year(141)
Currency translation adjustment(4)
Outstanding as of March 31, 2024$149 
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of Presentation and New Accounting Standards (Details)
 3 Months Ended
Mar. 31, 2024
segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of operating segments 3
Number of reportable segments 3
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Divestitures (Details)
$ in Millions, ₩ in Billions
 3 Months Ended
Feb. 01, 2024
USD ($)
Feb. 01, 2024
KRW (₩)
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Feb. 01, 2024
KRW (₩)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Proceeds from sale of business     $ 247 $ 0  
Net gain on sale of business     82 $ 0  
Disposed of by Sale | South Korea Divestiture          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Divestiture, consideration $ 294       ₩ 384.0
Proceeds from sale of business $ 247 ₩ 330.0      
Net gain on sale of business     $ 82    
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Intangible Assets - Narrative (Details) - USD ($)
Mar. 31, 2024
Jan. 01, 2024
Goodwill and Intangible Assets Disclosure [Abstract]    
Accumulated goodwill impairment $ 0 $ 0
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Intangible Assets - Schedule of goodwill (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2024
USD ($)
Goodwill [Line Items]  
Balance at the beginning of the period $ 918
Currency translation (8)
Balance at the end of the period 910
All Other  
Goodwill [Line Items]  
Balance at the beginning of the period 88
Currency translation (2)
Balance at the end of the period 86
T&HS | Operating segments  
Goodwill [Line Items]  
Balance at the beginning of the period 388
Currency translation (5)
Balance at the end of the period 383
F&II - LATAM | Operating segments  
Goodwill [Line Items]  
Balance at the beginning of the period 146
Currency translation (1)
Balance at the end of the period 145
F&II - U.S./Canada | Operating segments  
Goodwill [Line Items]  
Balance at the beginning of the period 296
Currency translation 0
Balance at the end of the period $ 296
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Investments - Schedule of investments (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Investments [Abstract]    
Equity investments $ 29 $ 27
Equity method investments 98 112
Marketable securities 4 4
Total investments $ 131 $ 143
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Investments - Narrative (Details) - $ / $
 3 Months Ended
Mar. 31, 2024
Dec. 13, 2023
Dec. 12, 2023
Equity Method Investments      
Foreign currency exchange rate   800 366
Argentina joint venture      
Equity Method Investments      
Joint venture, period in arrears 1 month    
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Narrative (Details)
bu in Millions, MMBTU in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2024
USD ($)
MMBTU
bu
Dec. 31, 2023
USD ($)
MMBTU
bu
Hedging relationships    
Loss expected to be reclassified into earnings during the next twelve months $ 52  
Loss expected to be reclassified into earnings during the next twelve months, income tax effect $ 18  
Corn Commodity    
Hedging relationships    
Futures contract (in bushels for corn) | bu 96 109
Natural Gas Commodity    
Hedging relationships    
Natural gas swap contract (in mmbtu of natural gas) | MMBTU 26 28
Foreign Currency Contracts | Not Designated as Hedging Instrument | Short    
Hedging relationships    
Derivative notional amount $ 445 $ 694
Foreign Currency Contracts | Not Designated as Hedging Instrument | Long    
Hedging relationships    
Derivative notional amount 171 182
Foreign Currency Contracts | Designated as Hedging Instrument | Short | Cash flow hedging    
Hedging relationships    
Derivative notional amount 328 449
Foreign Currency Contracts | Designated as Hedging Instrument | Long | Cash flow hedging    
Hedging relationships    
Derivative notional amount $ 480 $ 621
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Schedule of cash flow hedges included in AOCI (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]    
(Losses) included in AOCL $ (1,062) $ (1,056)
Cash flow hedging    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]    
(Losses) included in AOCL (55) (48)
Cash flow hedging | Commodity contracts    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]    
(Losses) included in AOCL (53) (46)
Tax effect of gains (losses) on cash flow hedges 19 17
Cash flow hedging | Foreign currency contracts    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]    
(Losses) included in AOCL 0 0
Tax effect of gains (losses) on cash flow hedges 2 1
Cash flow hedging | Interest rate contracts    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]    
(Losses) included in AOCL (2) (2)
Tax effect of gains (losses) on cash flow hedges $ 1 $ 1
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Balance Sheet Location (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Designated Hedging Instruments    
Fair value of derivatives    
Fair value of derivative instruments, assets $ 22 $ 21
Fair value of derivative instruments, liabilities 74 62
Fair value of derivative instruments, net assets/(liabilities) (52) (41)
Designated Hedging Instruments | Accounts receivable, net    
Fair value of derivatives    
Fair value of derivative instruments, assets 18 17
Designated Hedging Instruments | Other non-current assets    
Fair value of derivatives    
Fair value of derivative instruments, assets 4 4
Designated Hedging Instruments | Accounts payable    
Fair value of derivatives    
Fair value of derivative instruments, liabilities 72 58
Designated Hedging Instruments | Other non-current liabilities    
Fair value of derivatives    
Fair value of derivative instruments, liabilities 2 4
Designated Hedging Instruments | Commodity Contracts    
Fair value of derivatives    
Fair value of derivative instruments, assets 8 6
Fair value of derivative instruments, liabilities 60 46
Fair value of derivative instruments, net assets/(liabilities) (52) (40)
Designated Hedging Instruments | Commodity Contracts | Accounts receivable, net    
Fair value of derivatives    
Fair value of derivative instruments, assets 8 6
Designated Hedging Instruments | Commodity Contracts | Other non-current assets    
Fair value of derivatives    
Fair value of derivative instruments, assets 0 0
Designated Hedging Instruments | Commodity Contracts | Accounts payable    
Fair value of derivatives    
Fair value of derivative instruments, liabilities 58 44
Designated Hedging Instruments | Commodity Contracts | Other non-current liabilities    
Fair value of derivatives    
Fair value of derivative instruments, liabilities 2 2
Designated Hedging Instruments | Foreign Currency Contracts    
Fair value of derivatives    
Fair value of derivative instruments, assets 14 15
Fair value of derivative instruments, liabilities 14 16
Fair value of derivative instruments, net assets/(liabilities) 0 (1)
Designated Hedging Instruments | Foreign Currency Contracts | Accounts receivable, net    
Fair value of derivatives    
Fair value of derivative instruments, assets 10 11
Designated Hedging Instruments | Foreign Currency Contracts | Other non-current assets    
Fair value of derivatives    
Fair value of derivative instruments, assets 4 4
Designated Hedging Instruments | Foreign Currency Contracts | Accounts payable    
Fair value of derivatives    
Fair value of derivative instruments, liabilities 14 14
Designated Hedging Instruments | Foreign Currency Contracts | Other non-current liabilities    
Fair value of derivatives    
Fair value of derivative instruments, liabilities 0 2
Non-Designated Hedging Instruments    
Fair value of derivatives    
Fair value of derivative instruments, assets 8 5
Fair value of derivative instruments, liabilities 9 14
Fair value of derivative instruments, net assets/(liabilities) (1) (9)
Non-Designated Hedging Instruments | Accounts receivable, net    
Fair value of derivatives    
Fair value of derivative instruments, assets 7 5
Non-Designated Hedging Instruments | Other non-current assets    
Fair value of derivatives    
Fair value of derivative instruments, assets 1 0
Non-Designated Hedging Instruments | Accounts payable    
Fair value of derivatives    
Fair value of derivative instruments, liabilities 9 14
Non-Designated Hedging Instruments | Other non-current liabilities    
Fair value of derivatives    
Fair value of derivative instruments, liabilities 0 0
Non-Designated Hedging Instruments | Commodity Contracts    
Fair value of derivatives    
Fair value of derivative instruments, assets 1 0
Fair value of derivative instruments, liabilities 3 2
Fair value of derivative instruments, net assets/(liabilities) (2) (2)
Non-Designated Hedging Instruments | Commodity Contracts | Accounts receivable, net    
Fair value of derivatives    
Fair value of derivative instruments, assets 1 0
Non-Designated Hedging Instruments | Commodity Contracts | Other non-current assets    
Fair value of derivatives    
Fair value of derivative instruments, assets 0 0
Non-Designated Hedging Instruments | Commodity Contracts | Accounts payable    
Fair value of derivatives    
Fair value of derivative instruments, liabilities 3 2
Non-Designated Hedging Instruments | Commodity Contracts | Other non-current liabilities    
Fair value of derivatives    
Fair value of derivative instruments, liabilities 0 0
Non-Designated Hedging Instruments | Foreign Currency Contracts    
Fair value of derivatives    
Fair value of derivative instruments, assets 7 5
Fair value of derivative instruments, liabilities 6 12
Fair value of derivative instruments, net assets/(liabilities) 1 (7)
Non-Designated Hedging Instruments | Foreign Currency Contracts | Accounts receivable, net    
Fair value of derivatives    
Fair value of derivative instruments, assets 6 5
Non-Designated Hedging Instruments | Foreign Currency Contracts | Other non-current assets    
Fair value of derivatives    
Fair value of derivative instruments, assets 1 0
Non-Designated Hedging Instruments | Foreign Currency Contracts | Accounts payable    
Fair value of derivatives    
Fair value of derivative instruments, liabilities 6 12
Non-Designated Hedging Instruments | Foreign Currency Contracts | Other non-current liabilities    
Fair value of derivatives    
Fair value of derivative instruments, liabilities $ 0 $ 0
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Instruments and Hedging Activities - Cash Flow Hedges (Details) - Cash flow hedging - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Hedging relationships    
(Losses) Gains Recognized in AOCL on Derivatives $ (41) $ (58)
(Losses) Gains Reclassified from AOCL into Income (33) 18
Commodity contracts    
Hedging relationships    
(Losses) Gains Recognized in AOCL on Derivatives (42) (67)
Commodity contracts | Cost of sales    
Hedging relationships    
(Losses) Gains Reclassified from AOCL into Income (33) 9
Foreign currency contracts    
Hedging relationships    
(Losses) Gains Recognized in AOCL on Derivatives 1 9
Foreign currency contracts | Net sales/Cost of sales    
Hedging relationships    
(Losses) Gains Reclassified from AOCL into Income $ 0 $ 9
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements (Details) - Fair Value, Recurring - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Fair value of assets and liabilities    
Marketable securities $ 4 $ 4
Derivative assets 30 26
Derivative liabilities 83 76
Long-term debt 1,575 1,591
Level 1    
Fair value of assets and liabilities    
Marketable securities 4 4
Derivative assets 29 26
Derivative liabilities 53 43
Long-term debt 0 0
Level 2    
Fair value of assets and liabilities    
Marketable securities 0 0
Derivative assets 1 0
Derivative liabilities 30 33
Long-term debt 1,575 1,591
Level 3    
Fair value of assets and liabilities    
Marketable securities 0 0
Derivative assets 0 0
Derivative liabilities 0 0
Long-term debt $ 0 $ 0
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financing Arrangements - Schedule of Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Financing Arrangements    
Total long-term debt $ 1,740 $ 1,740
Total short-term borrowings 141 448
Total debt $ 1,881 $ 2,188
2.900% senior notes due June 1, 2030    
Financing Arrangements    
Debt, interest rate 2.90% 2.90%
Total long-term debt $ 596 $ 596
3.200% senior notes due October 1, 2026    
Financing Arrangements    
Debt, interest rate 3.20% 3.20%
Total long-term debt $ 499 $ 499
3.900% senior notes due June 1, 2050    
Financing Arrangements    
Debt, interest rate 3.90% 3.90%
Total long-term debt $ 391 $ 391
6.625% senior notes due April 15, 2037    
Financing Arrangements    
Debt, interest rate 6.625% 6.625%
Total long-term debt $ 253 $ 253
Revolving credit agreement    
Financing Arrangements    
Total long-term debt 0 0
Other long-term borrowings    
Financing Arrangements    
Total long-term debt 1 1
Commercial paper    
Financing Arrangements    
Short-term borrowings 16 327
Other short-term borrowings    
Financing Arrangements    
Short-term borrowings $ 125 $ 121
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financing Arrangements - Narrative (Details) - Commercial paper - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Long-term debt      
Maximum aggregate principal amount $ 1,000    
Average amount of commercial paper outstanding $ 118 $ 460  
Weighted average interest rate 5.51% 4.79%  
Weighted average maturity 8 days 7 days  
Short-term borrowings $ 16   $ 327
Basis spread 5.45%   5.50%
Weighted average maturity of outstanding balance 4 days   11 days
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pension and Other Postretirement Benefits - Components of net periodic benefit cost (Details) - Pension Plan - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
U.S. Plans    
Benefit plans    
Service cost $ 1 $ 0
Interest cost 3 4
Expected return on plan assets (4) (4)
Net periodic cost 0 0
Cash contribution expected during fiscal year 1  
Non-U.S. Plans    
Benefit plans    
Service cost 1 1
Interest cost 2 2
Expected return on plan assets (2) (2)
Net periodic cost 1 $ 1
Cash contribution expected during fiscal year 4  
Cash contributions $ 1  
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pension and Other Postretirement Benefits - Narrative (Details) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Postemployment Retirement Benefits    
Benefit plans    
Interest cost $ 1,000,000 $ 1,000,000
Service cost 0 0
U.S. Plans | Pension Plan    
Benefit plans    
Cash contribution expected during fiscal year 1,000,000  
Interest cost 3,000,000 4,000,000
Service cost 1,000,000 0
Non-U.S. Plans | Pension Plan    
Benefit plans    
Cash contribution expected during fiscal year 4,000,000  
Cash contributions 1,000,000  
Interest cost 2,000,000 2,000,000
Service cost $ 1,000,000 $ 1,000,000
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity - Treasury Stock (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Sep. 26, 2022
Treasury Stock      
Treasury stock:      
Purchase/acquisition of treasury stock (in shares) 5,000 0  
Repurchases of common stock $ 1    
2022 Stock Repurchase Program      
Treasury stock:      
Stock repurchase program, number of shares authorized     6,000,000
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity - Schedule of stock based compensation expense (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-based compensation expense    
Pre-tax compensation expense $ 13 $ 9
Income tax benefit (1) (1)
Total share-based compensation expense, net of income taxes 12 8
Stock options    
Share-based compensation expense    
Pre-tax compensation expense 2 1
Income tax benefit 0 0
Total share-based compensation expense, net of income taxes 2 1
RSUs | Employee    
Share-based compensation expense    
Pre-tax compensation expense 7 4
Income tax benefit (1) (1)
Total share-based compensation expense, net of income taxes 6 3
Performance shares and other share-based awards    
Share-based compensation expense    
Pre-tax compensation expense 4 4
Income tax benefit 0 0
Total share-based compensation expense, net of income taxes $ 4 $ 4
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity - Stock Options (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Share-based compensation      
Options granted (in shares) 178 197  
Assumptions used to measure the fair value of awards      
Expected life (in years) 5 years 6 months 5 years 6 months  
Risk-free interest rate 4.20% 4.00%  
Expected volatility 28.10% 28.30%  
Expected dividend yield 2.90% 2.90%  
Stock options, Number of Options      
Outstanding at the beginning of the period (in shares) 1,953    
Granted (in shares) 178 197  
Exercised (in shares) (165)    
Cancelled (in shares) (21)    
Outstanding at the end of the period (in shares) 1,945   1,953
Exercisable at the end of the period (in shares) 1,573    
Stock options, Weighted Average Exercise Price per Share      
Outstanding at the beginning of the period (in dollars per share) $ 96.61    
Granted (in dollars per share) 108.38    
Exercised (in dollars per share) 79.87    
Cancelled (in dollars per share) 103.69    
Outstanding at the end of the period (in dollars per share) 99.03   $ 96.61
Exercisable at the end of the period (in dollars per share) $ 98.53    
Additional information pertaining to stock options      
Average Remaining Contractual Term, Outstanding 5 years 5 months 8 days   4 years 11 months 19 days
Average Remaining Contractual Term, Exercisable 4 years 6 months 21 days    
Aggregate Intrinsic Value, Outstanding (in dollars) $ 38   $ 29
Aggregate Intrinsic Value, Exercisable (in dollars) 32    
Cash received from exercise of stock options $ 13    
Weighted average grant date fair value of stock options granted (in dollars per share) $ 26.33 $ 23.80  
Total intrinsic value of stock options exercised (in dollars) $ 5 $ 6  
Stock options      
Share-based compensation      
Term of award 10 years    
Period of vesting 3 years    
Additional information pertaining to stock options      
Unrecognized compensation cost $ 6    
Weighted-average period for amortization of unrecognized compensation cost 1 year 6 months    
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity - Restricted Stock Units (Details) - RSUs - Employee
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Share-based compensation  
Vesting terms 3 years
Number of Restricted Shares (in thousands)  
Non-vested at the beginning of the period (in shares) | shares 552
Granted (in shares) | shares 191
Vested (in shares) | shares (161)
Cancelled (in shares) | shares (18)
Non-vested at the end of the period (in shares) | shares 564
Weighted Average Fair Value per Share  
Non-vested at the beginning of the period (in dollars per share) | $ / shares $ 92.05
Granted (in dollars per share) | $ / shares 107.65
Vested (in dollars per share) | $ / shares 87.15
Cancelled (in dollars per share) | $ / shares 92.77
Non-vested at the end of the period (in dollars per share) | $ / shares $ 98.84
Other disclosures  
Unrecognized compensation cost | $ $ 32
Weighted-average period for amortization of unrecognized compensation cost 2 years
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity - Performance Shares (Details)
$ / shares in Units, shares in Thousands, $ in Millions
 1 Months Ended 3 Months Ended
Feb. 29, 2024
Mar. 31, 2024
USD ($)
metric
$ / shares
shares
Performance Shares    
Share-based compensation    
Number of tranches | metric   2
Granted (in shares)   86
Weighted-average fair value per share, granted (in dollars per share) | $ / shares   $ 127.97
Unrecognized compensation cost | $   $ 20
Remaining requisite service period (in years)   2 years 4 months 24 days
Cancelled (in shares)   1,000
Performance Shares | 2021 Awards    
Share-based compensation    
Award pay out achieved (as a percent) 200.00%  
Performance Shares | 2022 Awards    
Share-based compensation    
Estimated pay out (as a percent)   200.00%
Performance shares, vesting based on TSR    
Share-based compensation    
Percentage of share-based compensation award   50.00%
Performance shares calculation period   3 years
Vesting terms   3 years
Performance shares, vesting based on TSR | Minimum    
Share-based compensation    
Performance shares available for vesting (as a percent)   0.00%
Performance shares, vesting based on TSR | Maximum    
Share-based compensation    
Performance shares available for vesting (as a percent)   200.00%
Performance shares, vesting based on Adjusted ROIC    
Share-based compensation    
Percentage of share-based compensation award   50.00%
Performance shares calculation period   3 years
Vesting terms   3 years
Performance shares, vesting based on Adjusted ROIC | Minimum    
Share-based compensation    
Performance shares available for vesting (as a percent)   0.00%
Performance shares, vesting based on Adjusted ROIC | Maximum    
Share-based compensation    
Performance shares available for vesting (as a percent)   200.00%
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity - AOCL (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Accumulated Other Comprehensive Loss    
Balance at beginning of period $ 3,552  
Other comprehensive (loss) before reclassification adjustments (41) $ (52)
(Gain) reclassified from AOCL 34 (18)
Tax benefit 1 20
Net other comprehensive (loss) income (6) (50)
Balance at end of period 3,740  
AOCL    
Accumulated Other Comprehensive Loss    
Balance at beginning of period (1,056) (1,048)
Balance at end of period (1,062) (1,098)
Cumulative Translation Adjustment    
Accumulated Other Comprehensive Loss    
Balance at beginning of period (961) (1,008)
Other comprehensive (loss) before reclassification adjustments 0 6
(Gain) reclassified from AOCL 0 0
Tax benefit 0 0
Net other comprehensive (loss) income 0 6
Balance at end of period (961) (1,002)
Hedging Activities    
Accumulated Other Comprehensive Loss    
Balance at beginning of period (48) 6
Other comprehensive (loss) before reclassification adjustments (41) (58)
(Gain) reclassified from AOCL 33 (18)
Tax benefit 1 20
Net other comprehensive (loss) income (7) (56)
Balance at end of period (55) (50)
Pension and Postretirement Adjustment    
Accumulated Other Comprehensive Loss    
Balance at beginning of period (47) (46)
Other comprehensive (loss) before reclassification adjustments 0 0
(Gain) reclassified from AOCL 1 0
Tax benefit 0 0
Net other comprehensive (loss) income 1 0
Balance at end of period $ (46) $ (46)
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity - EPS (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Basic EPS    
Net Income Available to Ingredion $ 216 $ 191
Weighted average number of shares outstanding, basic 65.7 66.1
Basic earnings per common share of Ingredion (in dollars per share) $ 3.29 $ 2.89
Effect of Dilutive Securities:    
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards 1.1 1.0
Diluted EPS:    
Net Income Available to Ingredion $ 216 $ 191
Weighted average number of shares outstanding - diluted, Total 66.8 67.1
Diluted earnings per common share of Ingredion (in dollars per share) $ 3.23 $ 2.85
Antidilutive securities excluded in calculation of diluted EPS:    
Antidilutive securities excluded from computation of earnings per share amount (in shares) 0.5 0.7
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information - Net Sales and Operating Income (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Segment information    
Net sales $ 1,882 $ 2,137
Operating income, subtotal 216 296
Resegmentation costs (3) 0
Other matters 0 (5)
Operating income 213 291
T&HS    
Segment information    
Net sales 597 665
F&II - LATAM    
Segment information    
Net sales 616 667
F&II - U.S./Canada    
Segment information    
Net sales 541 608
Operating segments | T&HS    
Segment information    
Net sales 612 698
Operating income, subtotal 74 127
Operating segments | F&II - LATAM    
Segment information    
Net sales 626 677
Operating income, subtotal 101 122
Operating segments | F&II - U.S./Canada    
Segment information    
Net sales 567 635
Operating income, subtotal 87 92
All Other    
Segment information    
Net sales 131 201
Operating income, subtotal (4) (8)
Operating segments and all other    
Segment information    
Net sales 1,936 2,211
Intersegment sales    
Segment information    
Net sales (54) (74)
Intersegment sales | T&HS    
Segment information    
Net sales (15) (33)
Intersegment sales | F&II - LATAM    
Segment information    
Net sales (10) (10)
Intersegment sales | F&II - U.S./Canada    
Segment information    
Net sales (26) (27)
Intersegment sales, all other    
Segment information    
Net sales (3) (4)
All other, excluding intersegment sales    
Segment information    
Net sales 128 197
Corporate    
Segment information    
Operating income, subtotal $ (42) $ (37)
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information - Property, Plant and Equipment (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Segment information    
Total Property, plant and equipment, net $ 2,334 $ 2,370
All Other    
Segment information    
Total Property, plant and equipment, net 411 415
Texture & Healthful Solutions | Operating segments    
Segment information    
Total Property, plant and equipment, net 838 855
F&II - LATAM | Operating segments    
Segment information    
Total Property, plant and equipment, net 543 552
F&II - U.S./Canada | Operating segments    
Segment information    
Total Property, plant and equipment, net $ 542 $ 548
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2022
Mar. 31, 2024
Dec. 31, 2023
Commitments and Contingencies      
Tax benefit related to the exclusion of certain tax incentives $ 27    
BRAZIL | Reduction in Taxes | Foreign Tax Authority      
Commitments and Contingencies      
Brazilian deferred tax credits   $ 32 $ 32
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplementary Information - Accounts Receivable, Net (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Supplementary Information    
Accounts receivable — trade $ 1,128 $ 1,145
Accounts receivable — other 173 154
Allowance for credit losses (17) (20)
Total accounts receivable, net $ 1,284 $ 1,279
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplementary Information - Inventories (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Supplementary Information    
Finished and in process $ 852 $ 926
Raw materials 402 434
Manufacturing supplies 90 90
Total inventories $ 1,344 $ 1,450
XML 73 R61.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplementary Information - Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Quarterly Financial Information Disclosure [Abstract]    
Supplier finance program obligation $ 149 $ 153
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Accounts payable, Accrued liabilities and liabilities held for sale Accounts payable, Accrued liabilities and liabilities held for sale
XML 74 R62.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplementary Information - Schedule of Supply Chain Finance Program (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2024
USD ($)
Supplier Finance Program, Obligation [Roll Forward]  
Outstanding at the beginning of the year $ 153
Invoices added during the year 141
Invoices paid during the year (141)
Currency translation adjustment (4)
Outstanding as of March 31, 2024 $ 149
EXCEL 75 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 76 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 77 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 79 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 257 280 1 false 72 0 false 10 false false R1.htm 0000001 - Document - Cover Sheet http://www.ingredion.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Statements of Income (Unaudited) Sheet http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited Condensed Consolidated Statements of Income (Unaudited) Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) Sheet http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited Condensed Consolidated Statements of Comprehensive Income (Unaudited) Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) Sheet http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnauditedParenthetical Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.ingredion.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 6 false false R7.htm 0000007 - Statement - Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited) Sheet http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited) Statements 7 false false R8.htm 0000008 - Statement - Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited) (Parenthetical) Sheet http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnauditedParenthetical Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited) (Parenthetical) Statements 8 false false R9.htm 0000009 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 9 false false R10.htm 0000010 - Disclosure - Basis of Presentation and New Accounting Standards Sheet http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandards Basis of Presentation and New Accounting Standards Notes 10 false false R11.htm 0000011 - Disclosure - Divestitures Sheet http://www.ingredion.com/role/Divestitures Divestitures Notes 11 false false R12.htm 0000012 - Disclosure - Intangible Assets Sheet http://www.ingredion.com/role/IntangibleAssets Intangible Assets Notes 12 false false R13.htm 0000013 - Disclosure - Investments Sheet http://www.ingredion.com/role/Investments Investments Notes 13 false false R14.htm 0000014 - Disclosure - Derivative Instruments and Hedging Activities Sheet http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivities Derivative Instruments and Hedging Activities Notes 14 false false R15.htm 0000015 - Disclosure - Fair Value Measurements Sheet http://www.ingredion.com/role/FairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 0000016 - Disclosure - Financing Arrangements Sheet http://www.ingredion.com/role/FinancingArrangements Financing Arrangements Notes 16 false false R17.htm 0000017 - Disclosure - Pension and Other Postretirement Benefits Sheet http://www.ingredion.com/role/PensionandOtherPostretirementBenefits Pension and Other Postretirement Benefits Notes 17 false false R18.htm 0000018 - Disclosure - Equity Sheet http://www.ingredion.com/role/Equity Equity Notes 18 false false R19.htm 0000019 - Disclosure - Segment Information Sheet http://www.ingredion.com/role/SegmentInformation Segment Information Notes 19 false false R20.htm 0000020 - Disclosure - Commitments and Contingencies Sheet http://www.ingredion.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 20 false false R21.htm 0000021 - Disclosure - Supplementary Information Sheet http://www.ingredion.com/role/SupplementaryInformation Supplementary Information Notes 21 false false R22.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 22 false false R23.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 23 false false R24.htm 9954471 - Disclosure - Basis of Presentation and New Accounting Standards (Policies) Sheet http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandardsPolicies Basis of Presentation and New Accounting Standards (Policies) Policies http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandards 24 false false R25.htm 9954472 - Disclosure - Intangible Assets (Tables) Sheet http://www.ingredion.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.ingredion.com/role/IntangibleAssets 25 false false R26.htm 9954473 - Disclosure - Investments (Tables) Sheet http://www.ingredion.com/role/InvestmentsTables Investments (Tables) Tables http://www.ingredion.com/role/Investments 26 false false R27.htm 9954474 - Disclosure - Derivative Instruments and Hedging Activities (Tables) Sheet http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesTables Derivative Instruments and Hedging Activities (Tables) Tables http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivities 27 false false R28.htm 9954475 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.ingredion.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.ingredion.com/role/FairValueMeasurements 28 false false R29.htm 9954476 - Disclosure - Financing Arrangements (Tables) Sheet http://www.ingredion.com/role/FinancingArrangementsTables Financing Arrangements (Tables) Tables http://www.ingredion.com/role/FinancingArrangements 29 false false R30.htm 9954477 - Disclosure - Pension and Other Postretirement Benefits (Tables) Sheet http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsTables Pension and Other Postretirement Benefits (Tables) Tables http://www.ingredion.com/role/PensionandOtherPostretirementBenefits 30 false false R31.htm 9954478 - Disclosure - Equity (Tables) Sheet http://www.ingredion.com/role/EquityTables Equity (Tables) Tables http://www.ingredion.com/role/Equity 31 false false R32.htm 9954479 - Disclosure - Segment Information (Tables) Sheet http://www.ingredion.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.ingredion.com/role/SegmentInformation 32 false false R33.htm 9954480 - Disclosure - Supplementary Information (Tables) Sheet http://www.ingredion.com/role/SupplementaryInformationTables Supplementary Information (Tables) Tables http://www.ingredion.com/role/SupplementaryInformation 33 false false R34.htm 9954481 - Disclosure - Basis of Presentation and New Accounting Standards (Details) Sheet http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandardsDetails Basis of Presentation and New Accounting Standards (Details) Details http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandardsPolicies 34 false false R35.htm 9954482 - Disclosure - Divestitures (Details) Sheet http://www.ingredion.com/role/DivestituresDetails Divestitures (Details) Details http://www.ingredion.com/role/Divestitures 35 false false R36.htm 9954483 - Disclosure - Intangible Assets - Narrative (Details) Sheet http://www.ingredion.com/role/IntangibleAssetsNarrativeDetails Intangible Assets - Narrative (Details) Details 36 false false R37.htm 9954484 - Disclosure - Intangible Assets - Schedule of goodwill (Details) Sheet http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails Intangible Assets - Schedule of goodwill (Details) Details 37 false false R38.htm 9954485 - Disclosure - Investments - Schedule of investments (Details) Sheet http://www.ingredion.com/role/InvestmentsScheduleofinvestmentsDetails Investments - Schedule of investments (Details) Details 38 false false R39.htm 9954486 - Disclosure - Investments - Narrative (Details) Sheet http://www.ingredion.com/role/InvestmentsNarrativeDetails Investments - Narrative (Details) Details 39 false false R40.htm 9954487 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details) Sheet http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails Derivative Instruments and Hedging Activities - Narrative (Details) Details 40 false false R41.htm 9954488 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of cash flow hedges included in AOCI (Details) Sheet http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails Derivative Instruments and Hedging Activities - Schedule of cash flow hedges included in AOCI (Details) Details 41 false false R42.htm 9954489 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet Location (Details) Sheet http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails Derivative Instruments and Hedging Activities - Balance Sheet Location (Details) Details 42 false false R43.htm 9954490 - Disclosure - Derivative Instruments and Hedging Activities - Cash Flow Hedges (Details) Sheet http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails Derivative Instruments and Hedging Activities - Cash Flow Hedges (Details) Details 43 false false R44.htm 9954491 - Disclosure - Fair Value Measurements (Details) Sheet http://www.ingredion.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.ingredion.com/role/FairValueMeasurementsTables 44 false false R45.htm 9954492 - Disclosure - Financing Arrangements - Schedule of Debt (Details) Sheet http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails Financing Arrangements - Schedule of Debt (Details) Details 45 false false R46.htm 9954493 - Disclosure - Financing Arrangements - Narrative (Details) Sheet http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails Financing Arrangements - Narrative (Details) Details 46 false false R47.htm 9954494 - Disclosure - Pension and Other Postretirement Benefits - Components of net periodic benefit cost (Details) Sheet http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails Pension and Other Postretirement Benefits - Components of net periodic benefit cost (Details) Details 47 false false R48.htm 9954495 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) Sheet http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails Pension and Other Postretirement Benefits - Narrative (Details) Details 48 false false R49.htm 9954496 - Disclosure - Equity - Treasury Stock (Details) Sheet http://www.ingredion.com/role/EquityTreasuryStockDetails Equity - Treasury Stock (Details) Details 49 false false R50.htm 9954497 - Disclosure - Equity - Schedule of stock based compensation expense (Details) Sheet http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails Equity - Schedule of stock based compensation expense (Details) Details 50 false false R51.htm 9954498 - Disclosure - Equity - Stock Options (Details) Sheet http://www.ingredion.com/role/EquityStockOptionsDetails Equity - Stock Options (Details) Details 51 false false R52.htm 9954499 - Disclosure - Equity - Restricted Stock Units (Details) Sheet http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails Equity - Restricted Stock Units (Details) Details 52 false false R53.htm 9954500 - Disclosure - Equity - Performance Shares (Details) Sheet http://www.ingredion.com/role/EquityPerformanceSharesDetails Equity - Performance Shares (Details) Details 53 false false R54.htm 9954501 - Disclosure - Equity - AOCL (Details) Sheet http://www.ingredion.com/role/EquityAOCLDetails Equity - AOCL (Details) Details 54 false false R55.htm 9954502 - Disclosure - Equity - EPS (Details) Sheet http://www.ingredion.com/role/EquityEPSDetails Equity - EPS (Details) Details 55 false false R56.htm 9954503 - Disclosure - Segment Information - Net Sales and Operating Income (Details) Sheet http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails Segment Information - Net Sales and Operating Income (Details) Details 56 false false R57.htm 9954504 - Disclosure - Segment Information - Property, Plant and Equipment (Details) Sheet http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails Segment Information - Property, Plant and Equipment (Details) Details 57 false false R58.htm 9954505 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.ingredion.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.ingredion.com/role/CommitmentsandContingencies 58 false false R59.htm 9954506 - Disclosure - Supplementary Information - Accounts Receivable, Net (Details) Sheet http://www.ingredion.com/role/SupplementaryInformationAccountsReceivableNetDetails Supplementary Information - Accounts Receivable, Net (Details) Details 59 false false R60.htm 9954507 - Disclosure - Supplementary Information - Inventories (Details) Sheet http://www.ingredion.com/role/SupplementaryInformationInventoriesDetails Supplementary Information - Inventories (Details) Details 60 false false R61.htm 9954508 - Disclosure - Supplementary Information - Narrative (Details) Sheet http://www.ingredion.com/role/SupplementaryInformationNarrativeDetails Supplementary Information - Narrative (Details) Details 61 false false R62.htm 9954509 - Disclosure - Supplementary Information - Schedule of Supply Chain Finance Program (Details) Sheet http://www.ingredion.com/role/SupplementaryInformationScheduleofSupplyChainFinanceProgramDetails Supplementary Information - Schedule of Supply Chain Finance Program (Details) Details 62 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: ecd:TrdArrDuration - ingr-20240331.htm 4 ingr-20240331.htm ingr-20240331.xsd ingr-20240331_cal.xml ingr-20240331_def.xml ingr-20240331_lab.xml ingr-20240331_pre.xml ingr-20240331_g1.gif http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 82 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ingr-20240331.htm": { "nsprefix": "ingr", "nsuri": "http://www.ingredion.com/20240331", "dts": { "inline": { "local": [ "ingr-20240331.htm" ] }, "schema": { "local": [ "ingr-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "ingr-20240331_cal.xml" ] }, "definitionLink": { "local": [ "ingr-20240331_def.xml" ] }, "labelLink": { "local": [ "ingr-20240331_lab.xml" ] }, "presentationLink": { "local": [ "ingr-20240331_pre.xml" ] } }, "keyStandard": 248, "keyCustom": 32, "axisStandard": 27, "axisCustom": 0, "memberStandard": 43, "memberCustom": 28, "hidden": { "total": 8, "http://xbrl.sec.gov/dei/2023": 5, "http://fasb.org/us-gaap/2023": 2, "http://xbrl.sec.gov/ecd/2023": 1 }, "contextCount": 257, "entityCount": 1, "segmentCount": 72, "elementCount": 559, "unitCount": 10, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 696, "http://xbrl.sec.gov/dei/2023": 29, "http://xbrl.sec.gov/ecd/2023": 16 }, "report": { "R1": { "role": "http://www.ingredion.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "longName": "0000002 - Statement - Condensed Consolidated Statements of Income (Unaudited)", "shortName": "Condensed Consolidated Statements of Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } }, "R3": { "role": "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited", "longName": "0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } }, "R4": { "role": "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnauditedParenthetical", "longName": "0000004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical)", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets", "longName": "0000005 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "longName": "0000006 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited", "longName": "0000007 - Statement - Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited)", "shortName": "Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-22", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-22", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnauditedParenthetical", "longName": "0000008 - Statement - Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited) (Parenthetical)", "shortName": "Condensed Consolidated Statements of Equity and Redeemable Equity (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "longName": "0000009 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } }, "R10": { "role": "http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandards", "longName": "0000010 - Disclosure - Basis of Presentation and New Accounting Standards", "shortName": "Basis of Presentation and New Accounting Standards", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.ingredion.com/role/Divestitures", "longName": "0000011 - Disclosure - Divestitures", "shortName": "Divestitures", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.ingredion.com/role/IntangibleAssets", "longName": "0000012 - Disclosure - Intangible Assets", "shortName": "Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.ingredion.com/role/Investments", "longName": "0000013 - Disclosure - Investments", "shortName": "Investments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivities", "longName": "0000014 - Disclosure - Derivative Instruments and Hedging Activities", "shortName": "Derivative Instruments and Hedging Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.ingredion.com/role/FairValueMeasurements", "longName": "0000015 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.ingredion.com/role/FinancingArrangements", "longName": "0000016 - Disclosure - Financing Arrangements", "shortName": "Financing Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.ingredion.com/role/PensionandOtherPostretirementBenefits", "longName": "0000017 - Disclosure - Pension and Other Postretirement Benefits", "shortName": "Pension and Other Postretirement Benefits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.ingredion.com/role/Equity", "longName": "0000018 - Disclosure - Equity", "shortName": "Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.ingredion.com/role/SegmentInformation", "longName": "0000019 - Disclosure - Segment Information", "shortName": "Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.ingredion.com/role/CommitmentsandContingencies", "longName": "0000020 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.ingredion.com/role/SupplementaryInformation", "longName": "0000021 - Disclosure - Supplementary Information", "shortName": "Supplementary Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R22": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": null }, "R23": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrTrmntdFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrTrmntdFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandardsPolicies", "longName": "9954471 - Disclosure - Basis of Presentation and New Accounting Standards (Policies)", "shortName": "Basis of Presentation and New Accounting Standards (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.ingredion.com/role/IntangibleAssetsTables", "longName": "9954472 - Disclosure - Intangible Assets (Tables)", "shortName": "Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.ingredion.com/role/InvestmentsTables", "longName": "9954473 - Disclosure - Investments (Tables)", "shortName": "Investments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesTables", "longName": "9954474 - Disclosure - Derivative Instruments and Hedging Activities (Tables)", "shortName": "Derivative Instruments and Hedging Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.ingredion.com/role/FairValueMeasurementsTables", "longName": "9954475 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.ingredion.com/role/FinancingArrangementsTables", "longName": "9954476 - Disclosure - Financing Arrangements (Tables)", "shortName": "Financing Arrangements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsTables", "longName": "9954477 - Disclosure - Pension and Other Postretirement Benefits (Tables)", "shortName": "Pension and Other Postretirement Benefits (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.ingredion.com/role/EquityTables", "longName": "9954478 - Disclosure - Equity (Tables)", "shortName": "Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.ingredion.com/role/SegmentInformationTables", "longName": "9954479 - Disclosure - Segment Information (Tables)", "shortName": "Segment Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.ingredion.com/role/SupplementaryInformationTables", "longName": "9954480 - Disclosure - Supplementary Information (Tables)", "shortName": "Supplementary Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandardsDetails", "longName": "9954481 - Disclosure - Basis of Presentation and New Accounting Standards (Details)", "shortName": "Basis of Presentation and New Accounting Standards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.ingredion.com/role/DivestituresDetails", "longName": "9954482 - Disclosure - Divestitures (Details)", "shortName": "Divestitures (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProceedsFromDivestitureOfBusinesses", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-41", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } }, "R36": { "role": "http://www.ingredion.com/role/IntangibleAssetsNarrativeDetails", "longName": "9954483 - Disclosure - Intangible Assets - Narrative (Details)", "shortName": "Intangible Assets - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails", "longName": "9954484 - Disclosure - Intangible Assets - Schedule of goodwill (Details)", "shortName": "Intangible Assets - Schedule of goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.ingredion.com/role/InvestmentsScheduleofinvestmentsDetails", "longName": "9954485 - Disclosure - Investments - Schedule of investments (Details)", "shortName": "Investments - Schedule of investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.ingredion.com/role/InvestmentsNarrativeDetails", "longName": "9954486 - Disclosure - Investments - Narrative (Details)", "shortName": "Investments - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-59", "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "unitRef": "arsPerUSD", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-59", "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "unitRef": "arsPerUSD", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "longName": "9954487 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details)", "shortName": "Derivative Instruments and Hedging Activities - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails", "longName": "9954488 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of cash flow hedges included in AOCI (Details)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of cash flow hedges included in AOCI (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-78", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } }, "R42": { "role": "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails", "longName": "9954489 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)", "shortName": "Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-94", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-94", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails", "longName": "9954490 - Disclosure - Derivative Instruments and Hedging Activities - Cash Flow Hedges (Details)", "shortName": "Derivative Instruments and Hedging Activities - Cash Flow Hedges (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-148", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-148", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.ingredion.com/role/FairValueMeasurementsDetails", "longName": "9954491 - Disclosure - Fair Value Measurements (Details)", "shortName": "Fair Value Measurements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-150", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-150", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails", "longName": "9954492 - Disclosure - Financing Arrangements - Schedule of Debt (Details)", "shortName": "Financing Arrangements - Schedule of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LongTermDebtNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } }, "R46": { "role": "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails", "longName": "9954493 - Disclosure - Financing Arrangements - Narrative (Details)", "shortName": "Financing Arrangements - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-170", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-170", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "longName": "9954494 - Disclosure - Pension and Other Postretirement Benefits - Components of net periodic benefit cost (Details)", "shortName": "Pension and Other Postretirement Benefits - Components of net periodic benefit cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-177", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-177", "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } }, "R48": { "role": "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "longName": "9954495 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details)", "shortName": "Pension and Other Postretirement Benefits - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-184", "name": "us-gaap:DefinedBenefitPlanInterestCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "us-gaap:DefinedBenefitPlanInterestCost", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-184", "name": "us-gaap:DefinedBenefitPlanInterestCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "us-gaap:DefinedBenefitPlanInterestCost", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.ingredion.com/role/EquityTreasuryStockDetails", "longName": "9954496 - Disclosure - Equity - Treasury Stock (Details)", "shortName": "Equity - Treasury Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-14", "name": "us-gaap:TreasuryStockSharesAcquired", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-14", "name": "us-gaap:TreasuryStockSharesAcquired", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails", "longName": "9954497 - Disclosure - Equity - Schedule of stock based compensation expense (Details)", "shortName": "Equity - Schedule of stock based compensation expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.ingredion.com/role/EquityStockOptionsDetails", "longName": "9954498 - Disclosure - Equity - Stock Options (Details)", "shortName": "Equity - Stock Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } }, "R52": { "role": "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "longName": "9954499 - Disclosure - Equity - Restricted Stock Units (Details)", "shortName": "Equity - Restricted Stock Units (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-188", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-188", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "longName": "9954500 - Disclosure - Equity - Performance Shares (Details)", "shortName": "Equity - Performance Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-196", "name": "ingr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfTranches", "unitRef": "metric", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-196", "name": "ingr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfTranches", "unitRef": "metric", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.ingredion.com/role/EquityAOCLDetails", "longName": "9954501 - Disclosure - Equity - AOCL (Details)", "shortName": "Equity - AOCL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } }, "R55": { "role": "http://www.ingredion.com/role/EquityEPSDetails", "longName": "9954502 - Disclosure - Equity - EPS (Details)", "shortName": "Equity - EPS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "longName": "9954503 - Disclosure - Segment Information - Net Sales and Operating Income (Details)", "shortName": "Segment Information - Net Sales and Operating Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ingr:OperatingIncomeLossBeforeOtherCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } }, "R57": { "role": "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails", "longName": "9954504 - Disclosure - Segment Information - Property, Plant and Equipment (Details)", "shortName": "Segment Information - Property, Plant and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:PropertyPlantAndEquipmentNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-56", "name": "us-gaap:PropertyPlantAndEquipmentNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } }, "R58": { "role": "http://www.ingredion.com/role/CommitmentsandContingenciesDetails", "longName": "9954505 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-250", "name": "ingr:EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitRelatedToNonTaxableBrazilICMSIncentives", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-250", "name": "ingr:EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitRelatedToNonTaxableBrazilICMSIncentives", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.ingredion.com/role/SupplementaryInformationAccountsReceivableNetDetails", "longName": "9954506 - Disclosure - Supplementary Information - Accounts Receivable, Net (Details)", "shortName": "Supplementary Information - Accounts Receivable, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-4", "name": "ingr:AccountsReceivableTradeCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "ingr:AccountsReceivableTradeCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.ingredion.com/role/SupplementaryInformationInventoriesDetails", "longName": "9954507 - Disclosure - Supplementary Information - Inventories (Details)", "shortName": "Supplementary Information - Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:InventoryFinishedGoodsAndWorkInProcess", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:InventoryFinishedGoodsAndWorkInProcess", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.ingredion.com/role/SupplementaryInformationNarrativeDetails", "longName": "9954508 - Disclosure - Supplementary Information - Narrative (Details)", "shortName": "Supplementary Information - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:SupplierFinanceProgramObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SupplierFinanceProgramTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": null }, "R62": { "role": "http://www.ingredion.com/role/SupplementaryInformationScheduleofSupplyChainFinanceProgramDetails", "longName": "9954509 - Disclosure - Supplementary Information - Schedule of Supply Chain Finance Program (Details)", "shortName": "Supplementary Information - Schedule of Supply Chain Finance Program (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:SupplierFinanceProgramObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplierFinanceProgramObligationIncrease", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SupplierFinanceProgramTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ingr-20240331.htm", "unique": true } } }, "tag": { "ingr_A2021AwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "A2021AwardsMember", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2021 Awards", "label": "2021 Awards [Member]", "documentation": "Award granted in 2021." } } }, "auth_ref": [] }, "ingr_A2022AwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "A2022AwardsMember", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2022 Awards", "label": "2022 Awards [Member]", "documentation": "2022 Awards" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r34", "r712" ] }, "us-gaap_AccountsPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable [Member]", "documentation": "Obligations incurred and payable to vendors for goods and services received." } } }, "auth_ref": [ "r29" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/SupplementaryInformationAccountsReceivableNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationAccountsReceivableNetDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r277", "r278" ] }, "ingr_AccountsReceivableNetMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "AccountsReceivableNetMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "label": "Accounts Receivable, Net [Member]", "documentation": "Accounts receivable, an item in the statement of financial position in which the fair value amounts of the derivative instruments are included." } } }, "auth_ref": [] }, "ingr_AccountsReceivableOtherCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "AccountsReceivableOtherCurrent", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/SupplementaryInformationAccountsReceivableNetDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationAccountsReceivableNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable \u2014 other", "label": "Accounts Receivable, Other, Current", "documentation": "Amount of other receivables, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [] }, "ingr_AccountsReceivableTradeCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "AccountsReceivableTradeCurrent", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/SupplementaryInformationAccountsReceivableNetDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationAccountsReceivableNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable \u2014 trade", "label": "Accounts Receivable, Trade, Current", "documentation": "Amount of trade receivables, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and Postretirement Adjustment", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r5", "r20", "r45", "r811", "r812", "r813" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r55", "r172", "r550" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Activities", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r188", "r197", "r198", "r489", "r681", "r811" ] }, "ingr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectTaxEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectTaxEffect", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax effect of gains (losses) on cash flow hedges", "label": "Accumulated Other Comprehensive Income (Loss) Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges Effect Tax Effect", "documentation": "Total tax effect of the accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. The change includes an entity's share of an equity investee's increase or decrease in deferred hedging gains or losses." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of accumulated other comprehensive income (loss)", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r196", "r197", "r515", "r517", "r518", "r519", "r520", "r521" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "verboseLabel": "(Losses) included in AOCL", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r44", "r45", "r122", "r179", "r547", "r578", "r579" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r196", "r197", "r515", "r517", "r518", "r519", "r520", "r521" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited", "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "verboseLabel": "AOCL", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r20", "r45", "r496", "r499", "r525", "r574", "r575", "r811", "r812", "r813", "r821", "r822", "r823" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Translation Adjustment", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r4", "r20", "r45", "r197", "r198", "r517", "r518", "r519", "r520", "r521", "r811" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r762" ] }, "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalFinancialInformationDisclosureTextBlock", "presentation": [ "http://www.ingredion.com/role/SupplementaryInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Supplementary Information", "label": "Additional Financial Information Disclosure [Text Block]", "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r114" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-In Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r475", "r476", "r477", "r584", "r821", "r822", "r823", "r883", "r900" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r768" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r768" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r768" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r768" ] }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash charges to net income:", "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r733", "r744", "r754", "r779" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r736", "r747", "r757", "r782" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r768" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r775" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r740", "r748", "r758", "r775", "r783", "r787", "r795" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r793" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails": { "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Pre-tax compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r473", "r479" ] }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total share-based compensation expense, net of income taxes", "label": "Share-Based Payment Arrangement, Expense, after Tax", "documentation": "Amount, after tax, of expense for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/SupplementaryInformationAccountsReceivableNetDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationAccountsReceivableNetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowance for credit losses", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r180", "r279", "r289" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities excluded from computation of earnings per share amount (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r240" ] }, "ingr_ArgentinaJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ArgentinaJointVentureMember", "presentation": [ "http://www.ingredion.com/role/InvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Argentina joint venture", "label": "Argentina joint venture [Member]", "documentation": "Joint venture between Grupo Arcor and Ingredion (\"Arcor\" joint venture)." } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r154", "r176", "r209", "r247", "r262", "r268", "r286", "r322", "r323", "r325", "r326", "r327", "r329", "r331", "r333", "r334", "r485", "r491", "r513", "r543", "r616", "r712", "r724", "r847", "r848", "r888" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r169", "r182", "r209", "r286", "r322", "r323", "r325", "r326", "r327", "r329", "r331", "r333", "r334", "r485", "r491", "r513", "r712", "r847", "r848", "r888" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtSecurities", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities", "label": "Debt Securities, Available-for-Sale", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r280", "r290", "r533", "r829" ] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateAxis", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Date [Axis]", "label": "Award Date [Axis]", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880" ] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateDomain", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Date [Domain]", "label": "Award Date [Domain]", "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r790" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r791" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r786" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r786" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r786" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r786" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r786" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r786" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails", "http://www.ingredion.com/role/EquityStockOptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r789" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r788" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r787" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r787" ] }, "country_BR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "BR", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "BRAZIL", "label": "BRAZIL" } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r82", "r86" ] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandards" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation and New Accounting Standards", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r133" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r49", "r171", "r678" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents, beginning of period", "periodEndLabel": "Cash and cash equivalents, end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r49", "r130", "r207" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Increase (decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r130" ] }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss expected to be reclassified into earnings during the next twelve months", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months", "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months." } } }, "auth_ref": [ "r92" ] }, "ingr_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsTax", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss expected to be reclassified into earnings during the next twelve months, income tax effect", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months, Tax", "documentation": "Represents the estimated amount of income tax effect on existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months." } } }, "auth_ref": [] }, "us-gaap_CashFlowHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowHedgingMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow hedging", "label": "Cash Flow Hedging [Member]", "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk." } } }, "auth_ref": [ "r81" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r766" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfTreasuryStockTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfTreasuryStockTable", "presentation": [ "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Treasury Stock [Table]", "label": "Class of Treasury Stock [Table]", "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock." } } }, "auth_ref": [ "r62", "r63", "r64", "r65" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r767" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r767" ] }, "us-gaap_CommercialPaperAverageOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommercialPaperAverageOutstanding", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average amount of commercial paper outstanding", "label": "Commercial Paper, Average Outstanding", "documentation": "Average amount outstanding of commercial paper." } } }, "auth_ref": [ "r162", "r163" ] }, "ingr_CommercialPaperProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "CommercialPaperProgramMember", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails", "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial paper", "label": "Commercial Paper Program [Member]", "documentation": "Commercial paper program established in July 2021." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r138", "r316", "r317", "r664", "r845" ] }, "us-gaap_CommodityContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommodityContractMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Commodity contracts", "terseLabel": "Commodity Contracts", "label": "Commodity Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices." } } }, "auth_ref": [ "r695", "r711" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends declared (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r143" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r714", "r715", "r716", "r718", "r719", "r720", "r721", "r821", "r822", "r883", "r898", "r900" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r113" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r113", "r604" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r113" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock \u2014 authorized 200.0 shares \u2014 $0.01 par value, 77.8 shares issued at March\u00a031, 2024 and December\u00a031, 2023", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r113", "r545", "r712" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r772" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r771" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r773" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r770" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Retirement Benefits [Abstract]", "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income attributable to Ingredion", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r46", "r193", "r195", "r202", "r537", "r559" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Comprehensive income (loss) attributable to non-controlling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r10", "r77", "r80", "r193", "r195", "r201", "r536", "r558" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r80", "r149", "r193", "r195", "r200", "r535", "r557" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails", "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r210", "r249", "r260", "r261", "r262", "r263", "r264", "r266", "r270", "r322", "r323", "r324", "r325", "r327", "r328", "r330", "r332", "r333", "r847", "r848" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails", "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r210", "r249", "r260", "r261", "r262", "r263", "r264", "r266", "r270", "r322", "r323", "r324", "r325", "r327", "r328", "r330", "r332", "r333", "r847", "r848" ] }, "ingr_CornCommodityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "CornCommodityMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corn Commodity", "label": "Corn Commodity [Member]", "documentation": "Represents the commodity futures contract of the entity having the underlying commodity as corn." } } }, "auth_ref": [] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate", "label": "Corporate, Non-Segment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r27", "r261", "r262", "r263", "r264", "r270", "r826" ] }, "ingr_CorporateReconcilingItemsAndEliminationsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "CorporateReconcilingItemsAndEliminationsMember", "presentation": [ "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All other, excluding intersegment sales", "label": "Corporate Reconciling Items And Eliminations [Member]", "documentation": "Segment Reporting, Reconciling Item And Eliminations" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r126", "r531" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtCurrent", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails": { "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets", "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term borrowings", "totalLabel": "Total short-term borrowings", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r177" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.ingredion.com/role/FinancingArrangements" ], "lang": { "en-us": { "role": { "verboseLabel": "Financing Arrangements", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r139", "r208", "r335", "r341", "r342", "r343", "r344", "r345", "r346", "r351", "r358", "r359", "r361" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails", "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r30", "r110", "r111", "r155", "r156", "r210", "r336", "r337", "r338", "r339", "r340", "r342", "r347", "r348", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r357", "r524", "r688", "r689", "r690", "r691", "r692", "r819" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt, interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r39", "r337" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails", "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Financing Arrangements", "terseLabel": "Long-term debt", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r210", "r336", "r337", "r338", "r339", "r340", "r342", "r347", "r348", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r357", "r360", "r524", "r688", "r689", "r690", "r691", "r692", "r819" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails", "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r40", "r210", "r336", "r337", "r338", "r339", "r340", "r342", "r347", "r348", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r357", "r524", "r688", "r689", "r690", "r691", "r692", "r819" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails", "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r40", "r60", "r61", "r93", "r94", "r95", "r98", "r141", "r142", "r210", "r336", "r337", "r338", "r339", "r340", "r342", "r347", "r348", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r357", "r360", "r524", "r688", "r689", "r690", "r691", "r692", "r819" ] }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtLongtermAndShorttermCombinedAmount", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total debt", "label": "Debt, Long-Term and Short-Term, Combined Amount", "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt." } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining requisite service period (in years)", "label": "Deferred Compensation Arrangement with Individual, Requisite Service Period", "documentation": "Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r66", "r72" ] }, "ingr_DeferredTaxLiabilitiesIndirectTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "DeferredTaxLiabilitiesIndirectTaxCredits", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Brazilian deferred tax credits", "label": "Deferred Tax Liabilities, Indirect Tax Credits", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from indirect tax credits." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash contributions", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r383", "r393", "r435", "r695", "r696", "r697", "r698" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit plans", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash contribution expected during fiscal year", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year", "documentation": "Amount of contributions received and expected to be received by defined benefit plan from employer in current fiscal year." } } }, "auth_ref": [ "r698", "r851" ] }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Expected return on plan assets", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan." } } }, "auth_ref": [ "r368", "r405", "r430", "r697", "r698" ] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest cost", "label": "Defined Benefit Plan, Interest Cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r368", "r372", "r404", "r429", "r697", "r698" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net periodic cost", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r402", "r427", "r697", "r698" ] }, "us-gaap_DefinedBenefitPlanServiceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanServiceCost", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service cost", "label": "Defined Benefit Plan, Service Cost", "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r370", "r403", "r428", "r697", "r698" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r12", "r252" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails": { "parentTag": "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails", "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivative instruments, assets", "verboseLabel": "Derivative assets", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r183", "r184", "r512", "r586", "r587", "r588", "r589", "r590", "r592", "r593", "r594", "r595", "r596", "r610", "r611", "r652", "r655", "r656", "r657", "r658", "r659", "r680", "r716", "r899" ] }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Fair value of derivative instruments, net assets/(liabilities)", "label": "Derivative Assets (Liabilities), at Fair Value, Net", "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments." } } }, "auth_ref": [ "r14" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r594", "r596", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r617", "r618", "r619", "r620", "r630", "r631", "r632", "r633", "r636", "r637", "r638", "r639", "r652", "r653", "r656", "r658", "r714", "r716" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r83", "r85", "r87", "r89", "r594", "r596", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r617", "r618", "r619", "r620", "r630", "r631", "r632", "r633", "r636", "r637", "r638", "r639", "r652", "r653", "r656", "r658", "r680", "r714", "r716" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r152", "r494", "r501" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r22", "r83", "r87" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Table]", "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r22", "r83", "r87", "r89", "r90", "r91", "r493" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging relationships", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r493" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails": { "parentTag": "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails", "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivative instruments, liabilities", "verboseLabel": "Derivative liabilities", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r183", "r184", "r512", "r586", "r587", "r588", "r589", "r592", "r593", "r594", "r595", "r596", "r617", "r619", "r620", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r680", "r899" ] }, "ingr_DerivativeNonmonetaryNotionalAmountEnergyMeasure1": { "xbrltype": "energyItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "DerivativeNonmonetaryNotionalAmountEnergyMeasure1", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Natural gas swap contract (in mmbtu of natural gas)", "label": "Derivative Nonmonetary Notional Amount Energy Measure1", "documentation": "Nominal energy measure used to calculate payments on a derivative instrument as reporting date." } } }, "auth_ref": [] }, "ingr_DerivativeNonmonetaryNotionalAmountVolume1": { "xbrltype": "volumeItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "DerivativeNonmonetaryNotionalAmountVolume1", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Futures contract (in bushels for corn)", "label": "Derivative Nonmonetary Notional Amount Volume1", "documentation": "Nominal volume used to calculate payments on a derivative instrument as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r881", "r882" ] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivatives", "label": "Derivatives, Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated as Hedging Instrument", "verboseLabel": "Designated Hedging Instruments", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r22" ] }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://www.ingredion.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Axis]", "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r167" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://www.ingredion.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Domain]", "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "presentation": [ "http://www.ingredion.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposed of by Sale", "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]", "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r13", "r26" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Divestiture, consideration", "label": "Disposal Group, Including Discontinued Operation, Consideration", "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "presentation": [ "http://www.ingredion.com/role/Divestitures" ], "lang": { "en-us": { "role": { "terseLabel": "Divestitures", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r99", "r136" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://www.ingredion.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Domain]", "label": "Disposal Group Name [Domain]", "documentation": "Name of disposal group." } } }, "auth_ref": [ "r699", "r702" ] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends declared, common stock", "label": "Dividends, Common Stock", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r9", "r143" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r728" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r761" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_DomesticPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticPlanMember", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Domestic Plan", "label": "Domestic Plan [Member]", "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r852", "r853", "r854" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per common share of Ingredion:", "verboseLabel": "Earnings per share", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Basic earnings per common share of Ingredion (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r203", "r216", "r217", "r218", "r219", "r220", "r224", "r227", "r237", "r238", "r239", "r241", "r503", "r504", "r538", "r560", "r682" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic EPS", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted earnings per common share of Ingredion (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r203", "r216", "r217", "r218", "r219", "r220", "r227", "r237", "r238", "r239", "r241", "r503", "r504", "r538", "r560", "r682" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted EPS:", "label": "Earnings Per Share, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract", "presentation": [ "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities excluded in calculation of diluted EPS:", "label": "Earnings Per Share, Diluted, Other Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareReconciliationAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per common share attributable to Ingredion common shareholders:", "label": "Earnings Per Share Reconciliation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Effects of foreign exchange rate changes on cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r514" ] }, "ingr_EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitRelatedToNonTaxableBrazilICMSIncentives": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitRelatedToNonTaxableBrazilICMSIncentives", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax benefit related to the exclusion of certain tax incentives", "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit) Related to Non-Taxable Brazil ICMS Incentives", "documentation": "Effective Income Tax Rate Reconciliation, Non-Taxable Brazil ICMS Incentives, Amount" } } }, "auth_ref": [] }, "ingr_EliminationsAndReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "EliminationsAndReconcilingItemsMember", "presentation": [ "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intersegment sales, all other", "label": "Eliminations And Reconciling Items [Member]", "documentation": "Eliminations And Reconciling Items" } } }, "auth_ref": [] }, "ingr_EmployeeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "EmployeeMember", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee", "label": "Employee", "documentation": "Employee of entity." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract", "presentation": [ "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation expense", "label": "Share-Based Payment Arrangement, Additional Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation cost", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r474" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average period for amortization of unrecognized compensation cost", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r474" ] }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails": { "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax benefit", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement." } } }, "auth_ref": [ "r473" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails", "http://www.ingredion.com/role/EquityStockOptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r726" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r726" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r726" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r800" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r726" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r726" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r726" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r726" ] }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityClassOfTreasuryStockLineItems", "presentation": [ "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity", "label": "Equity, Class of Treasury Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited", "http://www.ingredion.com/role/EquityAOCLDetails", "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r21", "r164", "r196", "r197", "r198", "r211", "r212", "r213", "r215", "r221", "r223", "r242", "r287", "r288", "r363", "r475", "r476", "r477", "r481", "r482", "r495", "r496", "r497", "r498", "r499", "r500", "r502", "r515", "r517", "r518", "r519", "r520", "r521", "r525", "r574", "r575", "r576", "r584", "r642" ] }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "presentation": [ "http://www.ingredion.com/role/InvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]", "label": "Equity Method Investment, Nonconsolidated Investee [Axis]", "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity." } } }, "auth_ref": [ "r168", "r209", "r286", "r513" ] }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "presentation": [ "http://www.ingredion.com/role/InvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]", "label": "Equity Method Investment, Nonconsolidated Investee [Domain]", "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity." } } }, "auth_ref": [ "r168", "r209", "r286", "r513" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/InvestmentsScheduleofinvestmentsDetails": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/InvestmentsScheduleofinvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investments", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r257", "r282", "r805", "r830" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/InvestmentsScheduleofinvestmentsDetails": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/InvestmentsScheduleofinvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investments", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "documentation": "Amount of investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r281" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r769" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r733", "r744", "r754", "r779" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r730", "r741", "r751", "r776" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r775" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of assets and liabilities", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r506", "r507", "r510" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r506", "r507", "r510" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r349", "r393", "r394", "r395", "r396", "r397", "r398", "r507", "r526", "r527", "r528", "r689", "r690", "r695", "r696", "r697" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Axis]", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r506", "r507", "r508", "r509", "r511" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r349", "r393", "r398", "r507", "r526", "r695", "r696", "r697" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r349", "r393", "r398", "r507", "r527", "r689", "r690", "r695", "r696", "r697" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r349", "r393", "r394", "r395", "r396", "r397", "r398", "r507", "r528", "r689", "r690", "r695", "r696", "r697" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Domain]", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementInputsDisclosureTextBlock", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]", "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis." } } }, "auth_ref": [ "r153" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r349", "r393", "r394", "r395", "r396", "r397", "r398", "r526", "r527", "r528", "r689", "r690", "r695", "r696", "r697" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r505", "r511" ] }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r82", "r84", "r90" ] }, "ingr_FinancingCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "FinancingCostsNet", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Financing costs", "label": "Financing Costs, Net", "documentation": "The net amount of expense (income) derived from financing activities, including: the aggregate cost of borrowed funds accounted for as interest that was charged against earnings during the period; the noncash expenses charged against earnings in the period to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments; income derived from investments in cash and cash equivalents; and foreign currency transaction gains and losses." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, accumulated amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r174", "r303" ] }, "ingr_FoodAndIndustrialIngredientsLATAMSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "FoodAndIndustrialIngredientsLATAMSegmentMember", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails", "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "F&II - LATAM", "label": "Food And Industrial Ingredients - LATAM Segment [Member]", "documentation": "Food And Industrial Ingredients - LATAM Segment" } } }, "auth_ref": [] }, "ingr_FoodAndIndustrialIngredientsU.S.CanadaSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "FoodAndIndustrialIngredientsU.S.CanadaSegmentMember", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails", "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "F&II - U.S./Canada", "label": "Food And Industrial Ingredients - U.S./Canada Segment [Member]", "documentation": "Food And Industrial Ingredients - U.S./Canada Segment" } } }, "auth_ref": [] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Tax Authority", "label": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyExchangeRateTranslation1", "presentation": [ "http://www.ingredion.com/role/InvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency exchange rate", "label": "Foreign Currency Exchange Rate, Translation", "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency." } } }, "auth_ref": [ "r522", "r523" ] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Contracts", "verboseLabel": "Foreign currency contracts", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r680", "r695", "r710" ] }, "us-gaap_ForeignPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignPlanMember", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-U.S. Plans", "label": "Foreign Plan [Member]", "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r852", "r853", "r854" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r737", "r748", "r758", "r783" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r737", "r748", "r758", "r783" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r737", "r748", "r758", "r783" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r737", "r748", "r758", "r783" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r737", "r748", "r758", "r783" ] }, "us-gaap_GainContingenciesByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainContingenciesByNatureAxis", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain Contingencies, Nature [Axis]", "label": "Gain Contingencies, Nature [Axis]", "documentation": "Information by nature of gain contingency." } } }, "auth_ref": [ "r846" ] }, "us-gaap_GainContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainContingenciesLineItems", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Gain Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r846" ] }, "us-gaap_GainContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainContingenciesTable", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain Contingencies [Table]", "label": "Gain Contingencies [Table]", "documentation": "Sets forth the existing conditions, situations, or sets of circumstances involving uncertainties as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization, and previously disclosed contingent gains that were recognized as income in the period." } } }, "auth_ref": [ "r846" ] }, "us-gaap_GainContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainContingencyNatureDomain", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain Contingency, Nature [Domain]", "label": "Gain Contingency, Nature [Domain]", "documentation": "Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization." } } }, "auth_ref": [ "r846" ] }, "us-gaap_GainLossOnSaleOfBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfBusiness", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 }, "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.ingredion.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net gain on sale of business", "terseLabel": "Net gain on sale of business", "label": "Gain (Loss) on Disposition of Business", "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant." } } }, "auth_ref": [ "r490", "r817" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at the beginning of the period", "periodEndLabel": "Balance at the end of the period", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r173", "r291", "r532", "r686", "r712", "r833", "r840" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.ingredion.com/role/IntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r135" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r298" ] }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated goodwill impairment", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r293", "r300", "r686" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillLineItems", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r686" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r125", "r209", "r247", "r261", "r267", "r270", "r286", "r322", "r323", "r325", "r326", "r327", "r329", "r331", "r333", "r334", "r513", "r684", "r847" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r22", "r493" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r22" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r22" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Income before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r123", "r158", "r247", "r261", "r267", "r270", "r539", "r552", "r684" ] }, "ingr_IncomeLossFromEquityMethodInvestmentPeriodInArrears": { "xbrltype": "durationItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "IncomeLossFromEquityMethodInvestmentPeriodInArrears", "presentation": [ "http://www.ingredion.com/role/InvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Joint venture, period in arrears", "label": "Income (Loss) From Equity Method Investment, Period In Arrears", "documentation": "Income (Loss) From Equity Method Investment, Period In Arrears" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://www.ingredion.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Axis]", "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r699", "r702" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "presentation": [ "http://www.ingredion.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "presentation": [ "http://www.ingredion.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]", "label": "Disposal Groups, Including Discontinued Operations [Table]", "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r16", "r26", "r32", "r100", "r101", "r102", "r103", "r104", "r105", "r106", "r107", "r108", "r137" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r304", "r313", "r627" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r313", "r627" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority [Axis]", "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r18" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority [Domain]", "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r160", "r161", "r222", "r223", "r255", "r480", "r483", "r561" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r11" ] }, "ingr_IncreaseDecreaseInAccountsReceivableAndPrepaidExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "IncreaseDecreaseInAccountsReceivableAndPrepaidExpense", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable and prepaid expenses", "label": "Increase (Decrease) in Accounts Receivable and Prepaid Expense", "documentation": "The net change during the reporting period in the total amount due within one year (or one business cycle) from all parties associated with underlying transactions that are classified as operating activities, plus the net change during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r11" ] }, "us-gaap_IncreaseDecreaseInMarginDepositsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInMarginDepositsOutstanding", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Margin accounts", "label": "Increase (Decrease) in Margin Deposits Outstanding", "documentation": "The increase (decrease) during the reporting period in money or securities placed with a broker or counterparty as security for a trading or derivative position." } } }, "auth_ref": [ "r11" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in working capital:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited", "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity", "verboseLabel": "Accumulated Other Comprehensive Loss", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Temporary Equity", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.ingredion.com/role/EquityEPSDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r228", "r229", "r230", "r239", "r446" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r740", "r748", "r758", "r775", "r783", "r787", "r795" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r793" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r729", "r799" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r729", "r799" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r729", "r799" ] }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetIncludingGoodwill", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net of accumulated amortization of $305 and $299", "label": "Intangible Assets, Net (Including Goodwill)", "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance." } } }, "auth_ref": [] }, "us-gaap_InterestRateContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateContractMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofcashflowhedgesincludedinAOCIDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest rate contracts", "label": "Interest Rate Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate." } } }, "auth_ref": [ "r676", "r680", "r695" ] }, "us-gaap_IntersegmentEliminationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntersegmentEliminationMember", "presentation": [ "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intersegment sales", "label": "Intersegment Eliminations [Member]", "documentation": "Eliminating entries used in operating segment consolidation." } } }, "auth_ref": [ "r249", "r260", "r261", "r262", "r263", "r264", "r266", "r270" ] }, "us-gaap_InventoryFinishedGoodsAndWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsAndWorkInProcess", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/SupplementaryInformationInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished and in process", "label": "Inventory, Finished Goods and Work in Process, Gross", "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale." } } }, "auth_ref": [ "r808" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 }, "http://www.ingredion.com/role/SupplementaryInformationInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets", "http://www.ingredion.com/role/SupplementaryInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "totalLabel": "Total inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r181", "r679", "r712" ] }, "us-gaap_InventoryRawMaterialsAndSupplies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsAndSupplies", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/SupplementaryInformationInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials", "label": "Inventory, Raw Materials and Supplies, Gross", "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed." } } }, "auth_ref": [ "r808" ] }, "us-gaap_InvestmentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTableTextBlock", "presentation": [ "http://www.ingredion.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of investments", "label": "Investment [Table Text Block]", "documentation": "Tabular disclosure of investment." } } }, "auth_ref": [ "r803", "r804", "r828" ] }, "us-gaap_InvestmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTextBlock", "presentation": [ "http://www.ingredion.com/role/Investments" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Investment [Text Block]", "documentation": "The entire disclosure for investment." } } }, "auth_ref": [ "r803", "r804", "r828" ] }, "us-gaap_Investments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Investments", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/InvestmentsScheduleofinvestmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/InvestmentsScheduleofinvestmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total investments", "label": "Investments", "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments." } } }, "auth_ref": [ "r542" ] }, "us-gaap_InvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Investments [Abstract]", "label": "Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAllOtherInvestmentsAbstract", "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "auth_ref": [] }, "ingr_LarryFernandesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "LarryFernandesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Larry Fernandes [Member]", "documentation": "Larry Fernandes" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r36", "r209", "r286", "r322", "r323", "r325", "r326", "r327", "r329", "r331", "r333", "r334", "r486", "r491", "r492", "r513", "r603", "r683", "r724", "r847", "r888", "r889" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r118", "r157", "r549", "r712", "r820", "r831", "r884" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and stockholders' equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r38", "r170", "r209", "r286", "r322", "r323", "r325", "r326", "r327", "r329", "r331", "r333", "r334", "r486", "r491", "r492", "r513", "r712", "r847", "r888", "r889" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Liabilities, Other than Long-Term Debt, Noncurrent", "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Maximum aggregate principal amount", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r35" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long", "label": "Long [Member]", "documentation": "Indicates an ownership position in, or purchase of, a security." } } }, "auth_ref": [] }, "ingr_LongTermDebtFairValueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "LongTermDebtFairValueNoncurrent", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-term debt", "label": "Long-term Debt, Fair Value, Noncurrent", "documentation": "The fair value amount of long-term debt, classified as noncurrent, whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails": { "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0, "order": 1.0 }, "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets", "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "verboseLabel": "Total long-term debt", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r178" ] }, "us-gaap_MarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecurities", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/InvestmentsScheduleofinvestmentsDetails": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/InvestmentsScheduleofinvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities", "label": "Marketable Securities", "documentation": "Amount of investment in marketable security." } } }, "auth_ref": [ "r96", "r806" ] }, "us-gaap_MaterialReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaterialReconcilingItemsMember", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails", "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All Other", "label": "Segment Reconciling Items [Member]", "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity." } } }, "auth_ref": [ "r53" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r318", "r319", "r320", "r321", "r442", "r530", "r573", "r595", "r596", "r645", "r647", "r649", "r650", "r660", "r674", "r675", "r685", "r693", "r705", "r713", "r849", "r890", "r891", "r892", "r893", "r894", "r895" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r767" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r767" ] }, "ingr_MechanicalStoresExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "MechanicalStoresExpense", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Mechanical stores expense", "label": "Mechanical Stores Expense", "documentation": "The aggregate expense recognized in the current period for mechanical stores." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r318", "r319", "r320", "r321", "r442", "r530", "r573", "r595", "r596", "r645", "r647", "r649", "r650", "r660", "r674", "r675", "r685", "r693", "r705", "r713", "r849", "r890", "r891", "r892", "r893", "r894", "r895" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r786" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r794" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r768" ] }, "ingr_NaturalGasCommodityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "NaturalGasCommodityMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Natural Gas Commodity", "label": "Natural Gas Commodity [Member]", "documentation": "Represents the commodity futures contract of the entity having the underlying commodity as natural." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Cash (used for) provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r206" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash from financing activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Cash provided by (used for) investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r206" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash from investing activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Cash provided by (used for) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r130", "r131", "r132" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash from operating activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income attributable to Ingredion", "terseLabel": "Net Income (Loss) Attributable to Parent", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r124", "r132", "r159", "r168", "r191", "r194", "r198", "r209", "r214", "r216", "r217", "r218", "r219", "r222", "r223", "r235", "r247", "r261", "r267", "r270", "r286", "r322", "r323", "r325", "r326", "r327", "r329", "r331", "r333", "r334", "r504", "r513", "r555", "r624", "r640", "r641", "r684", "r722", "r847" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Net income attributable to non-controlling interests", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r79", "r150", "r191", "r194", "r222", "r223", "r554", "r813" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Income Available to Ingredion", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r204", "r216", "r217", "r218", "r219", "r224", "r225", "r236", "r239", "r247", "r261", "r267", "r270", "r684" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Income Available to Ingredion", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r204", "r226", "r231", "r232", "r233", "r234", "r236", "r239" ] }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net income", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity." } } }, "auth_ref": [ "r31", "r150", "r151" ] }, "ingr_NetSalesAndCostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "NetSalesAndCostOfSalesMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales/Cost of sales", "label": "Net sales/Cost of sales", "documentation": "Primary financial statement caption encompassing net sales and cost of sales." } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandardsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "New Accounting Standards", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r767" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r737", "r748", "r758", "r775", "r783" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r765" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r764" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r775" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r794" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r794" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Non- Redeemable Non- Controlling Interests", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r75", "r363", "r821", "r822", "r823", "r900" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NondesignatedMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails", "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Not Designated as Hedging Instrument", "verboseLabel": "Non-Designated Hedging Instruments", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r22" ] }, "us-gaap_NonredeemableNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonredeemableNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Non-redeemable non-controlling interests", "label": "Nonredeemable Noncontrolling Interest", "documentation": "Portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent entity which is not redeemable by the parent entity." } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r825" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.ingredion.com/role/BasisofPresentationandNewAccountingStandardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r825" ] }, "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/EquityAOCLDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) before reclassification adjustments", "label": "OCI, before Reclassifications, before Tax, Attributable to Parent", "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r45" ] }, "ingr_OperatingExpensesExcludingRestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "OperatingExpensesExcludingRestructuringCharges", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses", "label": "Operating Expenses Excluding Restructuring Charges", "documentation": "Represent the amount of operating expenses excluding restructuring charges." } } }, "auth_ref": [] }, "ingr_OperatingIncomeExpenseOtherMattersNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "OperatingIncomeExpenseOtherMattersNet", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other matters", "label": "Operating Income (Expense), Other Matters, Net", "documentation": "The net amount of other matters included in operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r247", "r261", "r267", "r270", "r684" ] }, "ingr_OperatingIncomeLossBeforeOtherCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "OperatingIncomeLossBeforeOtherCharges", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating income, subtotal", "label": "Operating Income Loss Before Other Charges", "documentation": "The net result for the period of deducting operating expenses from operating revenues excluding specified charges." } } }, "auth_ref": [] }, "ingr_OperatingSegmentsAndCorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "OperatingSegmentsAndCorporateNonSegmentMember", "presentation": [ "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating segments and all other", "label": "Operating Segments And Corporate Non Segment [Member]", "documentation": "Operating Segments And Corporate Non Segment" } } }, "auth_ref": [] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails", "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r260", "r261", "r262", "r263", "r264", "r270" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r175" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "(Losses) Gains Recognized in AOCL on Derivatives", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r45", "r197", "r515", "r518", "r521", "r556", "r811" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "(Losses) on cash flow hedges, net of income tax effect of $10 and $16", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax", "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r185", "r186" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "(Losses) gains on cash flow hedges, income tax effect", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax", "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r187" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Losses (gains) on cash flow hedges reclassified to earnings, net of income tax effect of $9 and $4", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r186", "r189" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnauditedParenthetical" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Losses (gains) on cash flow hedges reclassified to earnings, income tax effect", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax", "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r187" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss)", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r21", "r28", "r192", "r195", "r199", "r515", "r516", "r521", "r534", "r556", "r811", "r812" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income:", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/EquityAOCLDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net other comprehensive (loss) income", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r10", "r19", "r149", "r192", "r195" ] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Losses related to pension and other postretirement obligations reclassified to earnings, net of income tax effect of $0", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax", "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan." } } }, "auth_ref": [ "r8", "r122", "r190", "r410" ] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnauditedParenthetical" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Losses on pension and other postretirement obligations reclassified to earnings, income tax effect", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax", "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan." } } }, "auth_ref": [ "r6" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/EquityAOCLDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax benefit", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r10", "r19", "r149" ] }, "us-gaap_OtherInventorySupplies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInventorySupplies", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/SupplementaryInformationInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Manufacturing supplies", "label": "Other Inventory, Supplies, Gross", "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r807" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued liabilities and liabilities held for sale", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r37", "r712" ] }, "ingr_OtherLongTermBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "OtherLongTermBorrowingsMember", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term borrowings", "label": "Other long-term borrowings", "documentation": "The member represents the other long-term borrowings." } } }, "auth_ref": [] }, "ingr_OtherNonCashChargesCreditsToNetIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "OtherNonCashChargesCreditsToNetIncome", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-cash charges", "label": "Other Non Cash Charges Credits To Net Income", "documentation": "Total other non-cash charges (credits) included in net income that results in no cash inflows or outflows in the period." } } }, "auth_ref": [] }, "us-gaap_OtherNoncurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentAssetsMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current assets", "label": "Other Noncurrent Assets [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentLiabilitiesMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Other Noncurrent Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingActivitiesCashFlowStatement", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Operating Activities, Cash Flow Statement", "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)." } } }, "auth_ref": [] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other operating expense", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r767" ] }, "ingr_OtherShareBasedAwardsUnderStockIncentivePlanAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "OtherShareBasedAwardsUnderStockIncentivePlanAbstract", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other disclosures", "label": "Other Share Based Awards, under Stock Incentive Plan [Abstract]", "documentation": "No definition available." } } }, "auth_ref": [] }, "ingr_OtherShortTermBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "OtherShortTermBorrowingsMember", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other short-term borrowings", "label": "Other Short-term Borrowings [Member]", "documentation": "The member represents the other short-term borrowings." } } }, "auth_ref": [] }, "us-gaap_OtherShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherShortTermInvestments", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term investments", "label": "Other Short-Term Investments", "documentation": "Amount of short-term investments classified as other." } } }, "auth_ref": [ "r97", "r541", "r809" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r735", "r746", "r756", "r781" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r738", "r749", "r759", "r784" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r738", "r749", "r759", "r784" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r763" ] }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromOtherInvestingActivities", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Payments for (Proceeds from) Other Investing Activities", "documentation": "Amount of cash (inflow) outflow from investing activities classified as other." } } }, "auth_ref": [ "r801", "r814" ] }, "us-gaap_PaymentsOfDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividends", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid, including to non-controlling interests", "label": "Payments of Dividends", "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests." } } }, "auth_ref": [ "r48" ] }, "ingr_PaymentsOnDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "PaymentsOnDebt", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on debt", "label": "Payments on Debt", "documentation": "The cash outflows for short-term and long-term debt obligations." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital expenditures and mechanical stores purchases", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r129" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r766" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r766" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefits" ], "lang": { "en-us": { "role": { "verboseLabel": "Pension and Other Postretirement Benefits", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r366", "r390", "r392", "r398", "r416", "r418", "r419", "r420", "r421", "r422", "r437", "r438", "r439", "r697" ] }, "us-gaap_PensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionPlansDefinedBenefitMember", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Plan", "label": "Pension Plan [Member]", "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits." } } }, "auth_ref": [ "r367", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r414", "r415", "r417", "r420", "r423", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r439", "r440", "r443", "r697", "r698", "r702", "r703", "r704" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r765" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r775" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r768" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r764" ] }, "ingr_PerformanceShareUnitsAwardAchievedAsPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "PerformanceShareUnitsAwardAchievedAsPercent", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award pay out achieved (as a percent)", "label": "Performance Share Units Award Achieved As Percent", "documentation": "Represents the vesting percentage achieved." } } }, "auth_ref": [] }, "ingr_PerformanceSharesAndOtherShareBasedAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "PerformanceSharesAndOtherShareBasedAwardsMember", "presentation": [ "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance shares and other share-based awards", "label": "Performance shares and other share-based awards", "documentation": "Share-based payment arrangement awarded for meeting performance target. Also includes other share based awards including RSUs granted to non-employee directors." } } }, "auth_ref": [] }, "ingr_PerformanceSharesMarketBasedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "PerformanceSharesMarketBasedMember", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance shares, vesting based on TSR", "label": "Performance shares, vesting based on TSR", "documentation": "Represents a stock-based award with vesting based on achievement of external market based performance targets (e.g. total shareholder return as compared to the total shareholder return of its peer group)." } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Shares", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "ingr_PerformanceSharesVestingBasedOnAdjustedROICMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "PerformanceSharesVestingBasedOnAdjustedROICMember", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance shares, vesting based on Adjusted ROIC", "label": "Performance Shares, Vesting Based on Adjusted ROIC [Member]", "documentation": "Represents a stock-based award with vesting based on achievement of internal performance based targets (e.g. three-year average Adjusted Return on Invested Capital (\"Adjusted ROIC\") against an established Adjusted ROIC target)." } } }, "auth_ref": [] }, "us-gaap_PositionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PositionAxis", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Position [Axis]", "label": "Position [Axis]", "documentation": "Information by position taken for a security." } } }, "auth_ref": [] }, "us-gaap_PositionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PositionDomain", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Position [Domain]", "label": "Position [Domain]", "documentation": "Indicates position taken for a security." } } }, "auth_ref": [] }, "us-gaap_PostemploymentRetirementBenefitsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PostemploymentRetirementBenefitsMember", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Postemployment Retirement Benefits", "label": "Postemployment Retirement Benefits [Member]", "documentation": "Special and contractual termination benefits provided in connection with termination of employment and payable upon retirement, but not payable from defined benefit plan. Excludes benefits payable upon termination from defined benefit pension and other postretirement plan, and postemployment benefits payable before retirement." } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r112", "r362" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r112", "r604" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r112", "r362" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock \u2014 authorized 25.0 shares \u2014 $0.01 par value, none issued", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r112", "r544", "r712" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and assets held for sale", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r810" ] }, "ingr_ProceedsFromBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ProceedsFromBorrowings", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from borrowings", "label": "Proceeds from Borrowings", "documentation": "The cash inflows from short-term and long-term borrowings. Excludes commercial paper." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDivestitureOfBusinesses", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://www.ingredion.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of business", "label": "Proceeds from Divestiture of Businesses", "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period." } } }, "auth_ref": [ "r47" ] }, "ingr_ProceedsFromPaymentsOfIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansNetOfSettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ProceedsFromPaymentsOfIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansNetOfSettlements", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Issuances of common stock for share-based compensation, net", "label": "Proceeds From Payments Of Issuance Of Shares Under Incentive And Share Based Compensation Plans, Net Of Settlements", "documentation": "Proceeds From Payments Of Issuance Of Shares Under Incentive And Share Based Compensation Plans, Net Of Settlements" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfCommercialPaper", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial paper borrowings, net", "label": "Proceeds from (Repayments of) Commercial Paper", "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper." } } }, "auth_ref": [ "r815", "r816", "r818" ] }, "us-gaap_ProceedsFromRepurchaseOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepurchaseOfEquity", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Repurchases of common stock, net", "label": "Proceeds from (Repurchase of) Equity", "documentation": "The net cash inflow or outflow resulting from the entity's share transaction." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from disposal of manufacturing facilities and properties", "label": "Proceeds from Sale of Property, Plant, and Equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r128" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash received from exercise of stock options", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r7", "r25" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://www.ingredion.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited", "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "verboseLabel": "Net income", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r168", "r191", "r194", "r205", "r209", "r214", "r222", "r223", "r247", "r261", "r267", "r270", "r286", "r322", "r323", "r325", "r326", "r327", "r329", "r331", "r333", "r334", "r484", "r487", "r488", "r504", "r513", "r539", "r553", "r583", "r624", "r640", "r641", "r684", "r708", "r709", "r723", "r813", "r847" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, net of accumulated depreciation of $3,444 and $3,428", "verboseLabel": "Total Property, plant and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r15", "r540", "r551", "r712" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r763" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r763" ] }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "QuarterlyFinancialInformationDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Quarterly Financial Information Disclosure [Abstract]" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r318", "r319", "r320", "r321", "r390", "r442", "r469", "r470", "r471", "r529", "r530", "r573", "r595", "r596", "r645", "r647", "r649", "r650", "r660", "r674", "r675", "r685", "r693", "r705", "r713", "r716", "r844", "r849", "r891", "r892", "r893", "r894", "r895" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r318", "r319", "r320", "r321", "r390", "r442", "r469", "r470", "r471", "r529", "r530", "r573", "r595", "r596", "r645", "r647", "r649", "r650", "r660", "r674", "r675", "r685", "r693", "r705", "r713", "r716", "r844", "r849", "r891", "r892", "r893", "r894", "r895" ] }, "us-gaap_ReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "label": "Receivables, Net, Current", "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value." } } }, "auth_ref": [ "r712" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesCashFlowHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "(Losses) Gains Reclassified from AOCL into Income", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r45", "r197", "r515", "r520", "r521", "r556", "r811" ] }, "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/EquityAOCLDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gain) reclassified from AOCL", "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r45" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r730", "r741", "r751", "r776" ] }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets", "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable non-controlling interests", "periodStartLabel": "Redeemable non-controlling interests, beginning balance", "periodEndLabel": "Redeemable non-controlling interests, ending balance", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity." } } }, "auth_ref": [ "r56", "r57", "r58", "r59" ] }, "us-gaap_ReductionInTaxesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReductionInTaxesMember", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reduction in Taxes", "label": "Reduction in Taxes [Member]", "documentation": "A potential favorable financial consequence resulting from a ruling or change in tax laws." } } }, "auth_ref": [] }, "ingr_ResegmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ResegmentCosts", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Resegmentation costs", "label": "Resegment Costs", "documentation": "Resegment Costs" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r731", "r742", "r752", "r777" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r732", "r743", "r753", "r778" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r739", "r750", "r760", "r785" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "RSUs", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RestructuringSettlementAndImpairmentProvisions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringSettlementAndImpairmentProvisions", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring/impairment charges", "label": "Restructuring, Settlement and Impairment Provisions", "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss." } } }, "auth_ref": [ "r127" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r115", "r143", "r548", "r577", "r579", "r581", "r605", "r712" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r164", "r211", "r212", "r213", "r215", "r221", "r223", "r287", "r288", "r475", "r476", "r477", "r481", "r482", "r495", "r497", "r498", "r500", "r502", "r574", "r576", "r584", "r900" ] }, "us-gaap_RetirementPlanSponsorLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanSponsorLocationAxis", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Sponsor Location [Axis]", "label": "Retirement Plan Sponsor Location [Axis]", "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r417", "r420", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r852", "r853", "r854" ] }, "us-gaap_RetirementPlanSponsorLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanSponsorLocationDomain", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Sponsor Location [Domain]", "label": "Retirement Plan Sponsor Location [Domain]", "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r417", "r420", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r852", "r853", "r854" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Axis]", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r367", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r414", "r415", "r417", "r420", "r423", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r439", "r440", "r441", "r443", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Domain]", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r367", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r414", "r415", "r417", "r420", "r423", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r439", "r440", "r441", "r443", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r248", "r249", "r260", "r265", "r266", "r272", "r274", "r276", "r364", "r365", "r531" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving credit agreement", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ingr_RobertRitchieMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "RobertRitchieMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Robert Ritchie [Member]", "documentation": "Robert Ritchie" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r794" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r794" ] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of accounts receivable, net", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r42" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.ingredion.com/role/EquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of net changes in accumulated other comprehensive loss", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r45", "r885", "r886" ] }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of cash flow hedges included in AOCI", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings." } } }, "auth_ref": [ "r88" ] }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "presentation": [ "http://www.ingredion.com/role/EquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of stock based compensation expense", "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]", "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit." } } }, "auth_ref": [ "r74" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r17", "r67", "r68", "r69", "r70" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of amount of gains and losses recognized in OCI and income statement location", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r83", "r87", "r493" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of fair value and balance sheet location of derivative instruments", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r84" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.ingredion.com/role/EquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of basic and diluted earnings per common share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r824" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "presentation": [ "http://www.ingredion.com/role/InvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Method Investments", "label": "Schedule of Equity Method Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r209", "r283", "r284", "r285", "r286", "r513" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsTable", "presentation": [ "http://www.ingredion.com/role/InvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Equity Method Investments [Table]", "label": "Schedule of Equity Method Investments [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available." } } }, "auth_ref": [ "r168", "r209", "r283", "r284", "r285", "r286", "r513" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.ingredion.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of assets and liabilities measured at fair value on a recurring basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r506", "r507" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Schedule of Goodwill [Table]", "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons." } } }, "auth_ref": [ "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r686" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r686", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r839", "r840", "r841", "r842" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of inventories", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r33", "r119", "r120", "r121" ] }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Components of net periodic benefit cost", "label": "Schedule of Net Benefit Costs [Table Text Block]", "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments." } } }, "auth_ref": [ "r144" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r50", "r51", "r52", "r54" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.ingredion.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of segment reporting of net sales, operating income and total assets", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r50", "r51", "r52", "r54" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock", "presentation": [ "http://www.ingredion.com/role/EquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of additional information pertaining to stock option activity", "label": "Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]", "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year." } } }, "auth_ref": [ "r146" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails", "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r444", "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.ingredion.com/role/EquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of stock option transactions", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r23", "r24", "r73" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.ingredion.com/role/EquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of valuation assumptions for stock options", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r148" ] }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.ingredion.com/role/EquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of restricted unit activity", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r725" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r727" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails", "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r244", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r270", "r276", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r314", "r315", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r686", "r802", "r897" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r274", "r275", "r588", "r591", "r593", "r646", "r648", "r651", "r661", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r677", "r694", "r716", "r850", "r897" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.ingredion.com/role/SegmentInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r243", "r244", "r245", "r246", "r247", "r259", "r264", "r268", "r269", "r270", "r271", "r272", "r273", "r276" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment information", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ingr_SeniorNotes2.2PercentDue1june2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "SeniorNotes2.2PercentDue1june2030Member", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2.900% senior notes due June 1, 2030", "label": "2.9% senior notes due June 1, 2030", "documentation": "Represents the 2.9 Percent Senior notes due June 1, 2030." } } }, "auth_ref": [] }, "ingr_SeniorNotes3.20PercentDueOctober12026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "SeniorNotes3.20PercentDueOctober12026Member", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "3.200% senior notes due October 1, 2026", "label": "3.2% senior notes due October 1, 2026", "documentation": "Represents the 3.20 Percent Senior notes issued on September 22,2016." } } }, "auth_ref": [] }, "ingr_SeniorNotes3.9PercentDue1june2050Member": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "SeniorNotes3.9PercentDue1june2050Member", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "3.900% senior notes due June 1, 2050", "label": "3.9% senior notes due June 1, 2050", "documentation": "Represents the 3.9 Percent Senior notes due June 1, 2050." } } }, "auth_ref": [] }, "ingr_SeniorNotes6.625PercentDue2037Member": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "SeniorNotes6.625PercentDue2037Member", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "6.625% senior notes due April 15, 2037", "label": "Senior Notes 6.625 Percent Due 2037 [Member]", "documentation": "Represents the senior note due on April 15, 2037." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period of vesting", "verboseLabel": "Vesting terms", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r706" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Fair Value per Share", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cancelled (in shares)", "terseLabel": "Cancelled (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r463" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cancelled (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r463" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r461" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollars per share)", "verboseLabel": "Weighted-average fair value per share, granted (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r461" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Non-vested at the beginning of the period (in shares)", "periodEndLabel": "Non-vested at the end of the period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r458", "r459" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Restricted Shares (in thousands)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Non-vested at the beginning of the period (in dollars per share)", "periodEndLabel": "Non-vested at the end of the period (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r458", "r459" ] }, "ingr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceSharesCalculationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceSharesCalculationPeriod", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance shares calculation period", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Performance Shares Calculation Period", "documentation": "The length of time used to calculate the final payments for performance shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r462" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r462" ] }, "ingr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEstimatedPayOutPercentageAsPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEstimatedPayOutPercentageAsPercent", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated pay out (as a percent)", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Estimated Pay Out Percentage (as a percent)", "documentation": "Estimated pay out percentage of share-based compensation award as of balance sheet date." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assumptions used to measure the fair value of awards", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r470" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r469" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r471" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails", "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r444", "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472" ] }, "ingr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfTranches": { "xbrltype": "integerItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfTranches", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of tranches", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Tranches", "documentation": "Number of tranches in share-based compensation award." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options, Weighted Average Exercise Price per Share", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable at the end of the period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r452" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable at the end of the period (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r452" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total intrinsic value of stock options exercised (in dollars)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares." } } }, "auth_ref": [ "r465" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cancelled (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r861" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cancelled (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r456" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Options granted (in shares)", "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures", "documentation": "Net number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r862" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair value of stock options granted (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r464" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Aggregate Intrinsic Value, Outstanding (in dollars)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at the beginning of the period (in shares)", "periodEndLabel": "Outstanding at the end of the period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r450", "r451" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options, Number of Options", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at the beginning of the period (in dollars per share)", "periodEndLabel": "Outstanding at the end of the period (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r450", "r451" ] }, "ingr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfAward": { "xbrltype": "percentItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfAward", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of share-based compensation award", "label": "Share Based Compensation Arrangement By Share Based Payment Award, Percentage of Award", "documentation": "Percentage of share-based compensation award." } } }, "auth_ref": [] }, "ingr_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional information pertaining to stock options", "label": "Share Based Compensation Arrangement by Share Based Payment Award, Stock Options, Additional Disclosures [Abstract]", "documentation": "No definition available." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails", "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails", "http://www.ingredion.com/role/EquityStockOptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r455" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r454" ] }, "ingr_ShareBasedCompensationDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ShareBasedCompensationDuringPeriod", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation, net of issuance", "label": "Share Based Compensation During Period", "documentation": "Increase (decrease) in equity for aggregate amount of noncash, equity-based remuneration. This may include the value of stock options, amortization of restricted stock, restricted stock units and adjustment for officers' compensation. This also includes the issuance of common shares upon the exercise of options." } } }, "auth_ref": [] }, "us-gaap_ShareRepurchaseProgramAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareRepurchaseProgramAxis", "presentation": [ "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Program [Axis]", "label": "Share Repurchase Program [Axis]", "documentation": "Information by share repurchase program." } } }, "auth_ref": [] }, "us-gaap_ShareRepurchaseProgramDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareRepurchaseProgramDomain", "presentation": [ "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Program [Domain]", "label": "Share Repurchase Program [Domain]", "documentation": "Name of the share repurchase program." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.ingredion.com/role/EquityPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance shares available for vesting (as a percent)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r855" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term of award", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r707" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected life (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r468" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Exercisable (in dollars)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r71" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average Remaining Contractual Term, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r71" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average Remaining Contractual Term, Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r147" ] }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "presentation": [ "http://www.ingredion.com/role/Equity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity", "label": "Shareholders' Equity and Share-Based Payments [Text Block]", "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)." } } }, "auth_ref": [ "r140", "r145" ] }, "us-gaap_ShortMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortMember", "presentation": [ "http://www.ingredion.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short", "label": "Short [Member]", "documentation": "Indicates the sale of a borrowed security or written option." } } }, "auth_ref": [] }, "us-gaap_ShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBorrowings", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails": { "parentTag": "us-gaap_DebtCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails", "http://www.ingredion.com/role/FinancingArrangementsScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term borrowings", "label": "Short-Term Debt", "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r109", "r155", "r712", "r896" ] }, "us-gaap_ShortTermDebtWeightedAverageInterestRateOverTime": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtWeightedAverageInterestRateOverTime", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average interest rate", "label": "Short-Term Debt, Weighted Average Interest Rate, over Time", "documentation": "Weighted average interest rate of short-term debt outstanding calculated over time." } } }, "auth_ref": [] }, "ingr_ShortTermDebtWeightedAverageMaturity": { "xbrltype": "durationItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ShortTermDebtWeightedAverageMaturity", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average maturity", "label": "Short Term Debt Weighted Average Maturity", "documentation": "Weighted average maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "ingr_ShortTermDebtWeightedAverageMaturityPointInTime": { "xbrltype": "durationItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "ShortTermDebtWeightedAverageMaturityPointInTime", "presentation": [ "http://www.ingredion.com/role/FinancingArrangementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average maturity of outstanding balance", "label": "Short Term Debt Weighted Average Maturity, Point In Time", "documentation": "Weighted average maturity of outstanding balance of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "ingr_SouthKoreaDivestitureMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "SouthKoreaDivestitureMember", "presentation": [ "http://www.ingredion.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "South Korea Divestiture", "label": "South Korea Divestiture [Member]", "documentation": "South Korea Divestiture" } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails", "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r166", "r244", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r270", "r276", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r305", "r314", "r315", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r686", "r802", "r897" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited", "http://www.ingredion.com/role/EquityAOCLDetails", "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r21", "r41", "r164", "r196", "r197", "r198", "r211", "r212", "r213", "r215", "r221", "r223", "r242", "r287", "r288", "r363", "r475", "r476", "r477", "r481", "r482", "r495", "r496", "r497", "r498", "r499", "r500", "r502", "r515", "r517", "r518", "r519", "r520", "r521", "r525", "r574", "r575", "r576", "r584", "r642" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.ingredion.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r274", "r275", "r588", "r591", "r593", "r646", "r648", "r651", "r661", "r663", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r677", "r694", "r716", "r850", "r897" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r211", "r212", "r213", "r242", "r531", "r580", "r585", "r597", "r598", "r599", "r600", "r601", "r602", "r604", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r617", "r618", "r619", "r620", "r621", "r623", "r625", "r626", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r642", "r717" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r211", "r212", "r213", "r242", "r531", "r580", "r585", "r597", "r598", "r599", "r600", "r601", "r602", "r604", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r617", "r618", "r619", "r620", "r621", "r623", "r625", "r626", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r642", "r717" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r734", "r745", "r755", "r780" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.ingredion.com/role/EquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Exercised (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r21", "r112", "r113", "r143", "r455" ] }, "ingr_StockRepurchaseProgram2022Member": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "StockRepurchaseProgram2022Member", "presentation": [ "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2022 Stock Repurchase Program", "label": "Stock Repurchase Program 2022 [Member]", "documentation": "Stock Repurchase Program 2022" } } }, "auth_ref": [] }, "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "presentation": [ "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchase program, number of shares authorized", "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased", "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Ingredion stockholders\u2019 equity", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r113", "r116", "r117", "r134", "r606", "r622", "r643", "r644", "r712", "r724", "r820", "r831", "r884", "r900" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Ingredion stockholders\u2019 equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets", "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited", "http://www.ingredion.com/role/EquityAOCLDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r75", "r76", "r78", "r164", "r165", "r197", "r211", "r212", "r213", "r215", "r221", "r287", "r288", "r363", "r475", "r476", "r477", "r481", "r482", "r495", "r496", "r497", "r498", "r499", "r500", "r502", "r515", "r517", "r521", "r525", "r575", "r576", "r582", "r606", "r622", "r643", "r644", "r662", "r723", "r820", "r831", "r884", "r900" ] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "terseLabel": "Stockholders' Equity Note [Abstract]", "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "ingr_SupplementaryInformationDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "SupplementaryInformationDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Supplementary Information", "label": "Supplementary Information", "documentation": "No definition available." } } }, "auth_ref": [] }, "us-gaap_SupplierFinanceProgramObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramObligation", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationNarrativeDetails", "http://www.ingredion.com/role/SupplementaryInformationScheduleofSupplyChainFinanceProgramDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier finance program obligation", "periodStartLabel": "Outstanding at the beginning of the year", "periodEndLabel": "Outstanding as of March 31, 2024", "label": "Supplier Finance Program, Obligation", "documentation": "Amount of obligation for supplier finance program." } } }, "auth_ref": [ "r306", "r307", "r308", "r311", "r312", "r687" ] }, "us-gaap_SupplierFinanceProgramObligationDecreaseSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramObligationDecreaseSettlement", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationScheduleofSupplyChainFinanceProgramDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Invoices paid during the year", "label": "Supplier Finance Program, Obligation, Settlement", "documentation": "Amount of decrease in obligation for supplier finance program from settlement." } } }, "auth_ref": [ "r310", "r687" ] }, "ingr_SupplierFinanceProgramObligationForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "SupplierFinanceProgramObligationForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationScheduleofSupplyChainFinanceProgramDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation adjustment", "label": "Supplier Finance Program, Obligation, Foreign Currency Translation Gain (Loss)", "documentation": "Supplier Finance Program, Obligation, Foreign Currency Translation Gain (Loss)" } } }, "auth_ref": [] }, "us-gaap_SupplierFinanceProgramObligationIncrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramObligationIncrease", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationScheduleofSupplyChainFinanceProgramDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Invoices added during the year", "label": "Supplier Finance Program, Obligation, Addition", "documentation": "Amount of increase in obligation for supplier finance program." } } }, "auth_ref": [ "r309", "r687" ] }, "us-gaap_SupplierFinanceProgramObligationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramObligationRollForward", "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationScheduleofSupplyChainFinanceProgramDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program, Obligation [Roll Forward]", "label": "Supplier Finance Program, Obligation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]", "label": "Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes obligation for supplier finance program." } } }, "auth_ref": [ "r307" ] }, "us-gaap_SupplierFinanceProgramTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramTableTextBlock", "presentation": [ "http://www.ingredion.com/role/SupplementaryInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of supplier chain finance program", "label": "Supplier Finance Program [Table Text Block]", "documentation": "Tabular disclosure of supplier finance program." } } }, "auth_ref": [ "r687", "r843" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r774" ] }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityCarryingAmountAttributableToParent", "crdr": "credit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets", "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payments subject to redemption", "periodStartLabel": "Share-based payments subject to redemption, beginning balance", "periodEndLabel": "Share-based payments subject to redemption, ending balance", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r322", "r325", "r326", "r327", "r333", "r334", "r478", "r546" ] }, "ingr_TemporaryEquityOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "TemporaryEquityOtherComprehensiveIncome", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss)", "label": "Temporary Equity, Other Comprehensive Income", "documentation": "The portion of other comprehensive income or loss attributable to temporary equity interest." } } }, "auth_ref": [] }, "ingr_TemporaryEquityShareBasedCompensationNetOfIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "TemporaryEquityShareBasedCompensationNetOfIssuance", "crdr": "credit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation, net of issuance", "label": "Temporary Equity, Share-Based Compensation, Net of Issuance", "documentation": "Increase (decrease) in temporary equity for share-based compensation, net of issuance during the period." } } }, "auth_ref": [] }, "ingr_TextureAndHealthfulSolutionsSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ingredion.com/20240331", "localname": "TextureAndHealthfulSolutionsSegmentMember", "presentation": [ "http://www.ingredion.com/role/IntangibleAssetsScheduleofgoodwillDetails", "http://www.ingredion.com/role/SegmentInformationNetSalesandOperatingIncomeDetails", "http://www.ingredion.com/role/SegmentInformationPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "T&HS", "verboseLabel": "Texture & Healthful Solutions", "label": "Texture And Healthful Solutions Segment [Member]", "documentation": "Represents information pertaining to Asia Pacific segment." } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual [Axis]", "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r827", "r887" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.ingredion.com/role/EquityRestrictedStockUnitsDetails", "http://www.ingredion.com/role/EquityScheduleofstockbasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual [Domain]", "label": "Title of Individual [Domain]" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r766" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r773" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r793" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r795" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.ingredion.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r796" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r797" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r795" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r795" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r798" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r796" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited", "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r62" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r62" ] }, "us-gaap_TreasuryStockCommonValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonValue", "crdr": "debit", "calculation": { "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Treasury stock (common stock: 12.2 and 12.6 shares at March\u00a031, 2024 and December\u00a031, 2023) at cost", "label": "Treasury Stock, Common, Value", "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r43", "r62", "r65" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase/acquisition of treasury stock (in shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r21", "r113", "r143" ] }, "us-gaap_TreasuryStockTransactionsExcludingValueOfSharesReissuedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockTransactionsExcludingValueOfSharesReissuedAbstract", "presentation": [ "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock:", "label": "Treasury Stock Transactions, Excluding Value of Shares Reissued [Abstract]" } } }, "auth_ref": [] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofEquityandRedeemableEquityUnaudited", "http://www.ingredion.com/role/EquityTreasuryStockDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repurchases of common stock, net", "terseLabel": "Repurchases of common stock", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r21", "r62", "r143" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsComponentsofnetperiodicbenefitcostDetails", "http://www.ingredion.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Plans", "label": "UNITED STATES" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r792" ] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract", "presentation": [ "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of Dilutive Securities:", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.ingredion.com/role/EquityEPSDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average number of shares outstanding - diluted, Total", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r226", "r239" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average common shares outstanding:", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.ingredion.com/role/EquityEPSDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ingredion.com/role/CondensedConsolidatedStatementsofIncomeUnaudited", "http://www.ingredion.com/role/EquityEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average number of shares outstanding, basic", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r224", "r239" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480463/815-10-45-5" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(19)", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(3)", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.3,4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(12)(c)", "Section": "S99", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(16)(c)", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "14", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "15", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "710", "SubTopic": "10", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482943/710-10-55-7" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-20/tableOfContent" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(h)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(d)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//820/tableOfContent" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-4" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.E.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1B" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(h))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477128/405-50-55-5" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r692": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r698": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r699": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r700": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r710": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r711": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r712": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r713": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r722": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r725": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r726": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r727": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r729": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r730": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r731": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r732": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r733": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r734": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r735": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r736": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r737": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r738": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r739": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r740": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r741": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r742": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r743": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r744": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r745": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r746": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r747": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r748": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r749": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r750": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r751": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r752": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r753": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r754": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r755": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r756": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r757": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r758": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r763": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r764": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r765": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r766": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//321/tableOfContent" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "325", "Publisher": "FASB", "URI": "https://asc.fasb.org//325/tableOfContent" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483049/450-30-50-1" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 83 0001046257-24-000018-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001046257-24-000018-xbrl.zip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

UW M6*-Y;$FW=NUC&FH6[9?F-GM5>?F9\[M9^4)ZI6^5P6S@4YCT==VAKAO^YQL\ M3HX$2;?2:TK_I*XW<&S[IS1-&98NV?0614B__EBP=V_#LIO_GS$) M#(=PR95*KU67FVM"GZ>BQ\*E0ITU<0"[QH28$GVCFN\9+^@&@+RF[JEH+,"* MA&!)44R9,QFXW1#?S!F<.<'__4M'D=N?7,FC)IV,;"N*H9RAF6/Z2%P)S&P" MJ-"I%,V8IQC0A\TE""J-/DQF3F:HE5Z[WEF4&!\SJ(MO-N#['A=OWJC&7I?- MIEQ56O7ZVD#"2F#Q!9]'D"".X1GPP"".0!VJ2Q/?<7T,*'BV!%K?U,NJP3XD@OQ/2I]!?03#+N[DGNB(4]\W(@MT6^(&]$WE @ M!?)H2MMP2VE_GO]!"<>-,[M$%LCXYOF%[ F5.(!X8TC-0-WB5M1&'&8\P)?AU1%@5'"WZV:W@A?9 _2B/B MLGUW72*F";]BA@OZ!'_Z!GH$X @,:'@!/'3J%*@8- \R.$+7(.911,N,[@+^ MC!D+X[16:GTOL73404F#DFYMSI9ITT2<,HL*QD' /&/#\X#=J E,Y-@6JA'S7:*@4MXE5H". M:"PL>44\(F%&SJ(@F3TC'FIX\.'*1KV)LN*!/OM!8V#IL?HD?R&#)#1-,;MBW5 G&.Q46U/U8R[P'$5L87)=0-$QE05?(@E.7!5RR/' 9 MD4P8-I6(I@'+XQ:@SKC 0=6:^JT$$*ZF_N".05; 6YQ()0+CC&$-WL_0DH#' M@?K%)7J6@'2OWBCZN0:&!65CT[$M,LN09-LA&/968)I+1LA^EC]%EZV]8/GX MH@O1F@@O7C+6Z$K#"D0:.(M5);*/XD91C=>DK&:GUN@T,N=DJ;6VG$]TL5&K M=[)%-@\T*#6/M/H-W>FQH>LFY=PMFZ7=.I? 5L^V\Y[BE;&+&,-IX44S!TVI M5WK?TMEWBY2PS)YOUE7.69-N-Q5^X!)LR?:3E-O;]/*)+^U,1C9O>WDZPD*" M5&M%?M2&<: ]7W8,PBN@RFV:]2$=/R33C,_2RY=@GWJ9678B1,VJC]EZ1860 MUYY44^151]5.1K+E^_9]G'W,DZ6NTYV7_!DJSUVA8K@I6JK?V$I=!@NUGJN4 M#%RUW4;#H2(&PQ6>.::7I084C&%:^) %#4$G6S:+^?ENX-7#^@?G[5,.0-H. M>Y?YCB]_->#5\%K)@JG9J!%>#)?I>(M8FD%,]"+P( I>C)7*=.+HKH1)O8:^ M++=)_4 ^ICKHW >62I1KMD7S%#7*8J=:D+'BXJ;X&9X>#>\RX56N!S(3MRLT%GG$RB7Z'JVSA&$96+W9+6FX$E5%E*K;F/ MIV08Y:;59+M+WEU?\>[ULUOMS\:+!$_LP-.[<"CF>KS0I66#HX'-;B$#%YOE M+;\E>Z7AK(60V]-"R"-G)EZ>:77@4/*S2H;PT@MBOI)W%]2@ M[/IE(UH^,9L53&!LZX$Y@)_/22I.EE>D7EMD9V?)GEB1=.MA60F<)?8[+\/^ M>O?P7<+BO!+W0WWJ?_EVC77)+N]NGZYOGQXW<8[*5+5I%J:N, M8]E<76&%C'OB>-)-BI+**S;4)13?U8S+? 9U.\LA'@X5F,@#$RV,B<.-%F9! MS/H^PX>8\+"'4M QM%AS44%IITX=(1]$E]H M/M)#6!O%CR4;4AK"VA"8B&$"!;86^<&&):PMX0F(ACHK.IMT+# ZQ=UH M03O-<"=G[MRG U/V@4BCYCWR+FNVLP(W FT5'D M!X>( [_2].*Y/[!]/!/I_*2>]&"X/X7=?FI847+;OB("(<".>]8!:[\3AXMVTD1MADW8\F"D$Y>!XP$.3DAYS?Z3,S M*&.]4H15=G(04'++M1%JG .28@WG?/:^!#DY(>NS=R;] M<%G=FE"*N.DI@2I?L2^,.0Y(BG7RF-AO"MO\ M2,B9MS,N;//BQY(1 L(V/RJ2JO502+>$;7XDY+Q^&QD#0R0,GQ[EE=S.&PB+ MBP>2JI7>(ZPK\?+?G#[0J3,A#@K$CK+R!,&Z,MBL^G,A9;!3UCNGVJ/IQ>:5 M/"IN8Z5$47);E-R>+Z>\7SBGE]*5[OL/3])-3?IZ<]N_O;SI?Y-N;K%\=?_I MYNXV60MZ0WRK%7YG?/-T_5V2XS-^?.K#=UC\6NK?7DF//^[OO['/_8=_25?] MI_[6Z]!*6X=EHFQ)][--)>#^FCMMN+(WUK-#=3RL@E66G(G-NM:6=SZ9RM&5 M=9(??EC$UPV8V,@2_-W$9067X.]L)#6> MP#JBTG>X;N1*U]CPE.FN[\311I(JGV6IS)]O)P/NVX-MML!SO=%6N.XYM7PZ M@N52B^@&<: V&.E:[Y8"P3"=8A.@9(GQK+MG,]#4I3(LXE\6%R^GR2=B55S- M>FG+/-_5%_OER?%^>=56U"[/=ZO/A$PN'N@+M7SZU;''[*0,//&?AC>Z]%V8 M'G6NWS33QV7I8[=6,*:?R-MF/?1:40\]C%;+9YV.DFB?%[22W \%\:=,E-P^ M/BIX3_!>.N^IA?.>#,KU3%;;W//>@5(*"H7.I>UZK&'VUEI_D]I@2K9%2Y4U MY6:[-2H/R7 W_,VV=;=OZ8_4>3$TZC[:IIZ5NQ34;(U6LC%L1NY*Q_+>])= M40[".S\4J8BB5K/."8IR\KW8>]N<2^3?'-MUI8EC#PTO;S=L(U;:W2PL-Y.M M$=6,/O>,/"F,TZCT&C+_IHW $A<">S66FH"E#O]8.@4S.2R.9SU+]&V".WC" M5CZX (89.Q=30ER'=)AZI _4]1Q?\WP'/ER.B/-,W12F:H%ET^ER8M<(W!Q MV.:#FS;B9F=AS)<]S+?(98=][$7!6Z1)?.3\DY"[+@P?_EJT6AAEI@P5I*N$ M;'5+TPR9#O!.7J'VDEF^1PZ9A,C-"S+=2F]G)9T38D[!OIU3@N?&>$(,!Q/2 M)"U0B,+:+6XS-$:91^IY09?KOJ7?3*D$'N2+@76_4PR71IUU.N7";!' .>A. M7C;@Q /$0^.-ZM7_4,=. 91ST:CT9!$0/D9DK H(;X*,)KA..\>M^#)RN9:9F'[^3 Q+ KIB M0AHFI@U\%ZYS<\](/_(@WH<\,QZ )&APW%E8:O%N^"4D20K'M"J]E*3JCR+( MRQL^\DQB6 J/C4,*[=Q""H>)^49',F&@=#G>BK\J)T.[%)&1P#&2!A101\/H MB.21-WA#D<;WR3JT:Y3*S(^-SAH8E@_+,6M#^851,KCN">EX_>8Y!)83+#?G M':O&N;>VA2]U;--DKC$6!';3+#DL[]INY63*%1]L$=CJ77['!B0 J('%Q>;P(1 MN=+;_6@47WDEI3#.,;*SPX:EL'?V*F*#$PCI>TI-MD^YLU@5IO.10&F-*%X) M)3Q5V&UP#Z53L'2_4=>]D&9B62*>YQ@#/RA)YMD2$*@:\U_@LL"!$99P86(: MJ#7S3/LQ>CW9FSJ;S0:K-\N%_2.P0?;.2&D;Z+ZJ'E; MU7LT?[A;W\UK!F6;_/'(EBQZ*45NM-"#.(G@NV ;P3;;J>04ML$3I[LGYN_\4N/*?[ /5)0*C(L]TCN5< MR?8]UR,6FXY@O%VPL<*/9J3B&21?B&MH>PLC[A:H+9'%&?#4:E^MN6AT1@S: M#_CSUA\/J',W?&3/NINQ)Z-1BE':P0W46K(.BB#G?LBI[I><72!GJY9T,G:K M?+\BV,:]<+HRL&F>0J(D8)U$=*O.$)WX036D2V,( BG13@MAVR+<\R[ FE3+*EF]%W]GCI,F:VT=Y1% M[1A)G>CN>3.]/M6!2J6GUA1>"J()X O@KP6^F@OPL:!);?=RO1QFG7"O\/;D M"&=9JV/C_+0I'A_G9U-Y(+_!E-X1U2X4T#]VZ&=3>LNAWV1JCY<>3DSM MG;/]](W:6L>IM710AR+C(Z62-Z+2K>W!0SV;?5C2ASVL"43,6$?VVM)^WN%K M&MA\>V*[!E+HPJ$F\8P7.NNYC5"*W15V[*[/;B$#& $ 8>DM,4JE-DL_U%*J M\TL1_Q='B]@U] :M=P;:D+:Z6J,E=XE.!^U&AY*AUFRWU=:_Y6XENFDTC==- MR#.M#AQ*?E;)$"9X0LWW1E=Q69F,/D9,\ M9)C/YZ27!I0,@#Z@T$AO_CQ+&<(,/6>":Q0SA;/.YU##7B+69L(LH--XXM 1 M7 =B2KJ9/Y3)Z\P^_+"(KQLPFX\HQ(]AL3>SFS[-2SR4C0O*G*U-\/-,;-;J@>@,/=KPS>'/ M-?CI//E]6ZZI2B/UIWI-SOA]H][*=,>R0,>B#:(EO6A)O^_J%*U6 M+M4IRE!%7_",X)E2!RA6I1GM(-=H8"S%'/7Q$ M%:^_6!DYW&]4 9F9NA^Q-KI&W)$T-.U7:43U9^J>21:8:O8P5K%0@ME3C7WY MESQ;VR!>YR)(LR.LES"JKS"HWW%,45'HH%#F ]5,XKK&$-8:A_!$WE+D$K:) MK"?$DD0L/=L<RE-I;V(&B_9,!X/N"FF*]?#RJDC) M08K9D:-K-Y5].%0UP0M(HFIS'9UGXM8)=K$Y.N<_-#58@;)^=L!" /N%54, XW[1'8[I:L1V FJZY9:W*^4W7I.PZUM'?)<^ I M)H.#1*9X$/VMBTJ/6,6_P'3P5BNBW1.2+G@C,.S3C) SOL[.F)UZ;HPI_&@. MX;>#^M@%?@F881T83@!V"LE_ERDY"46V_CC9ACMKQ'\*ZT5,!)],'Y?FWG88 MFVW5]J'#&D#EU32$ZQ0[@5IC2D#R:8 A\W M;S!5:+ON(V?>[97)ELS:R"&J)-R"4FRO+8ESYH^IU#Y4O&VN':T3D',3JMU/ M/$3G_!>Z8HCS$+LN#=_"ZC!J+T7\L"-'>6V5Y$$HO@\D"?84[+DWES*%/?%T M4R/9H*!<["E*+HF22SBFQD*ZQE8EEQ1%E%P2)9=.J^12X?-9(N^^$!/D'94> M1Y3&>JES/+TEH0(="Q(Y+DM #+M[Q>H>G4GT3:.@^+"Q9 %LF0$M\':OT\7!R$YKQS3( MBO(DPL CRGV<;&957*T$.Q:" 7B:6Q8&:.Z' ;K M '5>3D6=5/>AQY'M>%5PA<:28;W0(#M:-9+U84H(/!8;A@7FS]]9_KBJVVSO$!^3PDY*I2>?*9V\TN(Y,-8%@#85 MN[D 2&4 :HM6FP5@ 36EY=F.0;>+^0CC)01U7%G8P3W!9(XFW@TN[TE-: MQQCCY7\+_,GVB"EIP%5#3MB@SVY[ F-[/I(E)4,J#E8TY+A/<&)@6H"6: MYH_]H+JM3B<.$#BH,)>U#NTZ239[SU7L-?"W2<.Z5/TQ5B?Y#_L^&CQ6,/3@ MM^MHX!EQ*=>Q*\A9(R5"D+U6_CK^*6J*,INBDMS5*;[D[,G*VK4.UA+B9X]E MR'6L$W6FJOQ7YA'@XT+1YPH^E8&OO7,DK2QEH?A7_#>61ZQG T]P!9Y=JK(G M,564M[+_:L"]])OQ0O798 +S,J8DX\HP#5D-4&OUI/>2N][.9[1-X(,4\U?T MLBEZHB#BIM7P?K-M_=4PSJ?2:;9%P=8P0V23/=1.( M=!$B>?DD9?,\BCB)&^PH[6[4TN;GBK)-_GA$Q$9;9EDM,!E/3IRI M,O_[%X*?!#\=?EDV2[HJ2)'NKV)!CQ8?%@HEE&MHI MF$O?##(P3,,SPO1'U[.UGR/;A$5R_\:V:;UW49AB3X4I^,_/BDJ4F#.8;%>G MA!/)E/O])W5*)78D&^2H8[_"#/(_D;USV)>[=3FS+#!RR(#0QAAI5GKM-B]5S$[*8P :.3[5X_XC"S/$/^]^U%+D MD^2UZQT+!ZW@IQ98*!U>UR=( UT9XDLSET<">362/$<(-=%R+7;_#>%/ZWS]-]LZSD(T.MT ML%U%OYSLI)/EO77B'BB$M3$Q"!A/'7 M!7:G9? GSQ!P8O0?.=-M;MHS"CV-B(6,Z*4P8I+7E$JOT>:E+)' 33'V^1:X MP?W#SI$=.2B)' X"+[O*7F$*'4HJ9[9_&JS"23>O,J_"["X[UC:7Y)FQUD2L M=;LB]SS'&/BL:_>3?4^6V;6XZRPVG8\1/6N4 M:"[HP>WHO"J0BN!4%B0\@ "F8Z1/$*&"&QS;A.N>)0-;75-7%+LH3C3/J(-1 MA1EM;D+2I/%<&G]AIU!1<_T8 ;2V]U ^ .KFH=[SC5KMY-&DJ7Z !Y/7/!QD M+/K^TU*"-]8S."+(:O$3MO_]2T>1VY_"<[;B9&61IZ]UXR5Z=OB(*EX?,N>L7N:E'>3&F?$;SP$=_''&NW M/WU9BM!6ZRM42?H0&GD/0:[TE&8MN=^1K-<9#&BZC"M+=]YC&U.X?.4**JM' M#\[(G?/H8=%.UEYZ]LQP%O79+)35.GG9+^JU%%TJ/4SUL%[^&W#$IU:KT0KG#20Q"@.> /M*.X&GS!IZ3Z5T2+&_\ MWTM[/(ZL^/U;9,';-K:%.GF;8QG?#SZ\4J\?S!A;;?W$QI[!]&FL,FFW-@RW M'(M\:#-L P1$IDZ"^HU5-FP^Z%_^;A6/^-;2.L\L 5Y@54G$D^8M*XY$3?+? M[\311L&?JGPF*76EP8[37E&-C@?4F?M)+;[KSI%K_34F8PR^H. M$WA,2]R0A"/%&2"2_E2ZW_01YZC9KB<>:-)X*8$3]<+YR8[+BVW MDW7B/@HOJ]0 6I V,%GI=XN'D"GY8K%&H7:[) SZ.^)0T?4*EN/LQ.IEG$HW%A"-?@-2W5+O;OA$WC*S']9^/JNW MDM;2YNPGW#0> 9:0WP4!3&4 :R;-WH,#[*0J+C]0C\"7ND2)8V$W 7$0H+B# M $IKD-*Q#CNB@X-S&JZ=U MS#8H;;%)&KNH><&?<'^,42LXD).9^UI8CJ"MB-(7 G(;*8 <(-=&R#75O'JA MB&IS^8#DUK:JCCC4R[&X!PHY:XYEIO$;;DGMO'\IC'4.\;)&5F^)%]PJ%-9X M<=;X09NU"E,H1^O[QM),'U?DWG;PZ?-53)9Q8#;SJ55G%GL)BO4*F'*A!0J" MJ>J&":;U?P%=;:NGM"N@:KDVC>O@-/.14LD;4>G6]N"AGLT^ M7-J63BTL[@I_L95BR6!?#8M8F@&V"CM*RZJ^UI8F((>O::!;/[%=EOI_X5"3 M>,8+_?1JZ-X(!LDP&KLKI%Y]=@L9P A\;_DM,4II% WB@EBMN9"Z'/L71XNH M-_0&K7<&VI"VNEJC)7>)3@?M1H>2H=9LM]76O[$"=7C3:%H+;4*>:77@4/*S M2H8PP0MBOI)W%\$71QK +!R0TH81+UNO$)$1G^#D8B!5Y%IK5;;X<+B?)92; M?PUX#@2&[1!&>F +ZN!5,!S"S5BDD8/R\I?UQ&R#;<_"]?80.%PV$NDUTQF(3D"E<4RF3_,"#O7/@NYF:Q/\'$K)KEIKMIHH*,-80_CB4(;68";GR>^5 M=DV5TW^JU^2,WRO-;$]:-JAFK=5JB#&),>4TIG:M*WH1*-/#^/B=#.'CZTT#Q.N6RK%?%W=U M2K4>\^[$_"/CQ.>Y2PCP]9^I0<^\+-[&"V-IAQQ/ZXG.TWL<\W MJ;E&Z4S;E/?-M+.@Z:8!'KZI,"U;&. 5HVR;[/KLW$/I.%8O.&XJEFZ+I9N5 MYPC%IJ%7;X*EO-R\$H]8S$ GAV>@!1*W06+L #([>!BJH=CI0_;-MPT/(HME MG3OWQ];N.L/9/[%^TQ3LJ=6XO:&4KRUT"ODQ7XA)+(V>34MN2HEJFX?-ASGI MW?)R[X>'M8]WVF$N=1Z(P&YIL9LEEZ-UF+339%)'CL5U!;MQ CS!;NO8K=#6L<%<29K=Q*VPFFY 2>@BG7,F67;Z9L[UZ/ M3# E7_ \3:;,PI-RG4O3M9-OW2G!D)Q 4S#D6H:4BPK=Y%E:0C <)] 3#+=K M.7,ZQI,/SGO ;)?$<=YA%?IC6#MOGM7NB4.M--9JURN]9E.PEF MP5HT7J]T M=?VC-(Y+XRX9C$65>^XZJ28"M]23#%8B7"(Q&8DG3*?'RD39I$(WM46)(4%2 M05)!4D%205)!4D'2HR5IINB;LJ9J*_5FG6_6!MZV*/#:5BH]9?>*P *0' -2 MR!A!4D%20=+"^QZ4.8PD6B!P<"*"@QT'01Y!'D$>01Y!'D$>01Y!GM,A3Z:X MEEIT7$NM]/*J]"R@)3A?D*G5:^UD/\]S%^]<*,E;1"K.R?#?BGPNCF.Z@CR"/((\ M@CR"/((\@CSY'HA>EVTR-?1BQE^:;]VL]%)Z.6Y^;%F@0S"O((\@CR"/R+L( M:\5.?$<;$9>R;DGQX,:99%%/Y%B4)UXGR"/((\@CR,.'Q[.F4714.)^Y.O\@ MID_[VI^^X5#]TG:][]0;V7J:!]1**SN:N6Z3 (O@94$>01Y!'D$>01Y!GL-E M342-;,%\H$L0N^"/((\@CR/"!E,V;E@VN<+*I_+F.ZY\AU,UH>QI0?'VI6>TLVI MHH0 B^!E01Y!'D$>09Z];Q:MZ1?"5.)"?>9T#7E+O;OA3>B9I:G(3J4GBPRZ M$@"(YQR@XD,QXBIQU5Z">,4/4%PEKCI0?+K,F9MWWH@Z+#+MT!&8/\8+E3Z8 MMNLF;!FQ6\CO;J$@CR"/((\@CR#/29(G6Y0DT65G25M59AI24E<:>>>-KKLG[%00+,6%"G)(MWVL ML<^Z%9QFO]8\EX9OM9I'DXN=UJ>@77+!%8(K65-ZNHW)'3K%#!R8*3!2=OQ\GMPW#RT';&Q ,O],V[L/QQ5;>]:OC>-#97 M@,W/Y$;.+0$%JPM6/RY6SQ8AZFRX:5(0TZN,Z=O)4QN94U(%OPM^%_PN=_GF M]P;R>[V50PJZX'?![T?)[UG87:ES:PLMX\$]\3AUJI3-L&%:P* MIA5,*YCV($S[L*95:!HOI_%M!_AVY_ZA!?,MRVHY9R(J:K@7:VXX)LZS807O M5::]#7N?!P[>&LYP_4WL\=,E".8"TS?)Q*47T1^?HH0;PV+49S=]"A\6KDMS MDI@*FVKP\Z=70_=&%]U&3:VK")DP6R=\_5]JU3CO]IWI-SOB] MTFAGNF/9H)JUEISUW6),8DS+Q@08;W0X&Q.?ZU1O-<68-AE3N['R26'69/3C M5*4'>B'5:%R92;[I9=W$=2F>91XQ_&S.ELE(#Y9'O$E (#9(.LRW5+Y=BO MBPGXI5J.6&539G/;F;AL;<#. MK;(_+F?6+OLU=OJEP[] A=9P0O"SJMTDJ]=K) MG\;J!0TFQ=)ML71]&"M*0F*&8M/0JS?!4EZ2B0$Z1BSFYCHY[/\CD+@-$C7- M'_LF\:@NL>-LH1J*G6ECW^"!;[&L&?2[1^#+0+%<$\>"D8OUVWS]I@;1;H92 MOK903D6A. EMKSEA=D4U.AY0)SIDIN1="VK=/:>Y89!M\GQO">QT/+[XK3"! MW1/&;J9T$J6H=))N#L>Y!+_QA3S!;VOY3>4Q4[-;9^&QVYS.S@K?X0IG@K5UY*Z>C-=U6I=?D?^CB=$L]R6#E MIR42$Y*29TLWUK-#]#%T:NDNBE23@#0\@Y7 ^E,P$EO[*7WXRRK9?$\=5JHN(:/C(EI9 ME-!!@2N6_SM]?_2DJW 84[E;G\G=;J57K[63&PKG+MXY.]S""O,6D8IS,ORW M(I^+XYBN((\@CR"/((\@CR"/($_.9Z+79)M,#;V8\9?TK95ZO=)KM'?OO"C0 M(9A7D$>01Y G>]@CZD<# I@NIZ:X2ES%WU4GE5(4ZQ*!0;L)M5R"YM*99%%/ MLH>2X;H^5IT5>43EB4D+\@CRE)H\F?9RES0,ABD[%TR\?4'I=AD3;E>^@]NY M,#9[MDD03,'V M1)WNA?JC3"4NE'M*UY"WU+L;WH1N8IJ*5,&<2A8OS%Q(5 #HJ/E;1!3%54=Z ME8"VN.I(KSJI,FZL"2,+DT\;,$H?3-MU$[:,V+KD=^M2D$>01Y!'D$>0YR3) MDRU*LBY,$N4F,M-@KC7S[ A"Y \D;>TV$BCTFON$AL1L!%<+TMD2+W\.T25/JK=R;W M.%IQ\ MPIR<: O,00=2I=YF/;K5O"I6"587K'Z4K)XM"I7H-LQ3"W"EWF%,K^QRDE[P MN^!WP>\1OR>:&?/%[UWD]WHWV9E5\+O@=\'OF4WY->U>B^%R&8OCG*G-AC#E M!:L+5L^)U=<4KMI;_$W&D\K"*Q>L+%@Y)U9NK*D,OW B;KX;^SP7WQ.'IG5H M5V2ETE.39K;@6L&U@FOWPK4/:SHTI#%S&N.JE5ZS[/M=+*_EG,FHJ,YYK*;\ MF#C/AA6\5TF4E%^:;',H4#Q2*GDC*MW:'CS4L]F'2]O2J845K. OME+$@P]? M#8M8FD%,Z=&#+\8@C-W:?('WV,2CUW1@'!/;-9"R%PXUB6>\T$^OANZ-8) , MF+&[0NK59[>0 8S ]Y;?$J.41A%_!?%7:Z'6?>Q?'"U"WM ;M-X9:$/:ZFJ- MEMPE.AVT&QU*AEJSW59;_U8ZE>BFD1/-8$*>:77@4/*S2H8PP0MBOI)W%\$7 M1QK +!Q0HPDC7K9>(2(C/L')Q4"JR+76JLX'P^%^EE!N_C7@.1 [8 \PT@-; M4 >O@N$0;L8BC1P4DK^L)V:[TGMB_23M(7*2APSS^9STTH"2 = '%!KI66XW MUK-#==0AF+WKH/T&\F&I).!^/DODW4S*,0(2=R1]->U7M[P3_?##(N EP^0^ MEF$22_8(#$N"QYJ /W?Y-))Z-VCM.M4SS!R ,9MDXM*+Z(]/T7E9*%P7K &V:,'/,[E;JP>R-\QY#=\<_ER#G\Z3W[?EFJHT4G^JU^2,WS?J MK4QW+!N4K-3JG:PO/\B@U)6/6I-QO#(!?,/+NHG+4MRC@(\.XPQT-A($3Z## MJ/0=KANYTC5(/_WSP#GO3;.6YVSO RQCS.'=U$[G>X&5NM+8).M[[6Q/9KG4 M+)C+Z[# V-!UDQ9T6(!9%$/''DOVA**9:3U+Z &_@.-#]]=G?(/[=X*)\2PK]1D&^>\<>&AX>S4P+W36P M3NO.07=^COX)F!\KS!,E![+ O%GIR=V=DSOX.D)9%I5F6U4-;21M!/YW$)ZV MIFKNHD@#B;O[#UTVK%!@7-&) PS- K,2L72)C#'KXS_L"U$YK"A[(4X6^-ND M+!''TOLQZJ2)V%:EU]PYYX8?0T( 9E/-NRU@V@"88U3)W O>[Q14L86C@3?; M#CR8OF'9:M',Z.!"EY43G]'CD9'C.J!&&L_@X:.\Z74446:-?X#D:(,OQT?\'-30>*-Z]3_4L=-P(T]K M#@FCO*@BZM9"L$Q8Y(58Y(P8M[:%>[N7 24N,5?./])Z6#^YJ&1UQ3 M"E#=6"_4\FQGV]Q*$6[(0PQ'<8>] PNWG=K(4A#")]YK/P\ZUHI1F-!-F<6';M$E& M"FAS15DA#/?.]UP/-"HL40KWJ'7@GEV81YC%/&(FLUF<"3-8ZJY;/&9.ZTQ# ML%DK;."B'?"CPKX MV:6-)8DO$^I.*7]Q] PALKA0_3V Y/*M>3ELYVD>/B"X *K!U(UN^&NF9J:ZU:>3(D5PWJAKBBQ(DJL[&))L#2O()E'-SP?#\#A+L^[U)+*]OZ5BD>++,5F]5>JU=]C5$ M1(U'R*PK!;(39-J57GL7]TX$U+8@/U (AJ^[@9;'$WBV"W+8'DKP:'\(1/ = MU/KP5[C[%"9F,L**_>@"O;J(=%^!+KY]=\68;KMY;@X0,RCD+XRF ^-CL_LH&AJ]*-1K_241C(%3V1KEA\P M&03P4L!LK,T;93M;7'S5B3W5IBBUE\"V[82E7W@LYJOMQ.4#(\M-%)E=&4]O M*&F6F<@S+3=L-HS'[ ;->V@GMAR+VS+/;=]&+$-6L26^X9"MMR'0;](L>4NMMSSB0K",CGV*\Q"Q .+J6X5 M-\*_3(F1)HKQM'8CKYR[DJGY(P?(J@(9FP.D7>FIW+2/.:U@6.158Z56G0X\ M$1<[>%PL8):0#G?6%5 AC4G8Z6H.ZL0(4!RLQ-!Z4'0K/:6U2W4+$=/:)J9E MC\?4T0QB2A,RH4[,&#W#KD3"(BV^K$7<^GB@DXB3AC/:W2/I4IBJ64=S1-2^ M+@%R]K15G1$O>'BZSDM^PVF9KT"I*+L>4X0T(!:V'/!L[>?VDEA8+ON4Q"&] M[H:8>^>]IS&4V-XM!USV)WX3(-DX2:BI\I;R>UJV\8WK^L32DO(822BY(^+0 MZH#@%C#\B#5166IS#B(YWPT>DF?O#TC'/0H-?C1^W (QS;-/$K W@!,+QE ;W3M27WD6%Z-YR2 M+DTNM':LRB#\#!ZQL6$:Z1ILM"N]E",K(JZ^_US16'YH/&TTMP0BD;]WH+C/ MDOR]KQ$A5^;O-3N5GKH3!XJ$48X!EZ- WPUF>,975KE/3CXM@_MZ.*2:QR)( MH ?@%TNB;QKKM28YQ*.2%O9= ^1@G\LB3>VC8LN]Z(& FG?#ZY"$#T#!NZ#+ M(?P_!GA?@"M9WR37JI=0N1E0G7?J@AY72\1@:TR*L%A#[@\XH*EP,?G8K(L;=B47O8?BV MGBR7'X;TXL(@$!!I/(T-FO-*^"A>XPBX'DCC% _<]%;1'#G5I^7H7"Y3.V?2 M@#X;EH7Q+O"")HSV8D=A;QJGN4>-D\:'C4JO4>>EN)B 4IY04CH'QA)N;ZN\ M-* ^+6]BA?RF\.UNDGN%6;:A?@[(NJVCWTXF8[>P5!+HT"AG/F7+4V7 MW9;F>*15X\#"J@6*3\WKJ&<>M"S(L1(<+#@X)PZN'YB%VV!OI+2N*A<+,SOE MW,.VM/!?W7CI?89_HN&.6>_$X+T*\.P\"I9.YE#P>*14\D94NK4]>*AGLP^7 MMJ53"W,GX"^V4@3H*87[H,24INW(W-J42HL3#U_30,.+-8X$REXXU"28B?GI MU="]$0R2031V5TB]^NP6,H 1^-[R6V*4PCQ/ZA3$:>WYI8C_BZ-%S!MZ@]8[ M VU(6UVMT9*[1*>#=J-#R5!KMMMJZ]_8/C.\:>1$,YB09UH=.)3\K)(A3/"" MF*_DW47PQ9$&, L'U.K4&C#FQ15;NB[#X=[6)6 DD"JVPU)M+WQ,R<6K8$R$ MF[%((P=EX"_K*00RZXDUH@>3_!+%)POMD]Y21C@\/M,K*-U8SP[540?<6+ " M$UP$JG,_[*EDRB"5.)K4DIBP;ILF<5S<,(+'FT 5=/3>- H*"(^!L],M$LR0 MG('*-JGK2C:6IWPU7"I9L"3ZQ\R3['T>..>]-"FUYHR6WEN;-HR_$-5QL#$!=F &3,'CB );2&(+E M8'EA$WLP-NX!OII!W2=XW!?3UG[.;*).8)49ED_UOA=^AR^C8#]-D$*.#[)3 MKDGA_]AK41K%7\Q"";@:LW2U0%7X+!Q \:3HP'$3*T)1* M!H/G4 SV(^ 9M&9"JL7XQZ&L"P]P'#%-^#2D#F7GS. ""AP9FD%X]D^I?\*# M(L1Z/V,?Y4_1UU-QNOC#*UW\QG>GWR!9PF]MWXF^!6Z'@8PI0=F<)J79?8;G MXF1FHL_U!ZZA&\0!)-6DIQ&0']8Y$H+P5-LW=6F $R8ZVYNVK3]\*W $7@UO M%*W/[)'#J32-/0A?CE.-IJ;&XGO2G3QP0SGC#] I< MG?!$";PBQ/(K_$>:.'0"^H1E/_LLUPV?Y(+TD@9,>N"K?4>*C7K-6#,H'Q)X1U.V%%U+S'2=DX0%=Y$O-=UB3)1C3V%VF!F$8 M!)[L4#Q-PV9A3PPK/ @*3.T2YWVV>,1P<#5FM\+EBL:\W&R@& MG+')="!#8-U=WXR1F!U#,L9A_!E7&E=^NKC 07")#@H.';MH/:.'8%-#S:,Q M^/J 88:^ +$:D!/^!J[.83O* .+NS.U+I&9CIV$BITM/Q:7'1.4E>P@ L S M8$1VWHM)ZRSB@7$RF4Q, ZY(LG#(2G!I)-IMINH8YYVR0+ZQI%O[A0V!ZX\3<04$U^DD4:*Z2,@?E5"^QSETG^3 M\>23]#LEIC<"XDN/&))"ITWZ$%IS3^R2WQ]#D^[C&; 22,O@QAM+]S$L"JP6 M\B![6U7ZAI20^LP,)]-G?65WW=S@!?VG_O?HF4RH;/+8'[7'VODEL8B>^M ? MC^&/T8-K"0]@CIK/<; 6T6K MPAB^[T_(L"=>8*M>0]M ["QWOGB7EH]TXDW%I<)D4DPCIWNU#D(Q6C(^"/O-((.HYV=5>O29 M1G;"%:+@A=O/#@%[]<.C/P!B @Y[ZRHD&YB PNZ4'TC'TF\$%,:G#'$ ]F! :B8&<9J&'@>U[X)R&LQN& MLYM$"\,,=K!87'\X1&,)+!9X%/@&]FN:_XG&4_ VIEI=+W1'P9*W"$KGL^@< M)ZAD/S*N0E/R;'K AY7Z#FU8>%9DS6+35ANM)GSGF(!1YX'[E)@Z1@5&,&; M*-/.,Q4^9'8L,Z."9[JQA#L6KI_:39+X)&X6Q.'AO'7*H@VC#,A8N] M@"W8[.[-1K[JZ8WXTX-EUZ=<,H4<\USG"#!GV ;&EU("2[3O/X.>"NU0)EA! M5DYE),PM%'QJM=[D3?!%G?;0M1T GP8&4%7Z'QM<1.D?@ $4;%\CJL M@UL8$RZ[ZVSQ-6<+SP%V-UAT4K-!*/V'!B% $$\@J& X8TJ8'C%8X,BE89C. MC"DGF J+=[P0TP?/!,IC)R,=$XFS#*OO@\ MHW#;-"+P@4@87V >@#&>@!J, @.Y;.%S(S47 M_/?5$PJ.=J-8P7'!F82]"615P$W ,;,UB[G69>R()3R3AB20\D81WV"2\I.FT)"DKV"])V451EM_#4K;2$KG4@NB M(0X CVG,,M?"GS[0?#];"&!&:6%SKP(<8$936*+58U88UFZ5/EB4V<*-#5Y!F9_9@R"90^P-(W8I"(Z3 V1/WS'<'5#FT:7<'6!"X*(TBQ[C(PQ!.8R1F/[[\MHQ9&U MEJO[N=YGG(J'A)F6_(8KL*R04ZLE$LB>A+?Z2@P6+6%+/!,$4:@QY+/0BPL] MUW0LN5&D[Q6>CU8U\X-S=8+74TK:-GFZ4=\X>?I 6^$K;85M4J?!2P.W@9B_ M 7@G[K02"3IOD9X*\U: %#.7+B6I($6UM95D4H$R39^^,E@3<(P/;Y<8S1Y? M3.0C:R#2]D'L_!T8@<2GS7D$Y\Z2OM*!@Q'Z %K39"GD9GL\,6FT&0D(HE$L M/3[9R+N.ME!?H[!FH,'"X./$!WO<#?SHOFE*=ZCRS@+Q \(&5CG8$-%#(.*; MEF9"_71>$\N(R/8[ZEC>6/J[K-/"Q\TS1)JCOC$1"V:J=1 M2U;O"=9W$-C"\16TI%?)I*-*FOJ&O\&#_UFN^Z=]0B+.R-&9E*T*[W.LOXG M$27"793;Z62LJ5B>!CF-E1966M)]+1G/3,8O-S2GU W,J1+93K_9MH[ [5OZ MC>41Z]D8F+3/4@)66DHI!\W:*0?-U*FE-'NZ%#Q^.W.I4YBYM-+,B)81+8-@ M>\T-/5B-!7Z&X6$IEPD:="*T,#6)A>S?)?N%Q@Z9!%D5X&B 04Y9QAEVB "S MW&!QRRAE(WI&(G<#O)HQNH*S@&'@M,!OS]%(@TU,G0XQ+8163::JC!F5PI>@ M 8-NCN$P,R<06:"\/\#W03H[1CX"G\L8QB\-SW78#@P(G'O,[K@,T^E@0FAE MI251KTAO)^Z2K/E -@9?DC!G;_X=+-,&YLG]CF/?G7J3LY706J:C6^E9=O+\QFP-718X"J5V3=KA,,.C M-J*ZCS92-)NDXNS4,YQ0*/"$FNT8,!)T6N>PP> RIT+(C%!Q8((0=E#2#][3 MJ%K$@8?#S;&.Z5@\V MI\-:B^&;PY]K\--Y\GNU59/;2NI/]9J<\?M&O97ICF6#DNNU3JLK!E7>0;7E M#G^#ZK35E8]:4ZAT99';K2]+J<<7[#,?IOI<9R-W-CH4N4'1TF.<_N(Y3K$, ML8.I)[H84YOI1.?_A/LHT^8C"D6D[*)UL.539^?"Y67H,BAX1O!,C&=:V_.,6NG) MC;PZDPB>X00]@F?6\DQ[>YYA:4Z"9P3/G!K/K&F;M8IGFI6>,,T$RYP:R^S@ MS;0JO:[,/\N(T%5IKLJS\5^;<]%TR4X[:>]!5K+)LJ6*;!1>PHZ:F?HK-[H; M-EB.1-[7X(1F1*>G&9FBK.HTH=BN])J[]T;FH+F_0]U[#0D=?% 04>1E4\YM=@3H.)+("5. M8^U#('7KE5[RT(\02.7&3D(@[04Z,BNN5#1T3F\OG&5B2VJQ6^&BX_">EH9O M,91)@ZT[N;H\\-1EV^AJOH$G;OM_"VX4W+A_;FQLSXUL@SX9\Q#<*+A1<.-V MW+C]IDQW'UO_@AL%-YXP-VZ?O-;%I +!C((9!3/FE>&S/2^R=(5E=;+*PHPL MH'7.SGQGJ_"^886DUG%52+JQL!(9GL-/5G/HMI-ED+KM9!FD1JP,4O2T-060 MIL7>TVH^+ZF.%+PZ94!*)6,IB]BD$2#L:K]3JG:PO/\B@Q'G][0[G3K<-F,#:<.O@ M&!=B6K([MA9JEE/+1[&G=/VGCX7MC+C"$X9'Q;+*=N<:[X(%?F8 C7UG?7YZ698Y:[,OC.*Q+S?-#Z2*[WNS@=L M1!8>AQC92!IOA!&ETI/E9:791;Y=_F0&5_DGC6I\1NHR;_=H(U9)6;PC9)4U MXG1&CIGQDL8G:J6WK/%'5I.$ ]M>X&-34;HI/AK\X.,4#%-6#7"?!NFZ>\2> M\WZ7YG@$S!H%M,8^:X)]IB:/]6UGG_&> R+X4?!CT0I_#3^V,%UYY\,#!?/C M!FD@W'6FN/.=N+Z7-!-[) T-[-CB8E.UA1TG6$K6669$7K [#(M#3ANC,/=K MKA',EVGOW;"+*S;><;$S#-MC#/HC!:V)R;-#PS9CV"Z%+HN1G;$N*D$O<'L( MOV _,FGHV..PR4M\M-@VAW4NA#>%G=""#AEVT+H0!D;?)MCT;%]-T$)ZAHO> MP*R$B>VRYKD74?^:63+"7^>[EX00KL]N(0,8D^\MOX67;N[=M)[JP;\C9[8) M_4RK X#1SRKKS7Q!S%?R[B(SQ3D%V"1\=JM3:\#K%R>_=(K#X=ZF& @&D'EV MT(3P@O6%PJM@3(2;L4@C!P7T+^O3S-I@_S,.!H!?HFQG]C])9E$5![7T[(!9 M3S;D2V>"BT!U[H>-S=98L[ ,G:TYFM220\\ZIF@YK!U6V((2)#8VQ@*%"C(W M%-PP0W(&]H3)^F6A1'XUL#\7+(G^,?,DTQ+ZUJ7UI32FAF_5E=VC#MK4FSUQ M\V;2?><9>[U91/H?&W2J] _XE&@FO5)%\6&0K""9.M=\6I(5EFPHGR7,">P& M&5D33.VS;X9#PS2PQ1S(M]\D#&@U8UD.I?YK1X ]&@Y> !NQ7^=-'>-/\ M#_AXEYIF8"Y5P?QD,V#2+&AX:4L:X QL#6?:I14'>"8-*)BAH#W/I DPU)AH MU&=&*4O*9 R%C>7@7L<(.VA'8SN3+D<&=J.$"W\X_K-/WN?:6L+7L=4)#+U9 M6V_L8H<]3,,>O#JS2H##P89B:Q(,%\G#FOTY\!',Q!>#OK+%A <-<)5Q(@ 5 M?PB&ON_@C?!7V&SS3!IBGS3 3*(_, Z.U5O!?IDSPN!E2]8^:C&.#1B)!0NF M8T>P\")X")E,\"]LZ4?)&*%!WZCFHU7FLL9HRQZ,3R2:AIOME TJLG#G#5?L M31I]AM.M671^IT9IQ6K0F GZ/1]K'MX M#'[N.PCRE)YLNN\L]&13ZV SV$#.,;Q\M.CLL-ZAP<,DW6=@9_0TQLP?& 8M MH(,VED'+0/)"#!--D)H$C#Y-^I/5(*OXC-V//1QG[/J,;5ZMH 4>YAJ'O1EG M%TRH:P<=.<-6C*&C@#HI:&OJA#)AOI7Z4M\7I@-+]>/Q*N$!=];TPUNHV7$= M#N !7ABKWR$G>RZJ]4ZEI[:29Y;8[(+FKS!5[.8C!?J7,=L64^CN;PK=2J]3 M3Y[T6#H%UN9T.:\ K-"O=*4I_F)X"Y "8LJ=T3ND-EP4 "'L<,KP8<30QO+7 ML:$GOM@))/)2)M0#X<7DLN& K/L35).'EP[#4A^+&G>Q'V:&8R#=[,= EL9( M>#X?<@47O3#'^,8"!>8SR[=OZ;]3':;ZW,><Q3K.BGKGC$HIJ&EI1AOSTAZ/;1VUVP3F3*51L"S1 MW(LP%R^PS>^(@*+U/; ' B-DZ*.&#DAG3Q@%<-%1Y(2MCW'D41M?$&D:<5&+ M3WP'I(2;11L,_$49VDJ4)8PIXAG&;FT+I!;UP%0"1Q">2\?M@F8DN<+ MRUG^N*K;S,7'!Z>$4&5,2TK1$*$3QM8BRRR65,C;]RPP<::>3 2>3F/@NR-J M!CV6;PY0A*P>S+ M#2Z5LBUHTN>SI(+0MO-)#AEK*233[Z9#9J-BH+ (2 'PB)[)=H?8.&ALGU$^ MA]89.&%A%6-N!#3RD*11QR-HI+DNG79Q'RZ.69^"Q&4[#3K%4G@L(@94#&<$ M-ME40THV4 CUSK)=MY&MV MX'(;>:O2:W6363FSD>\FDN>@8AID$(8%.,7+FCH4N:TZ>-IR.YFQL ->UK2R MR6WD6$"YD\R%W0TOQJ@[.JKM+3V?&: M*!6_GY$K=93,*TS0?<@W\*C"'5X.,-)>XL'DOM+@LC0Z*2&AK3'27E/7.[>1 M@YO24E9)XW+*M(SVY@W;=,$(/X90>3$V)RR0C9LAN$F 0PQVA9ZJWVSM)PLU M!DR(\43Z-F$!)/S6F)M.$"]T:T& X07/%7B>"59%]!P0Z;9F,$.#[3&AAVBX MKL_J_@+U6;B26H;ML'W-( @./*_4U3J#@5)OUH,]!H>R_0X]"%GZ$T!0\#86 MV XBE>!K1F]>C$[V-C&BJT;"_!>QE=MMF>27K!% M5=2T@BU\V2$(KIF!'-<8"W;RO':AL;0IQ!= 1M2!22EATFK7U YW=6 :M7J3 MNSHP.*C"Z\!TRUG^Y -*(>I^7,*460JAY%M-9^-<6K[7=ZLZ.^OG?AJ+QU]M MGB+*IBWLCTWW$,XDBWJQW Z/O$DP-ZIYV=VR55L%&YHRE\%%\-UE8-[>6+?4 MBUJ&8'+(O*UTS8;Z1-Z"/])_%5%NRBURP+=-)ZQRXA:6V9*>YX-EUTQJU M[F"HB9I)NT!]:^&Y:3]55:V+?JI'C:PU"2U[1);,&[).)H0ROZ6X%]V\)&.G M6.VE*AF98TGV3L&S4--U\$&B)T=>?2N;;Y, ^=Y\&[6Q6S]J4;Z-2P EY,O^ M -3D D G4]]-U'0K/NAV.C6DLDF=1';J_J0.1KR3^?>;BQU1_$TPKF#G5VJ^T._PFI&;-:E;[8!&6'%.!8\44H\ET\+*?D@$)*B;.1:Q M;@68-[_E]!,AKPU6 $/HR\]L?)380>H@Q\6@;I75KP.JIV>8GLWR?X.R+">]I/*WGN MHU$OQ[F/62%>IH 'Q&0GD]S1_\_>NS>WC>1ZPU^%I9T]E:F2-;I?G"U5.4Z\ MZW.2.$_LV:G]:XLB6Q8W%*GAQ8[WTS\ NGF12(FD1$F4U/N^SQR'XJ4;#: ! M-/ #(RM&XP06A4KKMG PSEU&$&=@1+LA"-T:"?@@OO&(WX"GS[S\H]UN]#K% MZB,.4&D!/[0K5_XA!R4'M8]!';VDJ),HZ!"*YY1K.G#W4_X9%(\'Z&=+J&A1 M1$ )@@&'KD-J]M18=KZ)+YE@RF=A MYI77-_Y,^",JU;H-.6W5ZW'&J>6\;!.=7G%3D;'>9&(;LA;+V4 M\\QNJS;>N5.[K&RM%@])R.LEI\U/A*7H2-&Y*-%9@[%21'0ZJ4DT M4G2DZ)RWZ*S![RDB.MVT\C$I.5)RSEMR M%^LEIU\;)_'=JB8YEU"44)L1/*3NWM)(#^Y,32Z M@ZIA:$C6*95U/6:]ZA[5QLH^09(XS8([<76;6,\=(,L>9,D?N1CZ%-YV> MA 0[:]89[7XFV&N5$&.2S%%%YMC]V*O7K@YS'!KR[3AUY5L[>"7A..T0+SIQ M:=G]I*O7N9#T"LE0>1AJ]_.?'I[_[&ST2XXZ%X[:_5RDA]AR24P/R5$7RE&[ MGQ?T^A=R1BT9*@]#%0Z@)QEJ< H'4)*A#L10NX?5>\-3,,LOX40S+)Q8J&]8 M-2%/,O46WSWREYI)(\DON<(8-'VK5QLN6B9)%S8)'NVBX0E^2J?GD'J!5*ESW!H]6OS%-X5O-O M[V)KENCLO&LP*6?2L^Q[OB?25%L'%>I[GHP:K.EAO9JW'^/O&R]L-@D2D*:A M!JF-J?-W/"]Q\8X4_Y4B*T7V.&7*&P0U?T2]]#,]* M&Q-ZP;5@A_:13\N M!R4'=9*#ZFQ\5<8!WL9CX+RW)3HQ"\6S68%6NQDS[D4*;4:*/57^P710J,_* MO>5ZCC]G"*ZCNOC+1Z:Q^80Y2J=55]JP&D4:.)=!_59OE?JGW@?[(T/C0?68 MGD;W_344/S]*?K6MJP+4S,FM1[7H\TW\@VJJEL:4QQECGO+9UE2T%7.P3DZ) M/!/^N+7G^NA81EH7J> ]"Q%1XI.7'1V;\PTQ,X@%P&[+V5'RDY<=G9OTS3L@>Q<1(Z,[F'I2'!2L"K"8E*PL@5K]\9<0ZQIDJ(C1>?21&?W#F3# MX2F(SB5@=B6QH-7M&]KFP0/8C7ZG+CJ%>ZWE-^YVS4K(V3 MT$5RN?:R7+E!2]]O]1IW2@ADE M-1*1O%,N[Q0^@,G/.]VJ\YG,:-4"#NYD => MR,(' \F%Q#;PR2B,7,D#K^3ND>@1]FI)IA;(E3SP2A8.C.:W43; +\EE/O R M%P[B)9=SE!;_E@MYX(7<.8 '@\AI?;?938-> MDVNVES4KIV55MXD)PG+1#K1HY32$ZC;[V5O:)83"C]./?37DR.4\0$Y.QG(B4H1$/E-W[IMC"0 MW#S=SB]29J7,5DEF$R[O'F2VW3SI9DU29*7(5DED#]!QN-O&%&,ILU)FIG*[(IG8?%7+[ZO=6LME65T64W5=8VK PDP=>\Z7QK!@#[RW-'O.BASB5^*L/F^+ZI#SD"%O57>F MW,&&OBL;)ACGY+M(SAS&E"]PW\Q5/EDZ\,D7U=%FV"Z]?)D] <[A8J&$EK'D MF&TYYGRT2="7_3NY$+;ESHQ%B3O:F3!&N]GNROZ]1U PC:HC?OE MG8=74]C.TER@-UX;'GQ-RV5 N)YB3Q47&$":#E*;[5>;Y:U+6=55=XX]O]$T M?^Z;JL?T=96Z4EJXC M.]4>GFWN8(U@$ K'R-1VC1W(OFOYY"\#!*-D"[Z36NHE._B= R=EX&^4S4FM M$A1W!3GI]+1Z0=\.H0O(K_MM=R]/BF8^T

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�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ingr-20240331_htm.xml IDEA: XBRL DOCUMENT 0001046257 2024-01-01 2024-03-31 0001046257 2024-05-06 0001046257 2023-01-01 2023-03-31 0001046257 2024-03-31 0001046257 2023-12-31 0001046257 us-gaap:CommonStockMember 2023-12-31 0001046257 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001046257 us-gaap:TreasuryStockCommonMember 2023-12-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001046257 us-gaap:RetainedEarningsMember 2023-12-31 0001046257 us-gaap:NoncontrollingInterestMember 2023-12-31 0001046257 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001046257 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001046257 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001046257 us-gaap:CommonStockMember 2024-03-31 0001046257 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001046257 us-gaap:TreasuryStockCommonMember 2024-03-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001046257 us-gaap:RetainedEarningsMember 2024-03-31 0001046257 us-gaap:NoncontrollingInterestMember 2024-03-31 0001046257 us-gaap:CommonStockMember 2022-12-31 0001046257 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001046257 us-gaap:TreasuryStockCommonMember 2022-12-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001046257 us-gaap:RetainedEarningsMember 2022-12-31 0001046257 us-gaap:NoncontrollingInterestMember 2022-12-31 0001046257 2022-12-31 0001046257 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001046257 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001046257 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001046257 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001046257 us-gaap:CommonStockMember 2023-03-31 0001046257 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001046257 us-gaap:TreasuryStockCommonMember 2023-03-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001046257 us-gaap:RetainedEarningsMember 2023-03-31 0001046257 us-gaap:NoncontrollingInterestMember 2023-03-31 0001046257 2023-03-31 0001046257 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ingr:SouthKoreaDivestitureMember 2024-02-01 0001046257 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ingr:SouthKoreaDivestitureMember 2024-02-01 2024-02-01 0001046257 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember ingr:SouthKoreaDivestitureMember 2024-01-01 2024-03-31 0001046257 2024-01-01 0001046257 us-gaap:OperatingSegmentsMember ingr:TextureAndHealthfulSolutionsSegmentMember 2023-12-31 0001046257 us-gaap:OperatingSegmentsMember ingr:FoodAndIndustrialIngredientsLATAMSegmentMember 2023-12-31 0001046257 us-gaap:OperatingSegmentsMember ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember 2023-12-31 0001046257 us-gaap:MaterialReconcilingItemsMember 2023-12-31 0001046257 us-gaap:OperatingSegmentsMember ingr:TextureAndHealthfulSolutionsSegmentMember 2024-01-01 2024-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:FoodAndIndustrialIngredientsLATAMSegmentMember 2024-01-01 2024-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember 2024-01-01 2024-03-31 0001046257 us-gaap:MaterialReconcilingItemsMember 2024-01-01 2024-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:TextureAndHealthfulSolutionsSegmentMember 2024-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:FoodAndIndustrialIngredientsLATAMSegmentMember 2024-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember 2024-03-31 0001046257 us-gaap:MaterialReconcilingItemsMember 2024-03-31 0001046257 ingr:ArgentinaJointVentureMember 2024-01-01 2024-03-31 0001046257 2023-12-12 0001046257 2023-12-13 0001046257 ingr:CornCommodityMember 2024-03-31 0001046257 ingr:CornCommodityMember 2023-12-31 0001046257 ingr:NaturalGasCommodityMember 2024-03-31 0001046257 ingr:NaturalGasCommodityMember 2023-12-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ShortMember 2024-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ShortMember 2023-12-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:LongMember 2024-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:LongMember 2023-12-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2024-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-12-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2024-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2023-12-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2024-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2023-12-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2024-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2023-12-31 0001046257 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2024-03-31 0001046257 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2023-12-31 0001046257 us-gaap:CashFlowHedgingMember 2024-03-31 0001046257 us-gaap:CashFlowHedgingMember 2023-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2024-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:AccountsPayableMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:AccountsPayableMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:AccountsPayableMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:AccountsPayableMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:AccountsPayableMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:AccountsPayableMember us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-03-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:NondesignatedMember 2024-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2023-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:AccountsPayableMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:AccountsPayableMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:AccountsPayableMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:AccountsPayableMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:AccountsPayableMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:AccountsPayableMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:NondesignatedMember 2023-12-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2024-01-01 2024-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2024-01-01 2024-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember ingr:NetSalesAndCostOfSalesMember 2024-01-01 2024-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember ingr:NetSalesAndCostOfSalesMember 2023-01-01 2023-03-31 0001046257 us-gaap:CashFlowHedgingMember 2024-01-01 2024-03-31 0001046257 us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001046257 us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001046257 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001046257 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001046257 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001046257 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001046257 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001046257 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001046257 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001046257 ingr:SeniorNotes2.2PercentDue1june2030Member 2023-12-31 0001046257 ingr:SeniorNotes2.2PercentDue1june2030Member 2024-03-31 0001046257 ingr:SeniorNotes3.20PercentDueOctober12026Member 2023-12-31 0001046257 ingr:SeniorNotes3.20PercentDueOctober12026Member 2024-03-31 0001046257 ingr:SeniorNotes3.9PercentDue1june2050Member 2024-03-31 0001046257 ingr:SeniorNotes3.9PercentDue1june2050Member 2023-12-31 0001046257 ingr:SeniorNotes6.625PercentDue2037Member 2024-03-31 0001046257 ingr:SeniorNotes6.625PercentDue2037Member 2023-12-31 0001046257 us-gaap:RevolvingCreditFacilityMember 2024-03-31 0001046257 us-gaap:RevolvingCreditFacilityMember 2023-12-31 0001046257 ingr:OtherLongTermBorrowingsMember 2024-03-31 0001046257 ingr:OtherLongTermBorrowingsMember 2023-12-31 0001046257 ingr:CommercialPaperProgramMember 2024-03-31 0001046257 ingr:CommercialPaperProgramMember 2023-12-31 0001046257 ingr:OtherShortTermBorrowingsMember 2024-03-31 0001046257 ingr:OtherShortTermBorrowingsMember 2023-12-31 0001046257 ingr:CommercialPaperProgramMember 2024-01-01 2024-03-31 0001046257 ingr:CommercialPaperProgramMember 2023-01-01 2023-03-31 0001046257 ingr:CommercialPaperProgramMember 2023-01-01 2023-12-31 0001046257 country:US us-gaap:PensionPlansDefinedBenefitMember 2024-01-01 2024-03-31 0001046257 country:US us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-03-31 0001046257 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2024-01-01 2024-03-31 0001046257 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-03-31 0001046257 country:US us-gaap:PensionPlansDefinedBenefitMember 2024-03-31 0001046257 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2024-03-31 0001046257 us-gaap:PostemploymentRetirementBenefitsMember 2023-01-01 2023-03-31 0001046257 us-gaap:PostemploymentRetirementBenefitsMember 2024-01-01 2024-03-31 0001046257 ingr:StockRepurchaseProgram2022Member 2022-09-26 0001046257 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001046257 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001046257 ingr:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001046257 ingr:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001046257 ingr:PerformanceSharesAndOtherShareBasedAwardsMember 2024-01-01 2024-03-31 0001046257 ingr:PerformanceSharesAndOtherShareBasedAwardsMember 2023-01-01 2023-03-31 0001046257 2023-01-01 2023-12-31 0001046257 us-gaap:EmployeeStockOptionMember 2024-03-31 0001046257 ingr:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001046257 ingr:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0001046257 us-gaap:PerformanceSharesMember 2024-01-01 2024-03-31 0001046257 ingr:PerformanceSharesMarketBasedMember 2024-01-01 2024-03-31 0001046257 ingr:PerformanceSharesVestingBasedOnAdjustedROICMember 2024-01-01 2024-03-31 0001046257 srt:MinimumMember ingr:PerformanceSharesMarketBasedMember 2024-01-01 2024-03-31 0001046257 srt:MaximumMember ingr:PerformanceSharesMarketBasedMember 2024-01-01 2024-03-31 0001046257 srt:MinimumMember ingr:PerformanceSharesVestingBasedOnAdjustedROICMember 2024-01-01 2024-03-31 0001046257 srt:MaximumMember ingr:PerformanceSharesVestingBasedOnAdjustedROICMember 2024-01-01 2024-03-31 0001046257 us-gaap:PerformanceSharesMember 2024-03-31 0001046257 ingr:A2021AwardsMember us-gaap:PerformanceSharesMember 2024-02-01 2024-02-29 0001046257 ingr:A2022AwardsMember us-gaap:PerformanceSharesMember 2024-01-01 2024-03-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0001046257 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-03-31 0001046257 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-03-31 0001046257 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-03-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001046257 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001046257 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0001046257 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0001046257 ingr:OperatingSegmentsAndCorporateNonSegmentMember 2024-01-01 2024-03-31 0001046257 us-gaap:IntersegmentEliminationMember ingr:TextureAndHealthfulSolutionsSegmentMember 2024-01-01 2024-03-31 0001046257 us-gaap:IntersegmentEliminationMember ingr:FoodAndIndustrialIngredientsLATAMSegmentMember 2024-01-01 2024-03-31 0001046257 us-gaap:IntersegmentEliminationMember ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember 2024-01-01 2024-03-31 0001046257 ingr:EliminationsAndReconcilingItemsMember 2024-01-01 2024-03-31 0001046257 us-gaap:IntersegmentEliminationMember 2024-01-01 2024-03-31 0001046257 ingr:TextureAndHealthfulSolutionsSegmentMember 2024-01-01 2024-03-31 0001046257 ingr:FoodAndIndustrialIngredientsLATAMSegmentMember 2024-01-01 2024-03-31 0001046257 ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember 2024-01-01 2024-03-31 0001046257 ingr:CorporateReconcilingItemsAndEliminationsMember 2024-01-01 2024-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:TextureAndHealthfulSolutionsSegmentMember 2023-01-01 2023-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:FoodAndIndustrialIngredientsLATAMSegmentMember 2023-01-01 2023-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember 2023-01-01 2023-03-31 0001046257 us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-03-31 0001046257 ingr:OperatingSegmentsAndCorporateNonSegmentMember 2023-01-01 2023-03-31 0001046257 us-gaap:IntersegmentEliminationMember ingr:TextureAndHealthfulSolutionsSegmentMember 2023-01-01 2023-03-31 0001046257 us-gaap:IntersegmentEliminationMember ingr:FoodAndIndustrialIngredientsLATAMSegmentMember 2023-01-01 2023-03-31 0001046257 us-gaap:IntersegmentEliminationMember ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember 2023-01-01 2023-03-31 0001046257 ingr:EliminationsAndReconcilingItemsMember 2023-01-01 2023-03-31 0001046257 us-gaap:IntersegmentEliminationMember 2023-01-01 2023-03-31 0001046257 ingr:TextureAndHealthfulSolutionsSegmentMember 2023-01-01 2023-03-31 0001046257 ingr:FoodAndIndustrialIngredientsLATAMSegmentMember 2023-01-01 2023-03-31 0001046257 ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember 2023-01-01 2023-03-31 0001046257 ingr:CorporateReconcilingItemsAndEliminationsMember 2023-01-01 2023-03-31 0001046257 us-gaap:CorporateNonSegmentMember 2024-01-01 2024-03-31 0001046257 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-03-31 0001046257 2022-10-01 2022-12-31 0001046257 country:BR us-gaap:ReductionInTaxesMember us-gaap:ForeignCountryMember 2023-12-31 0001046257 country:BR us-gaap:ReductionInTaxesMember us-gaap:ForeignCountryMember 2024-03-31 0001046257 ingr:LarryFernandesMember 2024-01-01 2024-03-31 0001046257 ingr:LarryFernandesMember 2024-03-31 0001046257 ingr:RobertRitchieMember 2024-01-01 2024-03-31 0001046257 ingr:RobertRitchieMember 2024-03-31 0001046257 ingr:RobertRitchieMember 2024-01-01 2024-03-31 shares iso4217:USD iso4217:USD shares ingr:segment iso4217:KRW iso4217:ARS iso4217:USD utr:bu utr:MMBTU pure ingr:metric 0001046257 2024 Q1 --12-31 false http://fasb.org/us-gaap/2023#AccountsPayableCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccountsPayableCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent P612D 10-Q true 2024-03-31 false 1-13397 INGREDION INCORPORATED DE 22-3514823 5 Westbrook Corporate Center Westchester IL 60154 708 551-2600 Common Stock INGR NYSE Yes Yes Large Accelerated Filer false false false 65647485 1882000000 2137000000 1465000000 1650000000 417000000 487000000 189000000 187000000 -12000000 -9000000 3000000 0 213000000 291000000 19000000 32000000 82000000 0 276000000 259000000 58000000 65000000 218000000 194000000 2000000 3000000 216000000 191000000 65700000 66100000 66800000 67100000 3.29 2.89 3.23 2.85 218000000 194000000 10000000 16000000 -31000000 -42000000 -9000000 -4000000 -24000000 14000000 0 0 -1000000 0 0 6000000 212000000 144000000 1000000 -3000000 211000000 147000000 438000000 401000000 7000000 8000000 1284000000 1279000000 1344000000 1450000000 52000000 261000000 3125000000 3399000000 3444000000 3428000000 2334000000 2370000000 305000000 299000000 1286000000 1303000000 574000000 570000000 7319000000 7642000000 141000000 448000000 659000000 778000000 483000000 546000000 1283000000 1772000000 1740000000 1740000000 471000000 480000000 3494000000 3992000000 43000000 55000000 42000000 43000000 25000000.0 25000000.0 0.01 0.01 0 0 0 0 200000000.0 200000000.0 0.01 0.01 77800000 77800000 1000000 1000000 1146000000 1146000000 12200000 12600000 1179000000 1207000000 -1062000000 -1056000000 4818000000 4654000000 3724000000 3538000000 16000000 14000000 3740000000 3552000000 7319000000 7642000000 1000000 1146000000 -1207000000 -1056000000 4654000000 14000000 55000000 43000000 216000000 2000000 0.78 52000000 1000000 29000000 -12000000 -6000000 -1000000 1000000 1146000000 -1179000000 -1062000000 4818000000 16000000 43000000 42000000 1000000 1132000000 -1148000000 -1048000000 4210000000 16000000 48000000 51000000 191000000 3000000 0.71 47000000 1000000 21000000 -10000000 -50000000 -6000000 1000000 1133000000 -1127000000 -1098000000 4354000000 13000000 38000000 51000000 218000000 194000000 53000000 54000000 14000000 18000000 82000000 0 32000000 20000000 -6000000 44000000 -104000000 87000000 -135000000 -171000000 11000000 19000000 10000000 -16000000 209000000 -51000000 65000000 76000000 0 1000000 247000000 0 1000000 6000000 181000000 -81000000 149000000 318000000 134000000 267000000 -312000000 107000000 -1000000 0 2000000 2000000 51000000 47000000 -347000000 113000000 -6000000 -1000000 37000000 -20000000 401000000 236000000 438000000 216000000 1. Basis of Presentation and New Accounting Standards<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, all references herein to the “Company,” “Ingredion,” “we,” “us,” and “our” shall mean Ingredion Incorporated and its consolidated subsidiaries. These statements should be read in conjunction with the consolidated financial statements and the related notes to those statements contained in Ingredion’s Annual Report on Form 10-K for the year ended December 31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited Condensed Consolidated Financial Statements as of March 31, 2024 and for the first quarter of 2024 and 2023 included herein were prepared by us on the same basis as our audited Consolidated Financial Statements for the year ended December 31, 2023 and reflect all adjustments (consisting solely of normal recurring items unless otherwise noted) that are, in our opinion, necessary for the fair presentation of the Condensed Consolidated Statements of Income, Condensed Consolidated Statements of Comprehensive Income, Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Equity and Redeemable Equity, and Condensed Consolidated Statements of Cash Flows. The results for the interim period are not necessarily indicative of the results expected for the full year or any other future period.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies and estimates used in preparing these Condensed Consolidated Financial Statements were applied on the same basis consistent with those reflected in Ingredion’s Annual Report on Form 10-K for the year ended December 31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, we announced a strategic reorganization of our business. As more fully described in Note 10, under our new reportable segments, effective January 1, 2024, there are three reportable segments consisting of - Texture &amp; Healthful Solutions (“T&amp;HS”), Food &amp; Industrial Ingredients - Latin America (“F&amp;II - LATAM”) and Food &amp; Industrial Ingredients - U.S./Canada (“F&amp;II - US/Canada”).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Standards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2022-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments require filers to disclose information about supplier finance programs that is sufficient to allow financial statement users to understand their nature, activity during the period, changes from period to period and potential magnitude. The amendments in this ASU are effective for annual periods beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. We adopted this ASU at the beginning of our 2023 fiscal year and adopted the amendment on rollforward information at the beginning of our 2024 fiscal year. The disclosures required by this ASU are reflected in Note 12.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the FASB issued ASU No. 2023-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations - Joint Venture Formations (Subtopic 805-60).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amendments in this ASU require that a joint venture apply a new basis of accounting upon formation. By applying a new basis of accounting, a joint venture, upon formation, will recognize and initially measure its assets and liabilities at fair value (with exceptions to fair value measurement that are consistent with the business combinations guidance). The amendments in this ASU are effective prospectively for all joint venture formations with a formation date on or after January 1, 2025. A joint venture that was formed before January 1, 2025 may elect to apply the amendments retrospectively. We will adopt this ASU on a prospective basis at the beginning of our 2025 fiscal year and do not believe it will have a material impact on the Condensed Consolidated Financial Statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this ASU improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this ASU are effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Entities must apply the amendments in this ASU retrospectively to all prior periods presented in the financial statements. We are currently assessing the impact of this ASU on the Condensed Consolidated Financial Statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes (Topic 740)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax Disclosures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments require public business entities on an annual basis to disclose specific categories in the rate </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Additionally, the amendment requires information pertaining to taxes paid (net of refunds received) to be disaggregated by federal, state, and foreign taxes </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with further disaggregation for specific jurisdictions to the extent the related amounts exceed a quantitative threshold. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this ASU are effective for annual periods beginning after December 15, 2024, with early adoption permitted. </span>We are currently waiting for additional guidance to be issued on the quantitative thresholds before we can assess the impact of this ASU on the Condensed Consolidated Financial Statements. 3 3 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Standards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2022-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments require filers to disclose information about supplier finance programs that is sufficient to allow financial statement users to understand their nature, activity during the period, changes from period to period and potential magnitude. The amendments in this ASU are effective for annual periods beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. We adopted this ASU at the beginning of our 2023 fiscal year and adopted the amendment on rollforward information at the beginning of our 2024 fiscal year. The disclosures required by this ASU are reflected in Note 12.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the FASB issued ASU No. 2023-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations - Joint Venture Formations (Subtopic 805-60).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amendments in this ASU require that a joint venture apply a new basis of accounting upon formation. By applying a new basis of accounting, a joint venture, upon formation, will recognize and initially measure its assets and liabilities at fair value (with exceptions to fair value measurement that are consistent with the business combinations guidance). The amendments in this ASU are effective prospectively for all joint venture formations with a formation date on or after January 1, 2025. A joint venture that was formed before January 1, 2025 may elect to apply the amendments retrospectively. We will adopt this ASU on a prospective basis at the beginning of our 2025 fiscal year and do not believe it will have a material impact on the Condensed Consolidated Financial Statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this ASU improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this ASU are effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Entities must apply the amendments in this ASU retrospectively to all prior periods presented in the financial statements. We are currently assessing the impact of this ASU on the Condensed Consolidated Financial Statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes (Topic 740)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax Disclosures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments require public business entities on an annual basis to disclose specific categories in the rate </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Additionally, the amendment requires information pertaining to taxes paid (net of refunds received) to be disaggregated by federal, state, and foreign taxes </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with further disaggregation for specific jurisdictions to the extent the related amounts exceed a quantitative threshold. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this ASU are effective for annual periods beginning after December 15, 2024, with early adoption permitted. </span>We are currently waiting for additional guidance to be issued on the quantitative thresholds before we can assess the impact of this ASU on the Condensed Consolidated Financial Statements. 2. Divestitures<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">South Korea Divestiture</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2024, we completed the sale of our South Korea business, which we report for segment purposes in All Other, for a total consideration of 384.0 billion South Korean won, or approximately $294 million. We received 330.0 billion South Korea won, or $247 million net of certain transaction costs, when the transaction closed, and we will receive the remaining consideration in equal annual payments through February 2027. As a result, we recognized a pre-tax net gain of $82 million within Net gain on sale of business in the Condensed Consolidated Statements of Income.</span></div> 384000000000 294000000 330000000000 247000000 82000000 3. Intangible Assets<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the cost of an acquired entity over the fair value assigned to identifiable assets acquired and liabilities assumed. Ingredion assesses goodwill and indefinite-lived intangible assets for impairment annually (or more frequently if impairment indicators arise). Changes to our reportable segments effective January 1, 2024, as described in Note 10, resulted in a change to our reporting units.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of this effective date, we performed a qualitative assessment of the goodwill under our former reporting units to determine if it is more likely than not that the reporting unit’s goodwill is impaired. As a result of this analysis, we did not identify any indications that any of the carrying amounts of the reporting units exceeded their respective fair values. Next, we performed a quantitative assessment to reallocate goodwill to our new reporting units using a relative fair value approach. We evaluated these new reporting units for impairment as of January 1, 2024, and determined the fair value was in excess of carrying value for all our reporting units indicating no impairments are present. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The original carrying values of goodwill and accumulated impairment charges by reportable segment and All Other as of March 31, 2024 are presented below. There were no accumulated impairment charges by reportable segment.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">T&amp;HS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">F&amp;II - LATAM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">F&amp;II - U.S./Canada</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">388 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">918 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">383 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">296 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">910 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The original carrying values of goodwill and accumulated impairment charges by reportable segment and All Other as of March 31, 2024 are presented below. There were no accumulated impairment charges by reportable segment.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">T&amp;HS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">F&amp;II - LATAM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">F&amp;II - U.S./Canada</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">388 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">918 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">383 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">296 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">910 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 388000000 146000000 296000000 88000000 918000000 -5000000 -1000000 0 -2000000 -8000000 383000000 145000000 296000000 86000000 910000000 4. Investments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Investments as of March 31, 2024 and December 31, 2023 are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments classified as equity investments do not have readily determinable fair values. Beginning on the dates we entered into the agreements for equity method investments, our share of income from these investments is included within Other operating expense in the Condensed Consolidated Statements of Income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Argentina Joint Venture</span></div>On February 12, 2021, we entered into an agreement with an affiliate of Grupo Arcor, an Argentine food company, to establish Ingrear Holding S.A. (the “Argentina joint venture”), a joint venture to sell value-added ingredients to customers in the food, beverage, pharmaceutical and other industries in Argentina, Chile and Uruguay. Ingredion and Grupo Arcor have completed all closing conditions, pending customary antitrust review, to combine the manufacturing facilities, finalize the transaction and formally establish the Argentina joint venture, which is managed by a jointly appointed team of executives. The Argentina joint venture is accounted for on the equity method of accounting, and we recognize our share of income or expense in Other operating expense one month in arrears due to the timing of when results are available. On December 13, 2023, the new Argentine government allowed the Argentine peso to devalue from the exchange rate of approximately 366 pesos to one U.S. dollar, to 800 pesos to one U.S. dollar. As we recognize our share of earnings one month in arrears, the loss from the change in value of the peso in December 2023 was recorded in Other operating expense during the first quarter of 2024 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Investments as of March 31, 2024 and December 31, 2023 are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 29000000 27000000 98000000 112000000 4000000 4000000 131000000 143000000 P1M 366 800 5. Derivative Instruments and Hedging Activities<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commodity price hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We had outstanding futures and option contracts that hedged the forecasted purchase of approximately 96 million and 109 million bushels of corn as of March 31, 2024 and December 31, 2023. We also had outstanding swap contracts that hedged the forecasted purchase of approximately 26 million and 28 million mmbtus of natural gas as of March 31, 2024 and December 31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We hedge certain assets using foreign currency derivatives not designated as hedging instruments, which had a notional value of $445 million and $694 million as of March 31, 2024 and December 31, 2023. We also hedge certain liabilities using foreign currency derivatives not designated as hedging instruments, which had a notional value of $171 million and $182 million as of March 31, 2024 and December 31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge certain assets using foreign currency cash flow hedging instruments, which had a notional value of $328 million and $449 million as of March 31, 2024 and December 31, 2023. We also hedge certain liability positions using foreign currency cash flow hedging instruments, which had a notional value of $480 million and $621 million as of March 31, 2024 and December 31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We periodically enter into T-Locks to hedge our exposure to interest rate changes. We have settled T-Locks associated with the issuance of our senior notes due in 2030 and 2050. The realized loss upon settlement of these T-Locks was recorded in Accumulated other comprehensive loss (“AOCL”) and is amortized into earnings over the term of the senior notes. We did not have outstanding T-Locks as of either March 31, 2024 or December 31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The derivative instruments designated as cash flow hedges included in AOCL as of March 31, 2024 and December 31, 2023 are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Losses) included in AOCL as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commodity contracts, net of income tax effect of $19 and $17</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency contracts, net of income tax effect of $2 and $1</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate contracts, net of income tax effect of $1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(55)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, AOCL included $52 million of net losses (net of income taxes of $18 million) on commodities-related derivative instruments, T-Locks and foreign currency hedges designated as cash flow hedges that are expected to be reclassified into earnings during the next 12 months.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value and balance sheet location of our derivative instruments, presented gross in the Condensed Consolidated Balance Sheets, are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value of Hedging Instruments as of March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Designated Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-Designated Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Foreign Currency Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Foreign Currency Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net Assets/(Liabilities)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value of Hedging Instruments as of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Designated Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-Designated Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Foreign Currency Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Foreign Currency Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net Assets/(Liabilities)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(40)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information relating to our derivative instruments are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Losses) Gains <br/>Recognized in AOCL on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Losses) Gains <br/>Reclassified from AOCL into Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Derivatives in Cash Flow</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Income Statement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Hedging Relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commodity contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(42)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(67)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net sales/Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(58)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 96000000 109000000 26000000 28000000 445000000 694000000 171000000 182000000 328000000 449000000 480000000 621000000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The derivative instruments designated as cash flow hedges included in AOCL as of March 31, 2024 and December 31, 2023 are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Losses) included in AOCL as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commodity contracts, net of income tax effect of $19 and $17</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency contracts, net of income tax effect of $2 and $1</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate contracts, net of income tax effect of $1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(55)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 19000000 17000000 -53000000 -46000000 2000000 1000000 0 0 1000000 1000000 -2000000 -2000000 -55000000 -48000000 -52000000 -18000000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value and balance sheet location of our derivative instruments, presented gross in the Condensed Consolidated Balance Sheets, are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value of Hedging Instruments as of March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Designated Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-Designated Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Foreign Currency Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Foreign Currency Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net Assets/(Liabilities)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value of Hedging Instruments as of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Designated Hedging Instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-Designated Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Foreign Currency Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Foreign Currency Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net Assets/(Liabilities)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(40)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 8000000 10000000 18000000 1000000 6000000 7000000 0 4000000 4000000 0 1000000 1000000 8000000 14000000 22000000 1000000 7000000 8000000 58000000 14000000 72000000 3000000 6000000 9000000 2000000 0 2000000 0 0 0 60000000 14000000 74000000 3000000 6000000 9000000 -52000000 0 -52000000 -2000000 1000000 -1000000 6000000 11000000 17000000 0 5000000 5000000 0 4000000 4000000 0 0 0 6000000 15000000 21000000 0 5000000 5000000 44000000 14000000 58000000 2000000 12000000 14000000 2000000 2000000 4000000 0 0 0 46000000 16000000 62000000 2000000 12000000 14000000 -40000000 -1000000 -41000000 -2000000 -7000000 -9000000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information relating to our derivative instruments are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Losses) Gains <br/>Recognized in AOCL on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Losses) Gains <br/>Reclassified from AOCL into Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Derivatives in Cash Flow</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Income Statement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Hedging Relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commodity contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(42)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(67)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net sales/Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(58)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -42000000 -67000000 -33000000 9000000 1000000 9000000 0 9000000 -41000000 -58000000 -33000000 18000000 6. Fair Value Measurements<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure certain assets and liabilities at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. In determining fair value, we use various valuation approaches. The hierarchy of those valuation approaches is in three levels based on the reliability of inputs. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Below is a summary of the hierarchy levels:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 inputs consist of quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 2 inputs are </span></div><div style="margin-top:12pt;padding-left:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability or can be derived principally from or corroborated by observable market data.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis are presented below:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,591 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,591 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of cash equivalents, short-term investments, accounts receivable, short-term borrowings and accounts payable approximate fair values. Commodity futures, options and swap contracts are recognized at fair value. Foreign currency forward contracts, swaps and options are also recognized at fair value. The fair value of our Long-term debt is estimated based on quotations of major securities dealers who are market makers in the securities.</span></div> <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis are presented below:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,591 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,591 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 4000000 4000000 0 0 4000000 4000000 0 0 30000000 29000000 1000000 0 26000000 26000000 0 0 83000000 53000000 30000000 0 76000000 43000000 33000000 0 1575000000 0 1575000000 0 1591000000 0 1591000000 0 7. Financing Arrangements<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below are our debt carrying amounts, net of related discounts, premiums and debt issuance costs, as of March 31, 2024 and December 31, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.900% senior notes due June 1, 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">596 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">596 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.200% senior notes due October 1, 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.900% senior notes due June 1, 2050</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.625% senior notes due April 15, 2037</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving credit agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,740 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,740 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other short-term borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total short-term borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">448 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,881 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,188 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We maintain a commercial paper program under which we may issue senior unsecured notes of short maturities up to a maximum aggregate principal amount of $1.0 billion outstanding at any time. The notes may be sold from time to time on customary terms in the U.S. commercial paper market. We use the note proceeds for general corporate purposes. During the first quarter of 2024, the average amount of commercial paper outstanding was $118 million with an average interest rate of 5.51 percent and a weighted average maturity of 8 days. During the first quarter of 2023, the average amount of commercial paper outstanding was $460 million with an average interest rate of 4.79 percent and a weighted average maturity of 7 days. As of March 31, 2024, $16 million of commercial paper was outstanding with an average interest rate of 5.45 percent and a weighted average maturity of 4 days. As of December 31, 2023, $327 million of commercial paper was outstanding with an average interest rate of 5.50 percent and a weighted average maturity of 11 days. The amount of commercial paper outstanding under this program for the remainder of 2024 is expected to fluctuate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our short-term borrowings as of March 31, 2024 and December 31, 2023 primarily include amounts outstanding under various unsecured local country operating lines of credit.</span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below are our debt carrying amounts, net of related discounts, premiums and debt issuance costs, as of March 31, 2024 and December 31, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.900% senior notes due June 1, 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">596 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">596 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.200% senior notes due October 1, 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.900% senior notes due June 1, 2050</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.625% senior notes due April 15, 2037</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving credit agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,740 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,740 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other short-term borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total short-term borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">448 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,881 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,188 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.02900 0.02900 596000000 596000000 0.03200 0.03200 499000000 499000000 0.03900 0.03900 391000000 391000000 0.06625 0.06625 253000000 253000000 0 0 1000000 1000000 1740000000 1740000000 16000000 327000000 125000000 121000000 141000000 448000000 1881000000 2188000000 1000000000 118000000 0.0551 P8D 460000000 0.0479 P7D 16000000 0.0545 P4D 327000000 0.055 P11D 8. Pension and Other Postretirement Benefits<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic cost consist of the following for the periods presented:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">U.S. Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.84pt">The service cost component of net periodic cost is presented within either Cost of sales or Operating expenses in the Condensed Consolidated Statements of Income. The remainder of the net periodic cost primarily net.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will make cash contributions of $1 million and $4 million to our U.S. and non-U.S. pension plans in 2024. For the first quarter of 2024, we made an insignificant cash contribution to the U.S. plans and $1 million to the non-U.S. plans.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024 and 2023, the net periodic benefit cost for the postretirement plans consisted of $1 million of interest costs and no service costs.</span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic cost consist of the following for the periods presented:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">U.S. Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.84pt">The service cost component of net periodic cost is presented within either Cost of sales or Operating expenses in the Condensed Consolidated Statements of Income. The remainder of the net periodic cost primarily net.</span></div> 1000000 0 1000000 1000000 3000000 4000000 2000000 2000000 4000000 4000000 2000000 2000000 0 0 1000000 1000000 1000000 4000000 1000000 1000000 1000000 0 0 9. Equity<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On September 26, 2022, the Board of Directors approved a stock repurchase program authorizing us to purchase up to 6.0 million shares of our outstanding common stock until December 31, 2025. We may repurchase shares from time to time in the open market, in privately negotiated transactions, or otherwise, at prices we deem appropriate. We are not obligated to repurchase any shares under the authorization, and the repurchase program may be suspended, discontinued, or modified at any time, for any reason and without notice. The parameters of our stock repurchase program are not established solely with reference to the dilutive impact of shares issued under our stock incentive plan. However, we expect that, over time, share repurchases will offset the dilutive impact of shares issued under the stock incentive plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the first quarter of 2024, we repurchased approximately 5 thousand shares of common stock in open market transactions at a net cost of $1 million. During the first quarter of 2023, we did not repurchase any shares of common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-based Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Share-based compensation expense for the periods presented is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option expense, net of income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock units (“RSUs”):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU expenses, net of income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance shares and other share-based awards:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance shares and other share-based compensation expense, net of income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense, net of income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under our stock incentive plan, stock options are granted at exercise prices that equal the market value of the underlying common stock on the date of grant. The options have a 10-year term and are exercisable upon vesting, which occurs over a three-year period at the anniversary dates of the date of grant. We generally recognize compensation </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expense on a straight-line basis for all awards over the employee’s vesting period. We estimate a forfeiture rate at the time of grant and update the estimate throughout the vesting period of the stock options within the amount of compensation costs recognized in each period.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We granted non-qualified options to purchase 178 thousand shares and 197 thousand shares for the first quarter of 2024 and 2023. We estimated the fair value of each option grant by using the Black-Scholes option-pricing model with the following assumptions:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.295%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected life of options represents the weighted average period that we expect options granted to be outstanding giving consideration to vesting schedules and our historical exercise patterns. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the grant date for the period corresponding to the expected life of the options. Expected volatility is based on historical volatilities of our common stock, and dividend yields are based on our dividend yield at the date of issuance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the first quarter of 2024 is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Options<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Exercise Price per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,953</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96.61 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">178</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108.38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(165)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103.69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,945</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.03 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.44</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable as of March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,573</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98.53 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the first quarter of 2024, cash received from the exercise of stock options was approximately $13 million. As of March 31, 2024, the unrecognized compensation cost related to non-vested stock options totaled $6 million, which we expect to amortize over the weighted-average period of approximately 1.5 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information pertaining to stock option activity is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average grant date fair value of stock options granted (per share)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.33 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intrinsic value of stock options exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RSUs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have granted RSUs to certain key employees. The RSUs are primarily subject to cliff vesting, generally after three years, provided the employee remains in our service. The fair value of the RSUs is determined based upon the number of shares granted and the quoted market price of our common stock at the grant date.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes RSU activity in 2024:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Restricted<br/>Shares <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">552</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.05 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(161)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.77 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested as of March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">564</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98.84 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, the total remaining unrecognized compensation cost related to RSUs was $32 million, which will be amortized on a weighted-average basis over approximately 2.0 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Shares:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have a long-term incentive plan for senior management in the form of performance shares. The vesting of the performance shares is generally based on two performance metrics. Fifty percent of the performance shares awarded vest based on our total shareholder return as compared to the total shareholder return of our peer group, and the remaining fifty percent vest based on the calculation of our three-year average Adjusted Return on Invested Capital (“Adjusted ROIC”) against an established ROIC target.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the 2024 performance shares awarded based on our total shareholder return, the number of shares that ultimately vest can range from zero to 200 percent of the grant depending on our total shareholder return as compared to the total shareholder return of our peer group. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the People, Culture, and Compensation Committee (“Compensation Committee”) of the Board of Directors. Compensation expense is based on the fair value of the performance shares at the grant date, established using a Monte Carlo simulation model. We amortize the total compensation expense for these awards over a three-year graded vesting schedule.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the 2024 performance shares awarded based on Adjusted ROIC, the number of shares that ultimately vest can range from zero to 200 percent of the grant depending on our Adjusted ROIC performance against the target. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the Compensation Committee. We base compensation expense on the market price of our common stock on the grant date and the final number of shares that ultimately vest. We estimate the potential share vesting at least annually to adjust the compensation expense for these awards over the vesting period to reflect our estimated Adjusted ROIC performance against the target. We amortize the total compensation expense for these awards over a three-year graded vesting schedule.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the first quarter of 2024, we awarded 86 thousand performance shares at a weighted average fair value of $127.97 per share. As of March 31, 2024, the unrecognized compensation cost related to these awards was $20 million, which we will amortize over the remaining service period of 2.4 years. The 2021 performance share awards that vested in February 2024 achieved a 200 percent payout of the granted performance shares. As of March 31, 2024, we estimated the 2022 performance share awards will pay out at 200 percent. For the first quarter of 2024, one thousand performance shares were cancelled. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of accumulated other comprehensive (loss) for the first quarter of 2024 and 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Hedging Activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Pension and Postretirement Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AOCL</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(961)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(47)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive (loss) before reclassification adjustments </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss reclassified from AOCL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(961)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(55)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,062)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Hedging Activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Pension and Postretirement Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AOCL</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,008)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,048)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive gain (loss) before reclassification adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Gain) reclassified from AOCL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,002)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(50)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,098)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The following table provides the computation of basic and diluted earnings per common share (“EPS”) for the periods presented. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Income<br/>Available<br/>to Ingredion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Per<br/>Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Income<br/>Available<br/>to Ingredion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Per<br/>Share<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">216 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.89 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of Dilutive Securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">216 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Approximately 0.5 million and 0.7 million share-based awards of common stock were excluded for the first quarter of 2024 and 2023 from the calculation of the weighted average number of shares outstanding for diluted EPS because their effects were anti-dilutive. 6000000 5000 1000000 0 Share-based compensation expense for the periods presented is as follows:<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option expense, net of income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock units (“RSUs”):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU expenses, net of income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance shares and other share-based awards:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance shares and other share-based compensation expense, net of income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense, net of income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2000000 1000000 0 0 2000000 1000000 7000000 4000000 1000000 1000000 6000000 3000000 4000000 4000000 0 0 4000000 4000000 13000000 9000000 1000000 1000000 12000000 8000000 P10Y P3Y 178000 197000 We estimated the fair value of each option grant by using the Black-Scholes option-pricing model with the following assumptions:<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.295%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9%</span></td></tr></table></div> P5Y6M P5Y6M 0.042 0.040 0.281 0.283 0.029 0.029 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the first quarter of 2024 is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Options<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Exercise Price per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,953</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96.61 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">178</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108.38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(165)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103.69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,945</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.03 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.44</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable as of March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,573</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98.53 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1953000 96.61 P4Y11M19D 29000000 178000 108.38 165000 79.87 21000 103.69 1945000 99.03 P5Y5M8D 38000000 1573000 98.53 P4Y6M21D 32000000 13000000 6000000 P1Y6M <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information pertaining to stock option activity is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average grant date fair value of stock options granted (per share)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.33 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intrinsic value of stock options exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 26.33 23.80 5000000 6000000 P3Y <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes RSU activity in 2024:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Restricted<br/>Shares <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">552</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.05 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(161)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.77 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested as of March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">564</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98.84 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 552000 92.05 191000 107.65 161000 87.15 18000 92.77 564000 98.84 32000000 P2Y 2 0.50 0.50 P3Y 0 2 P3Y P3Y 0 2 P3Y P3Y 86000 127.97 20000000 P2Y4M24D 2 2 1000000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of accumulated other comprehensive (loss) for the first quarter of 2024 and 2023:</span><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Hedging Activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Pension and Postretirement Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AOCL</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(961)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(47)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive (loss) before reclassification adjustments </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss reclassified from AOCL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(961)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(55)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,062)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Hedging Activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Pension and Postretirement Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AOCL</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,008)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,048)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive gain (loss) before reclassification adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Gain) reclassified from AOCL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,002)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(50)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,098)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -961000000 -48000000 -47000000 -1056000000 0 -41000000 0 -41000000 0 -33000000 -1000000 -34000000 0 -1000000 0 -1000000 0 -7000000 1000000 -6000000 -961000000 -55000000 -46000000 -1062000000 -1008000000 6000000 -46000000 -1048000000 6000000 -58000000 0 -52000000 0 18000000 0 18000000 0 -20000000 0 -20000000 6000000 -56000000 0 -50000000 -1002000000 -50000000 -46000000 -1098000000 The following table provides the computation of basic and diluted earnings per common share (“EPS”) for the periods presented. <div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Income<br/>Available<br/>to Ingredion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Per<br/>Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Income<br/>Available<br/>to Ingredion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Per<br/>Share<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">216 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.89 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of Dilutive Securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">216 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 216000000 65700000 3.29 191000000 66100000 2.89 1100000 1000000.0 216000000 66800000 3.23 191000000 67100000 2.85 500000 700000 10. Segment Information<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2024, we changed our reportable segments to align them with changes in how our Chief Executive Officer, as the Chief Operating Decision Maker (“CODM”), manages the business, evaluates performance, and allocates resources. Our revised reportable segments consist of (1) Texture &amp; Healthful Solutions (“T&amp;HS”), (2) F&amp;II - LATAM, and (3) F&amp;II - U.S./Canada. In All Other, we include the business in Pakistan, PureCircle, Sugar Reduction, Protein Fortification, and South Korea until its sale on February 1, 2024.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are principally engaged in the production and sale of starches and sweeteners for a wide range of industries. Our T&amp;HS segment has a global focus and primarily manufactures texturizing food ingredients. Our F&amp;II - LATAM segment has a local focus and primarily manufactures food, ingredient, and industrial products, which we process from raw materials that we primarily source within South America and Mexico. Our F&amp;II - U.S./Canada segment has a local focus and primarily manufactures food, ingredient, and industrial products, which we process from raw materials sourced within the U.S. and Canada. All Other consists of the businesses of multiple operating segments that are not individually or collectively classified as reportable segments. Revenues from All Other are generated primarily by sweetener and starches sales by our Pakistan business, sales of stevia and other ingredients from our PureCircle and Sugar Reduction businesses, and pea protein ingredients from our Protein Fortification business. Net sales by product are not presented because such presentation is not practicable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below are our net sales to affiliated and unaffiliated customers by reportable segment and All Other for the periods presented:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"></td><td style="width:41.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.723%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">T&amp;HS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">F&amp;II - LATAM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">F&amp;II - U.S./Canada</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated<br/> Totals</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales including intersegment sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">612 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,936 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Less:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Intersegment sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">597 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">616 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">541 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,882 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales including intersegment sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">698 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">677 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">635 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Less:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Intersegment sales</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">665 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">667 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">608 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">197 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,137 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below is our operating income by reportable segment and All Other for the periods presented:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Texture &amp; Healthful Solutions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Food &amp; Industrial Ingredients - LATAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Food &amp; Industrial Ingredients - U.S./Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">216 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resegmentation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other matters</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">213 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">291 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CODM evaluates performance, makes strategic decisions, and allocates resources based on Property, plant and equipment, net for internal and external reporting purposes. Presented below is Property, plant and equipment, net by reportable segment and All Other as of March 31, 2024 and December 31, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Texture &amp; Healthful Solutions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">838 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">855 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Food &amp; Industrial Ingredients - LATAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">543 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Food &amp; Industrial Ingredients - U.S./Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">548 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Other (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">411 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,334 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,370 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.68pt">For purposes of presentation, All Other includes Corporate assets.</span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below are our net sales to affiliated and unaffiliated customers by reportable segment and All Other for the periods presented:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"></td><td style="width:41.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.723%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">T&amp;HS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">F&amp;II - LATAM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">F&amp;II - U.S./Canada</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated<br/> Totals</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales including intersegment sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">612 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,936 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Less:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Intersegment sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">597 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">616 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">541 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,882 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales including intersegment sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">698 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">677 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">635 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Less:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Intersegment sales</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">665 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">667 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">608 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">197 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,137 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below is our operating income by reportable segment and All Other for the periods presented:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Texture &amp; Healthful Solutions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Food &amp; Industrial Ingredients - LATAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Food &amp; Industrial Ingredients - U.S./Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">216 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resegmentation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other matters</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">213 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">291 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CODM evaluates performance, makes strategic decisions, and allocates resources based on Property, plant and equipment, net for internal and external reporting purposes. Presented below is Property, plant and equipment, net by reportable segment and All Other as of March 31, 2024 and December 31, 2023:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Texture &amp; Healthful Solutions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">838 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">855 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Food &amp; Industrial Ingredients - LATAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">543 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Food &amp; Industrial Ingredients - U.S./Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">548 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Other (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">411 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,334 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,370 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.68pt">For purposes of presentation, All Other includes Corporate assets.</span></div> 612000000 626000000 567000000 131000000 1936000000 -15000000 -10000000 -26000000 -3000000 -54000000 597000000 616000000 541000000 128000000 1882000000 698000000 677000000 635000000 201000000 2211000000 -33000000 -10000000 -27000000 -4000000 -74000000 665000000 667000000 608000000 197000000 2137000000 74000000 127000000 101000000 122000000 87000000 92000000 -4000000 -8000000 -42000000 -37000000 216000000 296000000 3000000 0 0 -5000000 213000000 291000000 838000000 855000000 543000000 552000000 542000000 548000000 411000000 415000000 2334000000 2370000000 11. Commitments and Contingencies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed an action in Brazil to recover previously taxable local government tax incentives. As we believe recovery is probable, we recorded a $27 million income tax benefit in 2022. As of both March 31, 2024 and December 31, 2023, we had $32 million of remaining tax incentives recorded within Other non-current assets in the Condensed Consolidated Balance Sheets.</span></div> -27000000 32000000 32000000 12. Supplementary Information<div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable, Net</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net as of March 31, 2024 and December 31, 2023 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable — trade</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,128 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,145 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable — other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowance for credit losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,284 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,279 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no significant contract assets or contract liabilities associated with our customers as of either March 31, 2024 or December 31, 2023. Liabilities for volume discounts and incentives were also not significant as of either March 31, 2024 or December 31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories as of March 31, 2024 and December 31, 2023 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished and in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">852 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">926 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing supplies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,344 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,450 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supply Chain Finance Programs</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under supply chain finance programs administered by third-party banks, our suppliers have the opportunity to sell receivables due from us to participating financing institutions and receive earlier payment at a discount. Our responsibility is limited to making payment on the terms originally negotiated with our supplier, regardless of whether such supplier sells its receivables to a financial institution. The payment terms we negotiate with a supplier are independent of whether such supplier participates in a supply chain finance program, and participation in any such program by a supplier has no effect on our income or cash flows.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024 and December 31, 2023, participating financial institutions held $149 million and $153 million of our liabilities recorded in <span style="-sec-ix-hidden:f-796"><span style="-sec-ix-hidden:f-797">Accounts payable and Accrued liabilities and liabilities held for sale</span></span> on our Condensed </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets. As of March 31, 2024, supply chain finance programs existed for operations in Brazil, China, Thailand, Mexico</span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Colombia and Peru.</span></div><div style="margin-top:12pt"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rollforward of our outstanding obligations confirmed as valid under our supply chain finance programs for the quarter ending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2024</span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is as follows.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.272%"><tr><td style="width:1.0%"></td><td style="width:83.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.423%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>March 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at the beginning of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Invoices added during the year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Invoices paid during the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net as of March 31, 2024 and December 31, 2023 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable — trade</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,128 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,145 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable — other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowance for credit losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,284 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,279 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1128000000 1145000000 173000000 154000000 17000000 20000000 1284000000 1279000000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories as of March 31, 2024 and December 31, 2023 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished and in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">852 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">926 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing supplies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,344 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,450 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 852000000 926000000 402000000 434000000 90000000 90000000 1344000000 1450000000 149000000 153000000 <div style="margin-top:12pt"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rollforward of our outstanding obligations confirmed as valid under our supply chain finance programs for the quarter ending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2024</span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is as follows.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.272%"><tr><td style="width:1.0%"></td><td style="width:83.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.423%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of<br/>March 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at the beginning of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Invoices added during the year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Invoices paid during the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 153000000 141000000 141000000 -4000000 149000000 false false <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 16, 2024, Larry Fernandes, our Senior Vice President, Chief Commercial and Sustainability Officer, terminated an existing written plan that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The original plan was adopted on February 27, 2023 and provided for the sale of up to 9,738 shares of our common stock between May 29, 2023 and January 31, 2025. As of the date of termination, Mr. Fernandes had sold 5,000 shares of common stock pursuant to the terms of the plan.</span></div> February 16, 2024 Larry Fernandes Senior Vice President, Chief Commercial and Sustainability Officer true February 27, 2023 9738 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 29, 2024, Robert Ritchie, our Senior Vice President, Food &amp; Industrial Ingredients, LATAM and U.S./Canada, entered into an amended written plan for the sale of up to 4,044 shares of our common stock that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The plan commences on May 30, 2024 and will expire on February 1, 2026, or on any earlier date on which all of the shares have been sold.</span></div> February 29, 2024 Robert Ritchie Senior Vice President, Food & Industrial Ingredients, LATAM and U.S./Canada 4044 true

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